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Zusammenfassung          
Der synaptischen Serinprotease Neurotrypsin wird eine essentielle Rolle in kognitiven 
Prozessen des Gehirns zugeschrieben, da das Fehlen von funktionellem Neurotrypsin im 
Menschen zu schwerer geistiger Behinderung führt. Neurotrypsin schneidet das Proteoglykan 
Agrin an zwei homologen Stellen und setzt dabei ein intermediäres 90-kDa und ein C-
terminales 22-kDa Fragment von der N-terminalen Hälfte Agrin’s frei. Agrin spielt eine 
essentielle Rolle bei der Reifung der neuromuskulären Synapse und ist essentiell für deren 
Stabilität. Neuere Erkenntnisse weisen zudem darauf hin, das Agrin auch eine wichtige Rolle 
in der Formation, der Stabilität und der Funktion von Synapsen im Zentralen Nervensystem 
(ZNS) ausübt. Anhand der morphologischen Analyse von ZNS Gewebe konnte gezeigt 
werden, dass Neurotrypsin in der Präsynapse lokalisiert. Zudem löst synaptische Aktivität die 
synaptische Sekretion von Neurotrypsin aus. Agrin dagegen ist hauptsächlich im extra-
zellulären Raum direkt an oder in der Nähe der Synapse zu finden. 
Um die Interaktion von Neurotrypsin und Agrin im ZNS zu erforschen, habe ich eine 
detaillierte biochemische Analyse dieser Interaktion im Gehirn der Maus durchgeführt. Mit 
der Analyse von Maushirnhomogenaten konnte ich zeigen, dass ausschliesslich jene Agrin-
Isoformen von Neurotrypsin im ZNS geschnitten werden, die Glykosaminoglykan-Seiten-
ketten tragen. Weiterführende Studien mit isolierten Synaptosomen, die durch subzelluläre 
Fraktionierung aus wildtype- und Neurotrypsin überexprimierenden Tieren angereichert 
wurden, zeigten, dass diese Isoformen den Grossteil von synaptischem Agrin repräsentieren 
und dass Neurotrypsin hauptsächlich synaptisches Agrin schneidet. 
Die funktionelle Rolle dieser Interaktion habe ich in vitro mit zellbiologischen 
Analysen untersucht, hauptsächlich in hippocampalen Neuronenkulturen, um die System-
komplexität zu reduzieren. Neurotrypsin und Agrin werden in den Zellen dieser Kulturen ge-
bildet, jedoch war die Analyse einer Interaktion der endogen gebildeten Proteine aufgrund des 
Fehlens von geeigneten Antikörpern und auch wegen der Vielfalt an gebildeten Agrin-
Isoformen nicht möglich. Aus diesem Grunde habe ich einen alternativen Ansatz etabliert, um 
die Interaktion von Neurotrypsin und Agrin und ihre funktionellen Auswirkungen zu 
untersuchen. In unserem Labor waren bereits Adenoviren kreiert worden, die eine effiziente 
Expression von Neurotrypsin in neuronalen Kulturen ermöglichen. Zur Vervollständigung des 
Virusrepertoires für finale Analysen habe ich eine Reihe an weiteren Viren kreiert, die 
verschiedene Agrin-Varianten exprimieren. Ich konnte zeigen, dass diese Viren eine effiziente 
und vor allem funktionelle Expression von Agrin in kultivierten Nervenzellen ermöglichen. 
Desweiteren besteht eine funktionelle Interaktion zwischen Virus-abhängig exprimierten 
Agrin und Neurotrypsin-Varianten in kultivierten Nervenzellen. Zudem konnte ich bereits 
publizierte Effekte von Agrin bestätigen, nämlich dass die Überexpression von Agrin zur ver-
mehrten Ausbildung von Filopodien auf sowohl Axonen als auch Dendriten von kultivierten 
Nervenzellen führt. Ich habe deshalb analysiert, ob Neurotrypsin diese Funktion von Agrin 
beeinflusst. Die Ausbildung von Filopodien wird in Nervenzellen als auch in cos7 Zellen 
ausschliesslich von transmembranem Agrin beeinflusst. Mit der Analyse von transient 
transfizierten cos7 Zellen habe ich ermittelt, dass Neurotrypsin diese Funktion von Agrin 
inhibiert. Dies geschieht jedoch unabhängig von der katalytischen Aktivität Neurotrypsin’s.  
Agrin spielt eine zentrale Rolle bei der Formation, der Erhaltung und der Funktion von 
ZNS Synapsen. Die lokale synaptische Spaltung durch Neurotrypsin könnte darauf hindeuten, 
dass das Agrin/Neurotrypsin System eine wichtige Funktion in der Regulierung adaptiver 
Reorganisationen der synaptischen Kreisläufe ausführt. Die Identifikation der funktionellen 
Auswirkungen dieser Interaktion könnte dazu beitragen, die Rolle von Neurotrypsin im 
Kontext kognitiver Gehirnfunktionen zu verstehen.           
Summary            
The synaptic serine protease neurotrypsin is considered to be essential for the 
establishment and maintenance of cognitive brain functions because humans lacking 
functional neurotrypsin suffer from severe mental retardation. Neurotrypsin cleaves the 
proteoglycan agrin at two homologous sites, releasing an intermediate 90-kDa and a C-
terminal 22-kDa fragment from the N-terminal moiety of agrin. Agrin is essential for 
neuromuscular junction maturation and maintenance and it has also recently been shown to 
play an important role in the formation, maintenance and function of CNS synapses. 
Morphological analyses of CNS tissue indicate that neurotrypsin is contained in presynaptic 
terminals and is externalised in association with synaptic activity, while agrin is localised to 
the extracellular space at or in the vicinity of the synapse. 
To elucidate the parameters of a potential neurotrypsin-dependent cleavage of agrin in 
the CNS in vivo, I performed a detailed biochemical analysis of the interaction of neurotrypsin 
and agrin in the murine brain. In brain homogenates I found that neurotrypsin exclusively 
cleaves glycanated variants of agrin. Studies with isolated synaptosomes obtained by 
subcellular fractionation from brains of wildtype and neurotrypsin-overexpressing mice 
revealed that neurotrypsin-dependent cleavage of agrin was concentrated at synapses, where 
the most heavily glycanated variants of agrin predominate.  
To determine the functional implications of this interaction, I performed cell biological 
in vitro analyses, mainly with dissociated hippocampal neuron cultures, employed to reduce 
system complexity. Both neurotrypsin and agrin are endogenously expressed in neuronal 
cultures but because of the lack of suitable antibodies and the presence of a variety of agrin 
isoforms, I established an alternative approach to analyse the interaction of both proteins in 
neuronal cultures. Neurotrypsin-expressing recombinant adenoviruses were produced in our 
lab to achieve efficient ectopic expression of neurotrypsin in cultured neurons. To complete 
the set of viruses for agrin and neurotrypsin co-expression analyses, I created several 
recombinant adenoviruses expressing different agrin variants. I established the functional and 
efficient virus-mediated expression of agrin variants in cultured neurons and also showed the 
functional interaction of ectopically expressed neurotrypsin and agrin variants in this neuronal 
culture system. In addition, I confirmed the recently published observation that the 
overexpression of transmembrane agrin variants causes the additional appearance of 
filopodia-like protrusions on dendrites as well as axons of cultured neurons. I therefore 
analysed if neurotrypsin interferes with this function of agrin. In both neurons and cos7 cells, 
the induction of filopodia-like protrusions is mediated exclusively by the transmembrane 
variant of agrin. The co-expression of agrin and neurotrypsin in transiently transfected cos7 
cells led to the inhibition of agrin’s function, however, independent of the catalytic activity of 
neurotrypsin.   
Because agrin has been shown to play an important role in the formation, maintenance 
and function of CNS synapses, its local cleavage at the synapse implicates the neuro-
trypsin/agrin system in the regulation of adaptive reorganisations of the synaptic circuitry. 
Determining the functional implications of this local interaction may be key to understanding 
neurotrypsin’s role in the context of cognitive functions, such as learning and memory. 
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The abbreviations used are:  
 
AChR,   acetylcholine receptor 
ADP,    adenovirus death protein 
AMPA,   α-amino-3-hydroxy-5-methly-4-isoxazole propionic acid 
AMPAR,   AMPA-type glutamate receptor 
AV,    adenovirus 
bp,    base pairs 
BRF,   branched retraction fibres  
CA2+,    calcium-ion 
CA1-3,   Cornus Ammonis 1-3 
CAM,    cell adhesion molecule 
CaMKII,   α-calcium-calmodulin-dependent protein kinase II 
cAMP,   cyclic adenosine monophosphate 
cDNA,   complementary DNA 
CSF,   cerebrospinal fluid 
CNS,    central nervous system 
DIV,    day in vitro 
DMEM,   Dulbecco’s Modified Eagle Medium  
DNA,    deoxyribonucleic acid 
eCFP,    enhanced cyan fluorescent protein 
ECM,    extracellular matrix 
eGFP,    enhanced green fluorescent protein 
ERK1/2,   extracellular signal-regulated kinase 1/2 
Ex,    embryonic day x 
FCS,   fetal calf serum 
FGF-2,   fibroblast growth factor 2 
FMR1,   fragile X mental retardation 1 gene 
FMRP,   FMR1 protein 
GABA,   γ-aminobutyric acid 
GABAA,   ionotropic GABA receptor 
GABAB,   metabotropic GABA receptor 
HBSS,   Hank’s Balanced Salt Solution 
HEK293,   human embryonic kidney cells, line 293 
IQ,    intelligence quotient 
K+,    potassium-ion 
kb,    kilo-base pairs 
kDa,    kilodalton 
L1CAM,   cell-adhesion molecule L1 
Lamp-1,   lysosomal-associated membrane protein 1 
LB,    lysogeny broth (Luria-Bertani broth) 
LDLR,   low-density lipoprotein receptor 
LG,   laminin-globular domain 
LG-3,    laminin-globular domain 3 of agrin 
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LN-agrin,   secreted agrin-x12, y4, z8 
LRP-1,   low-density lipoprotein receptor-related protein 1 
LTD,    long-term depression 
LTP,    long-term potentiation 
MAP,    mitogen-activated protein kinase 
MAP-2,   microtubule-associated protein 2 
MARCKS,   myristoylated alanine-rich C-kinase substrate protein 
mNT,    mouse neurotrypsin 
MOI,    multiplicity of infection 
Mr,    molecular mass 
MR,    mental retardation 
mRFP,   monomeric red fluorescent protein 
mRNA,   messenger RNA 
MuSK,   ‘muscle-specific’ kinase 
Na+,    sodium-ion 
NMDA,   N-methyl-D-aspartate 
NMDAR,   NMDA-type glutamate receptor 
NMJ,    neuromuscular junction 
NSMR,   nonsyndromic MR 
NtA,    N-terminal domain of secreted agrin 
NT-inact,   inactive mouse neurotrypsin 
Ntd,    neurotrypsin-deficient mice 
Nto-act,   mice overexpressing active human neurotrypsin 
Nto-inact,   mice overexpressing inactive mouse neurotrypsin 
pAd,    final recombinant E1, E3-deficient adenovirus vector 
PAI-1,   plasminogen activator inhibitor-1 
PB,    phosphate buffer 
PBS,    phosphate-buffered saline 
PKA,    protein kinase A 
Px,    postnatal day x 
PCR,    polymerase chain reaction 
RNA,    ribonucleic acid 
RT-PCR,   reverse transcriptase PCR 
SDS-PAGE,   sodium dodecyl sulfate polyacrylamide gel electrophoresis 
S.E.M.,   standard error of the mean 
SN-agrin,   transmembrane agrin-x12, y4, z8 
SN-agrin-mutant,  not cleavable variant of transmembrane agrin-x12, y4, z8 carrying 
point-mutations in the P1 positions (mutated to alanine, respectively) of 
the neurotrypsin cleavage sites 
SRCR,   scavenger receptor cysteine-rich 
STP,    short-term potentiation 
TBS,    Tris-buffered saline 
TBST,   TBS with Tween-20 
tPA,   tissue-type plasminogen activator 
uPA,    urokinase-type plasminogen activator 
wt,    wild-type 
XLMR,   X-chromosome-linked MR 
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1. Introduction 
 
1.1 The brain and behaviour 
The ability to perceive, to orientate within and to create our environment depends on a 
complex and refined machinery of sensory receptors connected to a highly flexible neuronal 
system, known as the central nervous system (CNS), that is able to discriminate and process 
the enormous range of information presented. The brain, a part of the CNS, is able to organise 
the continuous stream of sensory information and to integrate this information for appropriate 
behavioural responses. Furthermore, its ability to store information and to recall these 
memories enables the further refinement of future actions. The brain is composed of a variety 
of cell-types and the nerve cell or neuron constitutes the major information processing unit. 
The human brain consists of around 1011 neurons that can be classified into a multitude of 
different types (Kandel, 2000). However, all neurons share the same basic architecture (Fig. 
1). The complexity of neuronal functions depend less on the specialisation of these neurons 
and more on their ability to form a specific and refined network of anatomic circuits. Hence, 
neurons with basically similar properties can produce a variety of potentially different actions 
depending on the way they are connected with each other or with sensory receptors or with 
the final output units, the muscles. The communication interface between neurons or between 
neurons and their alternative target cells is called the synapse, a highly specialised cell-cell 
contact site (section 1.1.3). Each CNS neuron forms, on average, tens of thousands of 
synapses, establishing the complex communication pattern found within the CNS.  
Thus, the 1011 neurons in the human brain, forming 1015 synapses, generate a complex 
and organised but plastic network of anatomically defined circuits that have the capacity to 
translate experiences into a vast number of memories and actions (Chklovskii et al., 2004).                             
  
1.1.1 Neural plasticity 
The nervous system has the ability to adapt to environmental stimuli and to alter and 
improve its performance over time, regulated by experience. This general capacity to 
functionally adapt, by undergoing molecular and structural changes, is termed neural 
plasticity. The fact that neural changes induced by experience can persist for a very long time, 
virtually for the whole life of the individual, suggests that neural plasticity represents the basis 
of the higher brain functions such as learning and memory (Benfenati, 2007).  
A highly diverse array of neuron intrinsic mechanisms, influenced and controlled by 
its complex environment, are responsible for the positioning and maturation of neurons and 
their functional integration during development (Lagercrantz and Ringstedt, 2001; Dickson, 
2002; Du and Dreyfus, 2002; Garner et al., 2002; Shen, 2004; Liu et al., 2006; McAllister, 
2007). Neurons are highly polarised cells and are composed of distinct functional 
compartments, accounting for their specialised roles in communication and information 
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processing (Fig. 1). These distinct functional compartments enable the receipt of information 
(dendrites and cell body), the integration of all received information in time and space (initial  
 
 
 
Figure 1. Structure of neurons. A, Schematic drawing of connected neurons. Most neurons in the vertebrate 
nervous system have several main features in common. The cell body contains the nucleus and gives rise to two 
types of cell processes, axons and dendrites. Axons, the transmitting elements of neurons, can vary greatly in 
length; some can extend more than 3 m within the body. Most axons in the CNS are very thin (between 0.2 and 
20 μm in diameter) compared with the diameter of the cell body (50 μm or more). Many axons are insulated by a 
fatty sheath of myelin that is interrupted at regular intervals by the nodes of Ranvier. The action potential, the 
cell’s conducting signal, is initiated either at the axon hillock, the initial segment of the axon, or in some cases 
slightly farther down the axon at the first node of Ranvier. Branches of the axon of one neuron (the presynaptic 
neuron) transmit signals to another neuron (the postsynaptic cell) at a site called synapse. The branches of a 
single axon may form synapses with as many as 1000 other neurons. Whereas the axon is the output element of 
the neuron, the dendrites (apical and basal) are input elements of the neuron. Together with the cell body, they 
receive synaptic contacts from other neurons. Figure and text taken and modified from (Kandel, 2000). B, 
Examples of cultured dissociated hippocampal neurons grown for 14 days in vitro to visualise the complexity of 
synaptic connections between neurons. Immunofluorescence analyses, widefield microscopy. Dendritic 
processes of cultured neurons were visualised with antibodies against the dendritic marker microtubule-
associated protein 2 (MAP-2; green). Individual synapses along the dendrites, formed with axons of contacting 
neurons (not seen), were visualised using an antibody against the synaptic marker synaptophysin (red).  
 
segment of the axon), the rapid transfer of nerve impulses (axon) and the transmission of 
signals (synapses) to the respective target cells (Kandel, 2000). The establishment of 
functional neuronal circuits during development requires the refinement or remodelling of 
neuronal connections by various forms of neuronal activity (Lagercrantz and Ringstedt, 2001; 
Juttner and Rathjen, 2005). However, the complex and functional neuronal network 
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established in the adult CNS does not remain static but continuously undergoes changes to 
meet the demands of learning and memory processes (Duffau, 2006). These changes include 
the remodelling of specific functional circuits (De Paola et al., 2006) as well as the generation 
and integration of new neurons into the neuronal circuitry (Ming and Song, 2005; Kitabatake 
et al., 2007; Toni et al., 2007). These changes occur as modifications of neuronal circuits, 
most likely at the level of synaptic connections, including both changes in the efficacy of 
existing synapses and the addition or subtraction of synapses (Chklovskii et al., 2004).  
  
1.1.2 Synapses and dendritic spines 
Synapses are a form of cell-cell contact sites specialised to transmit information 
between neurons or neurons and other targets, e.g., the muscle. The predominant type within 
the CNS is the chemical synapse, employing small molecules (neurotransmitters) to stimulate 
a response in the postsynaptic cell. In contrast, electrical synapses, which involve a direct 
electrical coupling between cells, are far less frequent (Garner et al., 2006). Chemical 
synapses are asymmetric structures, composed of elements originating from both cells. The 
presynaptic bouton and postsynaptic reception apparatus are separated by a small gap called 
the synaptic cleft. An electrical signal generated by the source neuron, propagated as an action 
potential, triggers the presynaptic release of neurotransmitters into the synaptic cleft to 
stimulate postsynaptic receptors that translate this chemical signal back into electric 
information within the target cell (Benfenati, 2007). Basically, depending on the type of 
neurotransmitter employed and on postsynaptic receptor function, transmitted signals elicit 
excitatory, inhibitory or modulatory functions on the postsynaptic cell. However, these basic 
functional properties are determined and modified by a variety of physiological parameters 
depending on complex mechanisms of regulation, in turn influenced and triggered by synaptic 
activity (section 1.1.3).  
Synapse formation is a multi-step process formed in most cases at contact sites 
between an axon and a dendrite or between an axon and the cell body. However, also axo-
axonic as well as dendro-dendritic synapses exist (Garner et al., 2002; Garner et al., 2006). 
Several steps of maturation involve the assembly of cell-adhesion molecules (CAM) at 
contact sites, CAM-dependent or other receptor-ligand-dependent signalling and the 
subsequent assembly of sophisticated macromolecular protein complexes at pre- and 
postsynaptic specialisations (Garner et al., 2006; McAllister, 2007). Many steps of synapse 
formation rely directly on processes initiated and executed by neurons. However, recent 
findings confirm the important roles of astrocytes in synapse formation, maturation and 
function by both secretion of soluble factors and contact mediated processes (Oliet et al., 
2004; Allen and Barres, 2005; Nadkarni and Jung, 2007; Witcher et al., 2007).  
Astrocytes are a branched and star-shaped type of CNS glial cell and extend their 
processes in an area of around 100 μm. Processes of a single astrocyte contact neuronal 
membranes as well as the vasculature. By forming endfeet around the endothelia and smooth 
muscle cells and, on the neuronal side, by contacting synapses in several regions of the brain, 
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astrocytes play a key function in metabolic support of neurons. The observation that astrocytic 
processes contact both presynaptic and postsynaptic elements has led to the formulation of the 
concept of the three-sided or tripartite synapse (Fig. 2). By tightly enclosing the synapse, 
astrocyte processes provide a physical barrier to inhibit the diffusion of molecules, i.e., the 
spillover of neurotransmitters and other neuroactive substances outside the synaptic cleft. The 
synaptic functions of astrocytes are diverse and include the uptake, and therefore, clearance of 
synaptic transmitters released from the presynapse and the recycling of glutamate. Astrocytes 
also respond to synaptic activity by the release of gliotransmitters that can further influence 
synaptic activity (Fig. 2B). One astrocyte interacts with around 100.000 synapses and up to 60 
percent of all synapses are enwrapped by astrocytic processes. It is speculated that synaptic 
strength and the degree of substances that leave the synaptic proximity determines if an 
astrocytic process ensheaths or retracts from synapses (Oliet et al., 2004; Bains and Oliet, 
2007; Halassa et al., 2007; Witcher et al., 2007).  
 
 
 
Figure 2. The astrocytic process is the third active element forming the tripartite synapse. A, Electron 
micrograph showing a presynaptic (Pre) and postsynaptic (Post) terminal enwrapped by the astrocytic process 
(green) forming the tripartite synapse. B, The close association of the astrocytic process with the presynaptic and 
postsynaptic terminals exerts crucial roles in clearing K+ ions that accumulate following neuronal activity, and 
in the uptake of the synaptic transmitter glutamate by the activity of plasma-membrane glutamate transporters. 
Additionally, neurotransmitter release from presynaptic terminals can activate astrocytic metabotropic receptors, 
which induce the inositol (1,4,5)-trisphosphate (Ins(1,4,5)P3)-dependent release of Ca2+ from internal stores, 
which in turn triggers the release of several neuroactive compounds (gliotransmitters) from these cells. Locations 
of astrocytic transporters and receptors in this figure do not necessarily represent their exact spatial distribution. 
Figure and text taken and modified from (Halassa et al., 2007). 
 
The mature presynaptic terminal contains up to thousands of neurotransmitter-filled 
vesicles and a specialised molecular machinery mediating the docking and fusion of vesicles 
to release their contents at a specific region of the plasma membrane, called the active zone. 
Opposite the active zone, at the postsynaptic plasma membrane, a network of structural and 
scaffolding proteins is assembled, enabling the clustering of neurotransmitter receptors and 
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their associated signalling machinery. Both presynaptic and postsynaptic membranes are 
connected via a complex network of CAM and extracellular matrix (ECM) molecules that 
shape, stabilise and functionally modulate the synaptic structure (Yamaguchi, 2002; Dityatev 
and Schachner, 2003; Garner et al., 2006).  
In terms of synaptic diversity, the main types of chemical synapses, i.e., inhibitory and 
excitatory synapses, differ in their molecular composition and structural features (Triller and 
Choquet, 2003). γ-aminobutyric acid (GABA) is the main inhibitory neurotransmitter in the 
vertebrate CNS with a modulatory role in practically every aspect of brain function. 
Signalling of GABA occurs via ionotropic (GABAA) or metabotropic (GABAB) receptors 
expressed at the postsynaptic membrane of potentially every CNS neuron (Fritschy and 
Brunig, 2003). Most excitatory neurotransmission in the CNS is mediated by glutamate, 
which act on a variety of ionotropic or metabotropic receptors. Three subclasses of ionotropic 
glutamate receptors exist, named after their selective agonists. The ligand-gated ionotropic α-
amino-3-hydroxy-5-methly-4-isoxazole propionic acid-(AMPA)-type glutamate receptors 
(AMPAR) are the main mediators of excitatory neurotransmission but also kainate receptors 
contribute to postsynaptic responses. The voltage and ligand-gated N-methyl-D-aspartate 
(NMDA) receptors (NMDAR) are calcium (Ca2+) permeable ion channels that play important 
modulatory roles by regulating synaptic plasticity (section 1.1.3). Finally, the G-protein 
coupled metabotropic glutamate receptors, divided into several subclasses, act through diverse 
signalling pathways that function to modulate neurotransmission. Different types of glutamate 
receptors were shown to coincide at individual synapses and the additional variable 
expression and assembly of receptor subunits emphasises the complexity of glutamate-
dependent signalling (Frerking and Nicoll, 2000; Rubio, 2000; Lujan et al., 2005). 
The functional parameters vary between individual synapses, including a variability in 
neurotransmitter and receptor expression, the molecular composition of structural and 
signalling molecules, the synaptic structure and its size. This diversity becomes even 
morphologically apparent when the types of chemical synapses are compared. Inhibitory 
synapses appear as rather symmetrical structures with the postsynaptic sites mainly formed on 
dendritic shafts or the neuronal cell bodies (Keller, 2002). However, most of the CNS 
synapses are excitatory with distinct morphological properties. In strong contrast to inhibitory 
synapses, more than 90 percent of excitatory synapses form their postsynapse on a dendritic 
specialisation called the dendritic spine (Fig. 3A-C; (Nimchinsky et al., 2002)). Dendritic 
spines are thin protrusions from the dendritic shaft believed to create a micro-environment 
that restricts information flow between adjacent synapses on the same dendrite (Keller, 2002; 
Garner et al., 2006). The exact process of dendritic spine and therefore spine synapse 
formation is controversially discussed and three main hypotheses were formulated (Fig. 3D; 
(Ethell and Pasquale, 2005)). One model describes that dendritic spines originate from 
synapses that were originally formed on dendritic shafts, supported by the observation that the 
majority of synapses on young pyramidal neurons are mainly located on dendritic shafts (Fig. 
3D, model 1). In line with this model, axonal filopodia may be involved in synaptic contact 
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formation by finding an appropriate region for synapse formation on the dendritic shaft. 
Another model considers that the formation of dendritic spines is independent of axonal 
contact (Fig. 3D, model 2). This is based on findings on distal branches of Purkinje cells that 
form spines before the establishment of synaptic contacts. The third model states that 
dendritic filopodia are precursors of dendritic spines. In this line of thought, filopodia are 
believed to probe the dendritic environment to find an appropriate axonal contact site and to 
form initial synaptic contacts that further mature into spine synapses (Fig. 3D, model 3; Fig. 
4). This model is based on findings describing that dendrites extend a high number of 
filopodia during early stages of synapse formation and that, while synapse maturation 
proceeds, the number of filopodia decreases whereas the number of stable spine synapses 
increases. Owing to the potential of differential molecular compositions within different types 
of neurons or at specific neuronal sites, it is possible that dendritic spines emerge through 
different mechanisms. However, a multitude of recent findings, obtained with live imaging 
experiments in living animals, strongly support the hypothesis that dendritic filopodia are 
indeed precursors of dendritic spines (Ziv and Smith, 1996; Ethell and Pasquale, 2005; 
Holtmaat et al., 2005; Matus, 2005; Zuo et al., 2005a; Holtmaat et al., 2006; Knott et al., 
2006; Toni et al., 2007). 
 
Figure 3. Ultra-structural appear-
ance of dendritic spines. Character-
istic electron micro-scopic appear-
ance of several types of spines (S). 
A, A mushroom spine is shown. 
Note the constricted spine neck, the 
prominent irregular PSD, and the 
well-developed spine apparatus in 
this spine (arrow). Note also the 
density of the neuropil in this adult 
tissue. A stubby spine is illustrated 
in B. Purkinje cell spines are very 
abundant (C) and are often seen in 
close contact with astrocytic 
processes (asterisks). The spine 
necks and their emergence from the 
parent dendrite are not shown in 
this photomicrograph. Note the 
presence of cisternae of SER in 
virtually all Purkinje cell spines. Micrographs (A) and (B) are from rat hippocampus; (C) is from mouse 
cerebellum. Scale bars: 300 nm (A, B), 250 nm (C). Electron micrographs from the Atlas of Ultrastructural 
Neurocytology, J. Spacek (http://www.synapses.bu.edu/atlas/contents.htm), with permission from the author. 
Panels A-C and text taken and modified from (Nimchinsky et al., 2002). D, Three models of dendritic spine 
genesis. Figure and text taken and modified from (Ethell and Pasquale, 2005). 
 
Dendritic spines appear in variable shapes and are highly motile structures. 
Furthermore, morphology changes during synapse formation and at mature synapses are 
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correlated with changes in synapse efficacy and synaptic function (Hayashi and Majewska, 
2005; Matus, 2005; Segal, 2005; Tada and Sheng, 2006). The spine head size correlates with 
synaptic strength, presumably related to the number of AMPAR levels within the postsynaptic 
membrane (Fig. 4, 7). In addition, smaller weaker spines are more prone to undergo changes 
in spine and synaptic structure while larger spines appear to be more stable (Tada and Sheng, 
2006). It therefore becomes more and more apparent that dynamic rearrangements of dendritic 
spines are involved in changes of the synaptic circuitry. Several studies have confirmed that 
processes of learning and memory acquisition influence the generation of new spines, the 
disappearance of spines as well as the modulation of existing spines and synapses (Holtmaat 
et al., 2005; Zuo et al., 2005a; Zuo et al., 2005b; Holtmaat et al., 2006; Knott et al., 2006; 
Toni et al., 2007). Thus, the modulation of spine morphology leads to alterations in the 
synaptic transmission and contributes to neuronal plasticity, the precondition for processes 
such as learning and memory. 
 
 
Figure 4. Actin-based motility in 
the lifetime of a dendritic spine. A, 
Growing dendrites (dend) produce 
motile filopodia (filo) that extend 
and retract (gray outlines) until they 
contact an axon (ax) containing 
presynaptic transport vesicles (ptv). 
The dashed box indicates the area 
shown in B-D. B, C, Ptvs deliver 
molecular complexes of the 
structural proteins (blue) to the 
nascent presynaptic membrane, 
while molecules of the postsynaptic 
site (red) accumulate from a diffuse 
cytoplasmic pool. Herringbone 
lines indicate actin filaments, ‘v’ 
shapes indicate actin monomers. D, 
Spine maturation proceeds by the 
accumulation of synaptic vesicles
(sv) in the presynaptic bouton, then NMDA receptors (black boxes) followed by AMPA receptors (white boxes) 
in the postsynaptic membrane. E, A composite confocal image of the surface of a pyramidal cell dendrite in a 
hippocampal slice culture, taken from a transgenic mouse expressing a membrane-targeted GFP construct. Thin 
spines with small heads (t) and large spines with mushroom-shaped heads (m) are identified. A superimposed 
motility plot, derived from a time-lapse recording of the same dendrite, shows local levels of motility on a 
psuedocolor scale ranging from blue (lowest) through green and yellow to red (highest). Note the prominent 
motility associated with the tips of large spines (arrowheads). Scale bar: 2 mm. F, G, LTP-type stimulation 
produces increases in both actin polymerisation and size of the spine head. This is coupled with increased 
expression of AMPA receptors (white boxes). Large spines are motile and show rapid lamellipodial ruffling of 
the spine head indicated by alternative gray outlines (G, E). H, Prolonged stimulation of NMDA receptors 
produces long-lasting blockade of head motility accompanied by targeting of actin binding proteins (green) to 
the spine head. Figure and text taken and modified from (Matus, 2005). 
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1.1.3 Synaptic plasticity    
 Single neurons form thousands of synapses and their pattern of connection and 
function determines the parameters of neuronal circuits, essential for the basic and higher 
functions of the brain. Each synapse can act as its own computational unit and its individual 
function is believed to be mainly regulated by changes in neurotransmitter release and 
neurotransmitter receptor function. It is therefore considered that synapses, in particular 
excitatory synapses located on dendritic spines, are the major sites of neuronal plasticity in the 
CNS and that fundamental brain processes like learning and memory involve plastic changes 
in synapse structure and function (Frotscher et al., 2007; Shepherd and Huganir, 2007). The 
structural and functional reconfiguration of synapses is termed synaptic plasticity (Juttner and 
Rathjen, 2005).  
It is generally hypothesised that long-lasting activity-dependent changes in the 
efficacy of synaptic communication are of fundamental importance for the development of the 
neuronal circuitry and the storage of information in the mammalian brain. Model systems 
illustrating these changes in synaptic efficacy, thus synaptic plasticity, are long-term 
potentiation (LTP) and long-term depression (LTD) in the hippocampus, a brain region 
known to be involved in learning and memory processes (Bliss and Collingridge, 1993; Nicoll 
and Malenka, 1995; Akhondzadeh, 1999; Malenka and Nicoll, 1999).  
The Hippocampus is a bilateral structure in the mammalian brain and it can be 
structurally divided into the Ammons horn, the dentate gyrus and the subiculum. The 
Ammons horn can be further separated into three subfields, termed the Cornu Ammonis (CA) 
1-3. Viewed from the outer to the more medial layer, the Ammons horn includes alveus, strata 
oriens, oyramidal, radiatum, lacunosum and the molecular layer. The dendate gyrus is 
composed of closely packed cells that have dendritic brushes extending only towards the outer 
layer of the dentate gyrus. The subiculum is located at the distal borders of the CA1 region 
with the entorhinal cortex located ventrally and the retrosplenial cortex located dorsally to the 
hippocampal formation. Myelinated fibres, arising in part from the hippocampus, coat the 
surface of the hippocampus and mostly leave the region through a large efferent pathway, 
termed the fornix. Neuronal input reaches the hippocampus mainly in the dentate gyrus from 
the entorhinal cortex via a massive projection termed the perforant path. In turn, the dentate 
gyrus granule cells project via their Mossy fibres to the CA3 region. From the CA3 the 
Schaffer collaterals, parallel axons of CA3 pyramidal neurons, provide the major input to 
CA1. Other axons leave the cells of the CA3 via the fornix. Schaffer collaterals mainly form 
synapses with dendrites of CA1 pyramidal neurons in the stratum radiatum and stratum oriens 
layers (Fig. 5; (Akhondzadeh, 1999)). 
Most information concerning LTP were gathered from experiments performed with 
rodent hippocampal tissue but similar phenomena have also been reported to occur in the 
human CNS (Cooke and Bliss, 2006). Experimentally induced LTP is characterised by an 
abrupt and long-lasting increase in the efficacy of synaptic transmission, induced by brief 
trains of high-frequency stimulation of monosynaptic excitatory pathways. Although LTP was 
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initially described for synaptic connections in the hippocampus, it can be observed at 
excitatory synapses throughout the mammalian brain. In contrast to LTP, LTD is a process 
resulting in long-lasting attenuation of synaptic strength and is stimulated by lower 
frequencies of stimulation when compared to LTP (Berninger and Bi, 2002). LTP is provoked 
rapidly but it lasts up to days, if stimulated in vivo. The later phases of LTP require gene 
transcription and protein synthesis, in line with the requirements for long-lasting forms of 
memory. Yet, it is still controversial whether LTP is stimulated during learning and related to 
memory formation (Malenka and Nicoll, 1999). 
 
 
Figure 5. Basic anatomy of the hippocampus. The wiring diagram of the hippocampus is traditionally presented 
as a trisynaptic loop. The major input is carried by axons of the perforant path, which convey polymodal sensory 
information from neurons in layer II of the entorhinal cortex to the dentate gyrus. Perforant path axons make 
excitatory synaptic contact with the dendrites of granule cells: axons from the lateral and medial entorhinal 
cortices innervate the outer and middle third of the dendritic tree, respectively. Granule cells project, through 
their axons (the mossy fibres), to the proximal apical dendrites of CA3 pyramidal cells which, in turn, project to 
ipsilateral CA1 pyramidal cells through Schaffer collaterals and to contralateral CA3 and CA1 pyramidal cells 
through commissural connections. In addition to the sequential trisynaptic circuit, there is also a dense 
associative network interconnecting CA3 cells on the same side. CA3 pyramidal cells are also innervated by a 
direct input from layer II cells of the entorhinal cortex (not shown). The distal apical dendrites of CA1 pyramidal 
neurons receive a direct input from layer III cells of the entorhinal cortex. There is also substantial modulatory 
input to hippocampal neurons. The three major subfields have an elegant laminar organisation in which the cell 
bodies are tightly packed in an interlocking C-shaped arrangement, with afferent fibres terminating on selective 
regions of the dendritic tree. The hippocampus is also home to a rich diversity of inhibitory neurons that are not 
shown in the figure. Figure and text taken and modified from (Neves et al., 2008). 
 
NMDA receptor-dependent (e.g., in the CA1 region) as well as independent (e.g., at 
mossy fibres synapses in CA3) forms of LTP have been described and both forms are 
characterised by a rise of intracellular Ca2+ levels. LTP generation or its modulation is further 
influenced by metabotropic G-protein-coupled receptors (an excerpt of components of the 
molecular machinery involved in LTP is shown in Fig. 6). Modulations of the size or 
dynamics of postsynaptic Ca2+ increases have a massive effect on synaptic plasticity because 
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Ca2+ levels that do not reach the threshold for LTP may elicit LTD or short-term potentiation 
(STP). STP is characterised by a brief synaptic enhancement that decays after 5 to 20 minutes 
(Malenka and Nicoll, 1999). The biochemical pathways that translate the Ca2+ signal into 
synaptic strength are hardly understood and seem to involve a large variety of different 
proteins. One of the best characterised key-components of the molecular machinery of LTP is 
the α-calcium-calmodulin-dependent protein kinase II (CaMKII). In addition, a whole variety 
of additional kinases and downstream signalling cascades as well as retrograde messengers 
affecting presynaptic functions are involved in LTP-dependent processes, indicating its 
molecular complexity (Fig. 6). The LTP-dependent increase in synaptic strength is directly 
connected to the increase in AMPA receptor responsiveness, its upregulation and its insertion 
at postsynaptic sites (Malenka and Nicoll, 1999; Shepherd and Huganir, 2007). Therefore, the 
long-lasting modification of synaptic structure and function is an accepted mechanism by 
which experiences contribute to learning and are translated into memories (Malenka and 
Nicoll, 1999). 
 
 
 
Figure 6. Intracellular signalling mechanisms mediating NMDA receptor-dependent long-term potentiation 
(LTP). A, The initial induction signal is a Ca2+ transient which permeates NMDAR. This signal is then amplified 
by the release of Ca2+ from Ca2+/inositol triphosphate (InsP3)-sensitive intracellular stores. A parallel pathway 
which may be important for the induction of LTP is provided by metabotropic glutamate receptors (mGluRs). 
These receptors can couple, through G-proteins, to the phosphoinositide-specific phospholipase C (PLC), 
phospholipase A2 (PLA2) and adenylate cyclase (AC), to produce diacylglycerol (DAG), arachidonic acid (AA), 
and to regulate the levels of cAMP, respectively, Note that the initial NMDAR-mediated Ca2+ transient may be 
necessary for the activation of these mGluR cascades by L-glutamate. The amplified Ca2+ signal, in association 
with the other activators of protein kinases (zig-zag arrows), then leads to the phosphorylation of substrate 
proteins including, probably, AMPAR and NMDAR. Other enzymes, such as nitric oxide synthase (NOS), if 
present, may also be activated by the Ca2+ transient. Biochemical changes in the presynaptic terminal may be 
initiated by the action of retrograde messengers, such as arachidonic acid (AA), nitric oxide (NO) and K+, 
perhaps in conjunction with the action of L-glutamate on presynaptic mGluRs. B, Kinase-mediated signalling to 
the cell nucleus occurs via a number of intermediary steps, resulting in changes in transcription and eventual 
expression of proteins involved in long-lasting changes that mediate persistent LTP. Figures and text taken and 
modified from (Bliss and Collingridge, 1993; Cooke and Bliss, 2006). 
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The increase or decrease of synaptic strength is correlated with alterations in dendritc 
spine shape and size (Fig. 7). It has been shown that rapid tetanic stimulation, hence the 
induction of LTP, in hippocampal slices or cultures resulted in the rapid expansion of spine 
heads as well as the generation of new spines. In contrast, induction of LTD led to shrinkage 
of spines as well as a reduction in spine number (Segal, 2005; Tada and Sheng, 2006). The 
generation, destabilisation and morphology changes of dendritic spines rely on dynamics of 
the actin-cytoskeleton, in which actin polymerisation results in spine size increase and 
depolymerisation to shrinkage of spines (Fig. 7A). These processes are regulated by a variety 
of actin-binding proteins present in the spine, in turn regulated by signalling cascades. Actin 
polymerisation and thus spine structure is influenced by Ca2+-dependent signalling, 
potentially regulated by CaMKII activity. Finally, it has been shown that NMDAR-dependent 
signalling and LTP are associated with a long-lasting increase of polymerised actin within 
dendritic spines, resulting in an increase of spine volume (Ethell and Pasquale, 2005; Hayashi 
and Majewska, 2005; Lippman and Dunaevsky, 2005; Matus, 2005; Segal, 2005; Tada and 
Sheng, 2006). 
 
 
 
Figure 7. Dendritic spine geometry during synaptic 
activity. A, Rapid and bidirectional structural 
plasticity of the dendritic spine. A short burst of 
stimulation, typically inducing LTP, shifts the 
equilibrium of polymerised actin and actin monomers 
(F-actin/G-actin) toward F-actin (right leg). The 
increased amount of postsynaptic F-actin enlarges the 
postsynaptic spine and provides a binding site for 
other proteins. For some proteins, this is
sufficient as an activity-dependent delivery mechanism to the postsynapse. For other proteins, synergistic 
activation of other mechanisms, such as phosphorylation or other posttranslational modifications, are necessary 
for postsynaptic delivery. In contrast, prolonged low-frequency stimulation, typically inducing LTD, shifts the F-
actin/G-actin equilibrium toward G-actin (left leg). This reduces postsynaptic F-actin and, hence, other F-actin 
binding proteins, resulting in disassembly of the postsynaptic protein complex and a shrinkage of the dendritic 
spine. This will eventually disrupt anchorage of surface glutamate receptors, leading to loss of synaptic 
receptors. Other mechanisms, such as dephosphorylation or endocytosis, are likely involved as well. B, Ca2+ 
compartmentalisation and dendritic spine geometry during synaptic activity. Small dendritic spines (left) have 
relatively larger NMDA currents than AMPA currents, which may be electrophysiologically recorded as ‘silent’ 
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synapses (Groc et al., 2006). Ca2+ efflux from the spine is accomplished primarily through Ca2+ extrusion pumps 
(spine head conductance [gS]) located in the spine head. These spines are predominantly ‘pumpers’, as the spine 
neck is narrow and precludes Ca2+ diffusion into the dendrite (spine neck conductance [gN] is low). This results 
in large, prolonged Ca2+ signals in the spine and little Ca2+ increase in the dendritic shaft. Large dendritic spines 
(right), such as those observed after potentiation, have proportionally larger AMPA currents than NMDA 
currents. Ca2+ efflux from the spine head happens through two pathways: Ca2+ extrusion in the spine head (gS) 
and, due to the large radius of the spine neck, through Ca2+ diffusion in the dendritic shaft (gN). In these spines, 
Ca2+ increases are more moderate and transient, while dendritic Ca2+ concentrations are observed to change at 
the spine base. Figures and text taken and modified from (Hayashi and Majewska, 2005). 
← 
Studying the effects of LTP on a molecular and structural level have led to the 
identification of a wide variety of signalling cascades, influencing molecular as well as 
structural properties of the synapse. Plasticity-dependent changes of structural domains like 
dendritic spines and other plasticity-dependent modifications in synaptic structure are also 
directly influenced by ECM molecules. ECM molecules are known to be involved in synaptic 
development and plasticity, as signalling through their cell-surface receptors is known to 
modulate synaptic efficacy (Dityatev and Schachner, 2003; Pavlov et al., 2004; Dityatev and 
Schachner, 2006). Furthermore, rearrangements of cellular domains require the remodelling 
of the ECM, processes mediated by extracellular proteases. Extracellular proteolysis is 
implicated in general structural rearrangements at the synapse and proteases were shown to 
contribute directly to synaptic plasticity (Shiosaka, 2004; Juttner and Rathjen, 2005; Ethell 
and Ethell, 2007). Taken together, synaptic plasticity involves a large and diverse machinery 
of structural and functional rearrangements allowing the fine-tuning of synaptic contacts and 
thus neuronal circuit modification that is believed to be essential for processes involving 
learning and memory formation. 
 
1.1.4 Mental retardation disorders 
 The brain’s ability to process environmental stimuli and its ability to learn, remember 
and integrate this information for refined behavioural responses is mainly regulated at the 
level of the functional formation of neuronal networks. These networks are built and refined 
during development. Children show enhanced capacity for learning and memory compared to 
adults and the mechanisms for enhanced brain plasticity include postnatal neurogenesis in 
certain parts of the brain, the deletion of neurons, as well as changes at the synaptic level 
(Johnston, 2004). These synaptic changes include the generation or removal of synapses as 
well as activity-dependent refinement of synaptic contacts, summarised by the term synaptic 
plasticity (section 1.1.3). During the first two years of postnatal development in humans, 
approximately twice as many synapses are present in the cerebral cortex when compared to 
the adult. Further, synapse elimination and the refinement of synaptic circuits occurs mainly 
until around 16 years of age (Johnston, 2004). The complex molecular regulation of processes 
found to mediate, maintain or shape synaptic plasticity enable the refinement of the neuronal 
circuitry and are a precondition for processes such as learning and memory. However, the 
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demands for complex interactions and fine-tuning mechanisms render this system vulnerable 
to defects. Mutations or deletions of single proteins may provoke drastic phenotypes leading 
to the impairment of plasticity processes. Indeed, a diverse group of clinical disorders are 
caused by aberration or disruption of signalling cascades that have been implicated in learning 
and memory processes in animal models (Johnston, 2004). 
Mental retardation (MR), also termed intellectual disability, is a common form of 
nonprogressive cognitive impairment, generally defined by an overall intelligence quotient 
(IQ) below 70. It includes deficits in adaptive behaviour which manifest before the age of 18. 
MR affects around 1-3 percent of the general population and is widely diverse in its causes. 
Several non-genetic factors are known to act prenatally or during early childhood. These 
include infectious diseases, very premature birth or excessive maternal alcohol consumption 
during pregnancy. Genetic causes of MR include chromosomal abnormalities, like 
chromosomal microdeletions and monogenic diseases (Chelly and Mandel, 2001; Basel-
Vanagaite et al., 2007; Fernandez and Garner, 2007). 
Nonsyndromic mental retardation (NSMR) is characterised by cognitive defects that 
are not accompanied by major physical anomalies or neurological abnormalities. Hence, 
aberrations in molecular processes implicated in neuronal differentiation or synaptic plasticity 
are believed to be involved in the development of MR (Chelly and Mandel, 2001; Basel-
Vanagaite et al., 2007). Generally, genetically caused MR can be grouped into X-
chromosome-linked MR (XLMR) and autosomal MR. The XLMR variant fragile X syndrome 
is the most commonly inherited MR, associated with an X-chromosomal fragile site in the 
fragile X mental retardation 1 (FMR1) gene (Chelly and Mandel, 2001). This mutation is 
characterised by the expansion of a trinucleotide repeat that results in transcriptional silencing 
of the FMR1 gene. The FMR1 protein (FMRP) is a messenger RNA (mRNA) binding protein 
involved in the regulation of local synaptic protein synthesis. Interestingly, mutation or 
absence of FMRP leads to aberrations in spine morphology. In fragile X syndrome patients, as 
well as in related animal models of the disease, dendritic spines appear morphologically 
immature as long and thin protrusions. Spines are dynamic structures that mature during 
development and their maturation depends on electric activity (sections 1.1.2 and 1.1.3) and it 
has been described that these morphological changes require local protein synthesis. 
However, FMRP was reported to bind a large number of mRNAs but the distinct targets 
involved in spine maturation remain elusive (Zalfa et al., 2006). Synapses on dendritic spines 
are the major targets for plasticity related phenomena involved in learning and memory 
formation and it is therefore not surprising that other genomic mutations have been described 
that cause mental disorders like MR by altering spine formation and morphology (Blanpied 
and Ehlers, 2004; Carlisle and Kennedy, 2005). An additional variant of XLMR shown to be 
linked to aberrant spine plasticity is caused by mutations in the PAK3 gene (Boda et al., 2004; 
Boda et al., 2006; Kreis et al., 2007). 
 A recently identified mutation in the autosomal gene PRSS12 was shown to cause 
autosomal NSMR in humans (Molinari et al., 2002). PRSS12 codes for the synaptic protease 
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neurotrypsin and the described mutation caused a frameshift mutation leading to a complete 
functional inactivation of the enzyme (section 1.2.2.3). This finding highlights the importance 
of proteolytic processes in fine-tuning events of CNS plasticity.   
 
1.2 Proteases in the CNS 
Enzymes function by efficiently catalysing and directing chemical reactions, enabling 
the rapid conversion of molecular properties essential for the function of biological systems. 
Proteases are a class of enzymes that catalyse the hydrolysis of peptide bonds of their 
respective protein substrates, resulting in substrate cleavage. Proteases are categorised into 
families depending on the composition of the enzyme’s active site and therefore the mode of 
catalysis. In the CNS, members of several families of proteases are expressed, including 
serine proteases, matrix metalloproteinases (MMP), cysteine proteases and aspartic proteases. 
CNS-proteases are involved in almost all aspects of CNS development and maintenance, such 
as cell proliferation, migration, apoptosis, axonal growth, tissue and ECM remodelling, 
synaptogenesis as well as synaptic plasticity (Zhang et al., 2005; Shiosaka, 2004).  
In the context of synaptic plasticity, important related processes are the structural and 
functional modification of established synapses as well as the structural reorganisation of 
synaptic circuits involving the formation of new synapses and the elimination of existing ones 
(Chklovskii et al., 2004). Both mechanisms have been reported to involve proteolysis by 
extracellular proteases (Shiosaka, 2004). Explained by their high efficiency in substrate 
conversion, proteolytic processes in the CNS have to be tightly regulated to reach spatially 
and temporally restricted substrate cleavage. This is partially achieved by their production as 
inactive precursors (zymogens) and regulated activation (Khan and James, 1998) as well as 
termination of the proteolytic activity by removal or degradation of the active enzyme (Binder 
et al., 2007). Regulation may further be mediated by the interaction with specific 
endogenously expressed inhibitors that exist for each set of protease families. Imbalances 
within these complex regulation patterns affect the events crucial for CNS development and 
function and have been implicated in a variety of neuropathological changes (Lukes et al., 
1999; Zhang et al., 2005; Hook, 2006; Ethell and Ethell, 2007).     
 
1.2.1 Serine Proteases 
 Serine proteases, named after the catalytic serine at their active site, are the largest 
family of proteases, as almost one-third of all proteases belong to this family. They are 
secreted enzymes and enzymatically characterised by the so called “catalytic triade”, 
consisting of the three interacting amino acids serine, histidine and aspartate. These amino 
acids are positioned within the active-site cleft of the respective enzyme, enabling the 
optimised interaction with the substrate. Substrate peptide bond hydrolysis is initiated by a 
nucleophilic attack of the active-site serine on the carbonyl of the peptide substrate group 
(Fig. 8). The 4 existing clans of serine proteases mainly differ in the order and position of the 
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catalytic-triade amino acids within the primary structure of the respective enzyme (Hedstrom, 
2002). 
 
 
Figure 8: Catalytic mechanism of chymotrypsin-like serine proteases (Hedstrom, 2002). In the acylation half of 
the reaction, serine (Ser)195 attacks the carbonyl of the peptide substrate, assisted by histidine (His)57 acting as 
a general base, to yield a tetrahedral intermediate. The resulting His57-H+ is stabilised by the hydrogen bond to 
aspartate (Asp)102. The oxyanion of the tetrahedral intermediate is stabilised by interaction with the main chain 
NHs of the oxyanion hole. The tetrahedral intermediate collapses with expulsion of leaving group, assisted by 
His57-H+ acting as a general acid, to yield the acylenzyme intermediate. The deacylation half of the reaction 
essentially repeats the above sequence: water attacks the acylenzyme, assisted by His57, yielding a second 
tetrahedral intermediate. This intermediate collapses, expelling Ser195 and carboxylic acid product. The 
acylenzyme intermediate is well established, but the tetrahedral intermediates are inferred from solution 
chemistry. The transition states of the acylation and deacylation reactions will resemble the high energy 
tetrahedral intermediates, and the terms ‘transition state’ and ‘tetrahedral intermediate’ are often used 
indiscriminately in the literature. It is worth noting that a web of hydrogen bonding interactions links the 
substrate binding sites to the catalytic triad. As the reaction proceeds, changes in bonding and charge at the 
scissile bond will propagate to more remote enzyme-substrate interactions, and vice versa. Figure and text taken 
and modified from (Hedstrom, 2002). 
 
The chymotrypsin-like serine proteases, represented by over 240 proteases, are by far 
the biggest clan within the family of serine proteases and its members are involved in many 
critical physiological processes. These include cascades of sequentially activated serine 
proteases to drive blood coagulation and fibrinolysis as well as developmental processes, such 
as matrix remodelling, differentiation and wound healing (Hedstrom, 2002). Some 
chymotrypsin-like proteases have also been implicated in CNS-plasticity, e.g., tissue type 
plasminogen activator, plasminogen, neuropsin and neurotrypsin (section 1.2.2). The stringent 
roles in these tightly regulated processes demands proteases with adjustable activities and 
distinct substrate specificities (Hedstrom, 2002). Serine proteases are synthesised as inactive 
precursors (zymogens) and are usually converted to the active enzyme by limited proteolysis 
of an inhibitory segment. Activation of these secreted enzymes may already occur within an 
intracellular compartment or in the extracellular environment where they are supposed to 
function (Khan and James, 1998). The substrate specificities are usually defined by the 
characteristics of a substrate binding site adjacent to the active site cleft (Hedstrom, 2002; 
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Page et al., 2005). However, further interactions of the substrate with additional exosites of 
the protease may enhance substrate specificity (section 1.3.2). Further regulatory mechanisms 
include the regulated interaction with endogenously expressed serine protease-specific 
inhibitors (Bode and Huber, 1992) as well as the removal or degradation of the active enzyme, 
hence terminating its proteolytic activity (Binder et al., 2007). Thus, substrate specificity and 
further regulatory mechanisms render serine proteases optimal for specific actions involved in 
plastic changes of the synaptic circuitry.  
 
1.2.2 Chymotrypsin-like serine proteases and synaptic plasticity 
 Recent research has revealed the involvement of some chymotrypsin-like serine 
proteases as well as their inhibitors in CNS function, including synaptic plasticity (Shiosaka, 
2004; Yepes and Lawrence, 2004; Zhang et al., 2005; Galliciotti and Sonderegger, 2006). 
Plastic changes of synapse-strength, involved in learning and memory processes, are 
connected with morphological changes of the individual synapse or associated structures 
(section 1.1.3). Furthermore, network-plasticity involves the reorganisation of synaptic 
circuits, including the formation of new synapses and the elimination of existing ones 
(Chklovskii et al., 2004). The synaptic cleft is filled with a network of polysaccharides and 
ECM molecules, connecting and stabilising pre- and postsynaptic elements (Dityatev and 
Schachner, 2006). It is speculated that adhesion and de-adhesion of cells in general is 
modulated by extracellular proteolysis and it is well documented that pericellular proteolysis 
of the ECM is involved in the formation or remodelling of the neuromuscular junction. Thus, 
the morphological rearrangements of CNS synapses or their elimination require the re-
modulation of the ECM, mediated by proteases responsive to neuronal activity (Shiosaka, 
2004). In addition, cleavage or interaction with extracellular substrates may also lead to direct 
activation or inhibition of signalling cascades involved in plasticity events (Samson and 
Medcalf, 2006; Stephan et al., 2008).  
 
1.2.2.1 Tissue-type plasminogen activator and plasminogen 
 Tissue-type plasminogen activator (tPA) is a multidomain protein with a molecular 
mass (Mr) of 70 kilo Dalton (kDa) that contains a fibronectin type 1 domain, an epidermal 
growth factor domain, two kringle domains and the C-terminally located catalytic domain. 
The non-catalytic domains mediate protein-protein interactions, like the binding of tPA to 
fibrin. Because of its activation of Plasminogen, tPA was initially known as a fibrinolytic 
protease but its substrate spectrum extends to fibronectin and, more importantly, to the NR1 
subunit of the NMDAR (Shiosaka, 2004). In the CNS, tPA is an immediate early gene that is 
highly responsive to chemical and electrical stimuli. Its expression pattern suggests roles as a 
modulator of neurotransmission as both tPA mRNA and tPA proteins have been localised to 
synapses. In addition, depolarisation was shown to induce exocytosis of tPA from 
intracellular stores, with its activation occurring directly after secretion. The overexpression 
of tPA in neurons of mice causes enhanced LTP and improved learning of the water maze 
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task. In contrast, tPA-deficient mice show selective interference with the late phase of 
hippocampal LTP. However, the involvement of tPA in hippocampal-dependent learning is 
still controversially discussed. tPA-deficient mice also revealed a reduced capacity to learn an 
active avoidance task, which implicates tPA function in striatum-dependent plasticity. When 
rats were trained for a complex motor task, tPA expression was increased in Purkinje cells of 
the cerebellar cortex, indicating that tPA may be involved in cerebellar motor learning. 
 
 
Figure 9. Tissue-type plasminogen activator (tPA) signaling in the CNS. tPA and its endogenous inhibitor, 
neuroserpin, are released from presynaptic terminals in response to depolarisation. tPA participates in 
mechanisms of synaptic plasticity by several mechanisms. Both directly and via its binding to the low-density 
lipoprotein–related receptor 1 (LRP-1), tPA increases calcium (Ca2+) influx via NMDA receptors and potentiates 
dopamine (DA) D1 receptors signaling via the adenylate cyclase (AC)–cyclic adenosine monophosphate 
(cAMP)–protein kinase A (PKA) pathway. tPA also triggers conversion of plasminogen (Plgn) into plasmin 
(Pln), which has a proteolytic effect on the extracellular matrix (ECM) that is important for synaptic remodeling. 
LRP-1 is involved in endocytosis of tPA by the astrocyte and in transcytosis of tPA through an intact blood–
brain barrier. In the setting of acute injury, tPA is released from injured blood vessels and microglia and may 
contribute to ECM degradation and NMDA-mediated excitotoxicity. Neuroserpin inhibits these effects. Figure 
and text taken and modified from (Benarroch, 2007). 
 
How tPA influences all these plasticity-related phenomena is not completely clear but 
several reported actions may explain tPA’s functions. As mentioned above, tPA cleaves the 
NR1 subunit of the NMDAR but direct functional implications of this cleavage are so far not 
known. It is possible that this interaction leads to downstream effects of altered Ca2+-
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dependent signalling, modifying LTP. It was also reported that tPA interacts with the NR2B 
subunit of NMDAR. This interaction does not involve cleavage, however, binding of tPA to 
NR2B resulted in the ablation of NMDAR-dependent phosphorylation of the extracellular 
signal-regulated kinase 1/2 (ERK1/2) that is known to be involved in LTP and LTD (Ito-
Ishida et al., 2006). Additional functions of tPA include binding to and signalling through the 
low-density lipoprotein receptor-related protein 1 (LRP-1). Again, catalytic activity of tPA is 
not required for this process. The interaction of tPA and LRP-1 induces an increase of cyclic 
adenosine monophosphate (cAMP) levels and protein kinase A (PKA) activity, resulting in 
synaptic potentiation. The involvement of the tPA/LRP-1 interaction in synaptic plasticity-
related processes is supported by the general finding that low-density lipoprotein receptor 
(LDLR) family members, like LRP-1, are crucial for hippocampal CA1-dependent LTP. 
Theoretically, also a potential tPA-dependent proteolytic activity on ECM molecules could 
contribute to tPA’s role in synaptic plasticity. Importantly, tPA converts plasminogen into 
active plasmin also in the CNS, therefore activating another protease involved in synaptic 
plasticity (see below). Finally, extracellular tPA activity is regulated by inhibitors like 
neuroserpin and plasminogen activator inhibitor-1 (PAI-1), increasing the complexity of 
potential tPA-dependent functions (Shiosaka, 2004; Samson and Medcalf, 2006). Taken 
together, many different actions of tPA may explain its involvement in processes contributing 
to synaptic plasticity. These processes possibly occur independent as well as dependent on 
plasminogen activation (Fig. 9). 
 
 Plasminogen is a multidomain glycoprotein with a Mr of 92 kDa, consisting of an N-
terminal activation peptide, five kringle domains and a C-terminal catalytic domain. Again, 
the kringle domains mediate protein-protein interactions, such as substrate recognition, 
membrane association and inhibitor binding. Plasminogen can be activated by tPA, urokinase-
type plasminogen activator (uPA), kallikrein as well as by several coagulation factors and it 
plays an important role in fibrin clot degradation. In the CNS, plasminogen is highly 
expressed in the hippocampus, the cerebral cortex and the cerebellum and is most likely 
activated by tPA and uPA, both known to be expressed in the CNS. Activated plasminogen, 
termed plasmin, has a broad spectrum of substrates, including the ECM proteins laminin and 
fibronectin. Furthermore, plasmin was shown to activate MMPs, which can degrade other 
ECM molecules that are involved in synaptic plasticity (section 1.2). Several effects 
downstream of tPA-activation (see above) have been shown to involve plasmin activation, 
mediating processes involved in synaptic plasticity. The tPA-mediated activation of plasmin 
triggers dopamine release in the nucleus accumbens upon morphine injection, implicating the 
tPA-plasmin system in drug-dependent synaptic plasticity. Additionally, hippocampal CA1-
dependent LTP, triggered by tPA, was reported to depend partially on plasmin-mediated 
generation of neurotrophins. And finally, plasmin has been shown to enhance NMDAR-
dependent intracellular Ca2+ levels (Zhang et al., 2005; Samson and Medcalf, 2006). As 
already mentioned in the context of tPA functions, plasmin activity is also regulated by 
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inhibitors like neuroserpin and plasminogen activator inhibitor-1 (PAI-1), potentially 
regulating plasticity-dependent effects of plasmin (Zhang et al., 2005).  
 
1.2.2.2 Neuropsin 
 Neuropsin is a simple neuronal serine protease with a Mr of around 30 kDa, 
containing only one characteristic domain that mediates neuropsin’s proteolytic activity. This 
protease is mainly expressed in the hippocampus, the amygdala and the entorhinal cortex and 
its expression is caused by neuronal stimulation such as stimuli-induced epilepsy or LTP. 
Neuropsin is believed to be secreted by both synaptic activity-dependent and -independent 
mechanisms and stored extracellularly in its inactivated form, mostly within the synaptic cleft. 
Activation of neuropsin is dependent on synaptic activity and probably mediated by 
NMDAR-dependent signalling pathways. The inhibition of neuropsin activity by application 
of neutralising antibodies caused stimulus-induced progression of kindling epileptogenesis in 
vivo. In contrast, the bath application of neuropsin revealed a regulatory effect of early phase 
Schaffer collateral synapse LTP. In line with this evidence, neuropsin cleaves the synaptic 
cell-adhesion molecule L1 (L1CAM) upon stimulation of synaptic activity and cleavage 
occurs during early phase LTP. As blockage of L1CAM by specific antibodies as well as 
application of L1CAM fragments were shown to block early phase LTP, these data argue for 
a specific proteolysis-dependent effect of neuropsin on synaptic plasticity, maybe specific to 
the Schaffer collateral synapses (Shiosaka, 2004). 
 
1.2.2.3 Neurotrypsin 
Neurotrypsin is a multidomain serine protease and human neurotrypsin, with a Mr of 
around 97 kDa, contains a proline-rich basic domain, a kringle domain, 4 scavenger receptor 
cysteine-rich (SRCR) domains and the C-terminal protease domain (Fig. 10A; (Proba et al., 
1998)). In contrast, murine neurotrypsin protein has a Mr of approximately 85 kDa, because 
of the expression of only 3 SRCR domains (Fig. 10B; (Gschwend et al., 1997)). By 
comparison of primates with other mammalian orders it was shown that a deletion of the 
exons encoding the first SRCR domain occurred in the murine lineage only (Xu and Su, 
2005). The non-catalytic domains of neurotrypsin are believed to mediate protein-protein 
interactions, similar to the previously mentioned roles for the noncatalytic domains of tPA 
and plasminogen. These domains may mediate interactions with proteins involved in 
neurotrypsin targeting within the cell, its binding to the cell surface or ECM molecules, its 
interaction with substrates and/or the interaction with regulators of activation.  
Details about the mode of catalytic activation of neurotrypsin are so far not known. 
However, its zymogen activation site (Fig. 10, arrow) is located proximal to the protease 
domain and proposes an activation mechanism similar to other proteases of its clan. 
Proteolytic cleavage at the zymogen activation site is supposed to separate the protein into 
two chains that are linked via a disulfide bridge. The removal of an ‘activation segment’ or 
the induction of structural changes by activation cleavage are believed to unlock the 
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proteolytic activity (Khan and James, 1998). A potential candidate for neurotrypsin activation 
is the protease furin (unpublished observations), a member of the subtilisin superfamily of 
serine endoproteases (Thomas, 2002). Furin is an ubiquitously expressed enzyme localised to 
the secretory pathway and potentially activates neurotrypsin during its secretion. 
 
Figure 10. Schematic overview of 
neurotrypsin’s protein structure. A, human 
neurotrypsin (Proba et al., 1998); B, mouse 
neurotrypsin (Gschwend et al., 1997); C, 
truncated human neurotrypsin (Molinari et 
al., 2002).  PB – proline-rich basic domain; 
KR – kringle domain; SRCR – scavenger 
receptor cysteine-rich domain; PROT – 
protease domain. The arrow indicates the 
approximate position of the zymogen 
activation site of neurotrypsin.  
 
Neurotrypsin is expressed in endothelial cells of the blood vasculature, in the kidney, 
in the lung and is expressed in the nervous system (Gschwend et al., 1997; Yamamura et al., 
1997; Iijima et al., 1999; Wolfer et al., 2001; Aimes et al., 2003; Reif et al., 2007). Within the 
nervous system, neurotrypsin is expressed in a wide variety of regions (Fig. 11). This includes 
prominent expression in motorneurons of the spinal cord (Fig. 11E) and, concerning its 
expression in the brain, the cerebral cortex, the hippocampus and the amygdala (Fig. 11A-D; 
Fig. 12; (Gschwend et al., 1997; Iijima et al., 1999; Wolfer et al., 2001)). Neurotrypsin 
mRNA expression in the CNS is developmentally regulated and peaks around the first 
postnatal week in mice (Fig. 12; (Wolfer et al., 2001)). Furthermore, it was recently reported 
that neurotrypsin expression in motorneurons was downregulated after interruption of target 
contact by facial nerve axotomy and that its expression was re-established after facial 
motorneuron recovery and reinnervation of target muscles (Numajiri et al., 2006). Its 
prominent expression in CNS structures involved in learning and memory processes as well as 
its developmental and target contact regulated expression suggests a potential involvement of 
neurotrypsin function in crucial steps of CNS development and neuronal circuit refinement, 
hence synaptic plasticity. In support of this notion, neurotrypsin protein expression, analysed 
by immunoelectron microscopy, was localised to synapses in the cerebral cortex as well as in 
the hippocampus. Here, neurotrypsin was detected in presynaptic terminals, within vesicular 
structures in the area lining the synaptic cleft (Fig. 13; (Molinari et al., 2002; Stephan et al., 
2008)). Further analyses in cultured hippocampal neurons revealed that its synaptic 
recruitment as well as its exocytosis from synaptic terminals is regulated by neuronal activity. 
Depolarisation of neurons leads to the exocytosis of synaptic neurotrypsin and the 
externalised protease was shown to linger at the synapse for minutes before disappearing due 
to diffusion or degradation (Frischknecht et al., 2008). These observations suggest an activity-
dependent extracellular proteolytic function of neurotrypsin at the synapse.  
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Figure 11. In situ hybridisation of sections from different CNS regions of adult mice using DIG-labeled 
neurotrypsin antisense cRNA. A, Brain section cut in a dorsocaudal-rostroventral plane (angle: approximately 
30° to the coronal plane). The section was hybridised with a neurotrypsin antisense riboprobe. Labeling is seen 
in distinct layers throughout the neocortex (Te, temporal cortex; Oc, occipital cortex) with a more widespread 
labeling in the transition zones between iso- and allocortex (Ic, insular cortex; RS, retrosplenial cortex). In the 
allocortex, labeling is detected in the piriform cortex (Pir), with a strong labeling in the endopiriform nucleus 
(arrow), and in the hippocampal formation (see also D). Neurotrypsin expression is also seen in the lateral 
amygdala (arrowhead). Scale bar: 1 mm. B, C, Consecutive coronal sections of the parietal cortex, either stained 
with cresyl violet (B) or hybridised with neurotrypsin antisense riboprobe (C). Cortical layers are marked in (B). 
C, Large positive neurons are seen in the lower half of layer V. In layer VI, positive cells are found throughout 
the layer, but concentrated at the border to the white matter. Weak labeling is associated with cells scattered in 
layers II and III. No labeling is detected in layers I and IV. Scale bar in C represents 100 μm. D, Coronal section 
of the hippocampus. Labeling is detected in neurons of the subiculum (S), in pyramidal neurons of CA1 and 
CA3, and in granule neurons of the dentate gyrus (DG). Scale bar: 300 μm. E, Cross section of the cervical 
spinal cord. Large cells are labeled in the motor columns (arrowheads). Labeling is also detected in the DRG 
(arrow). Scale bar: 300 μm. Figure and text taken and modified from (Gschwend et al., 1997). 
 
Neurotrypsin was recognised to play an indispensable role for cognitive processes in 
humans when a four-nucleotide deletion in its coding region was identified as the cause of 
severe autosomal recessive nonsyndromic MR (Molinari et al., 2002). This frameshift 
mutation resulted in complete functional inactivation of neurotrypsin by causing the 
translation of a truncated enzyme lacking the protease domain (Fig. 10C). The affected 
children exhibited severe deficits in cognitive development after normal psychomotor 
development during the first 18 months, indicating that neurotrypsin does not play a critical 
role in early neural development or for the formation of synapses. Rather, neurotrypsin may 
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be crucial for the reorganisation of synapses and neuronal circuits which are required to 
establish and maintain higher cognitive functions during later developmental and adult stages. 
 
 
Figure 12. Semiquantitative synopsis of the time course of neurotrypsin mRNA expression in neural and 
nonneural tissues during pre- and postnatal development. Columns represent developmental stages. Rows 
represent cell populations, regions, or tissues. The shading pattern of each box indicates the average signal 
intensity, assigned to one of the four staining levels listed in the middle of the figure. Figure and text taken and 
modified from (Wolfer et al., 2001). 
 
Figure 13. Subcellular localisation of 
neurotrypsin in hippocampus and cerebral 
cortex of wildtype mice and humans. A-
D, Immuno-electron microscopy of the 
neuropil of the human cerebral cortex (A, 
B), the neuropil of the murine hippo-
campal CA1 area (C) and the murine 
cerebral cortex (D) localised neurotrypsin 
in presynaptic terminals, close to pre-
synaptic membranes lining the synaptic 
cleft. Silver intensified gold particles 
reporting neurotrypsin immuno-reactivity 
were accumulated at vesicles close to the 
presynaptic membrane opposite to the 
postsynaptic density (arrows). Scale bars: 
0.2 μm. A, B, taken and modified from 
(Molinari et al., 2002); C-D, taken and 
modified from (Stephan et al., 2008).  
 
The so far unique proteolytic target of neurotrypsin is agrin, a protein well known 
because of its crucial function in neuromuscular synapse (neuromuscular junction, NMJ) 
maturation and maintenance (Sanes and Lichtman, 2001; Kummer et al., 2006). However, 
recent reports also implicate agrin as a regulator of CNS synapses ((Annies et al., 2006; 
Hilgenberg et al., 2006; McCroskery et al., 2006; Ksiazek et al., 2007); section 1.3). Thus, 
assuming that agrin is also a substrate of neurotrypsin in the CNS, cleavage by neurotrypsin 
could regulate agrin’s action at the CNS synapse, which implicates neurotrypsin as an 
important regulator of structural and functional reorganisation of the synaptic circuitry. 
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1.3 Agrin is a substrate of neurotrypsin 
 
1.3.1 Agrin at the NMJ and in the CNS 
Agrin was initially isolated from the basal lamina of the synapse rich electric organ of 
Torpedo californica (Nitkin et al., 1987). The synaptic basal lamina is formed by a thin sheet 
of ECM molecules within the synaptic cleft of the NMJ. Initial interest in proteins expressed 
in the ECM of vertebrate muscles originated from findings that synaptic ECM factors were 
able to reinstruct the generation of synapses after muscle denervation. It was hypothesised 
that one or several factors immobilised in the synaptic basal lamina were able to induce pre- 
and postsynaptic differentiation (Bezakova and Ruegg, 2003). The first identified was agrin, 
named after its ability to aggregate acetylcholine receptors (AChR) in the postsynaptic 
membrane (Nitkin et al., 1987). The indispensable role for agrin in vertebrate NMJ function 
was confirmed by the generation of agrin-deficient mice. These mice developed a strong 
reduction in the number, size and density of postsynaptic AChR aggregates as well as 
abnormal intramuscular nerve branching and defective presynaptic differentiation in the 
muscle fibre membrane (Fig. 14). Agrin-deficient mice die at birth because of muscular 
defects resulting in an inability to breathe, indicating the importance of agrin in 
neuromuscular development (Gautam et al., 1996). The additional finding that the injection of 
agrin expression plasmids or purified agrin protein into non-synaptic regions of murine 
muscles induced the formation of fully functional and mature postsynaptic structures, placed 
agrin as a critical nerve-derived organiser of NMJ postsynaptic development (Sanes and 
Lichtman, 1999; Bezakova and Ruegg, 2003). More recent findings, however, have redefined 
the important role of agrin in the process of NMJ development and point to a function in NMJ 
maturation and maintenance, rather than in NMJ formation (Kummer et al., 2006). 
 
 
Figure 14. Development of pre- and postsynaptic structures in agrin mutant mice. Diaphragm muscles from 
control (A) and agrin-deficient (B) embryos at E18 were doubly stained for AChRs and axons, then drawn with a 
camera lucida. Myotubes run vertically. In controls, axonal branches (black) and AChR clusters (red) are 
confined to a central endplate band. In the mutant, AChR aggregates are smaller, less dense, and less numerous; 
axons form fewer but longer branches; and synaptic relationships are disorganised. Some of the dimmest, 
smallest AChR aggregates in mutant muscle are not shown. Scale bar: 100 μm. Figure and text taken and 
modified from (Gautam et al., 1996). 
 
Agrin is a large multidomain chimeric proteoglycan because its protein backbone alone has a 
predicted Mr of 225 kDa. However, mature forms of agrin have a Mr of up to around 600 kDa 
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Figure 15. Schematic overview of agrin’s protein structure (modified from (Hoch et al., 1993; Bezakova and 
Ruegg, 2003)). Alternative splicing leads to the expression of a variety of transmembrane (SN) or secreted (LN) 
agrin variants, containing variable inserts of several amino acids at the x, y, and z splice sites. Binding sites of 
agrin are indicated. NtA - N-terminal agrin domain; TM - transmembrane domain; F - follistatin-like domains; 
GAG - glycosaminoglycan side chains; LE - laminin-epidermal growth factor (EGF)-like domains; S/T - serine-
threonine-rich region; SEA - sperm protein, enterokinase and agrin domain; EG - EGF-like domains; LG - 
laminin-globular domains. 
 
due to attachment of chondroitin sulphate and heparan sulphate glycan sidechains and other 
additional N- and O-linked glycosylations (Fig. 15; (Rupp et al., 1991; Tsen et al., 1995; 
Parkhomovskiy et al., 2000; Xia and Martin, 2002; Bezakova and Ruegg, 2003; Winzen et al., 
2003)). In addition to its extensive and complex structure, several alternative splice variants of 
agrin have been identified, altering its structural as well as functional properties. Alternative 
splicing within the N-terminal region of agrin results in the expression of both secreted and 
transmembrane isoforms (Denzer et al., 1995; Neumann et al., 2001). The N-terminal domain 
responsible for secretion of agrin variants was shown to bind to laminin and to mediate 
integration of agrin into the ECM. This interaction with laminin is crucial for agrin’s function 
at the NMJ as it mediates agrin’s integration in the synaptic basal lamina. In contrast, the 
transmembrane domain is believed to target agrin to alternative domains of cells that do not 
contain basal laminae (Bezakova and Ruegg, 2003). Secreted and transmembrane variants are 
further alternatively spliced at three independent sites within agrin’s C-terminal half (Fig. 15). 
Alternative splicing at these sites, termed x, y and z splice sites for rat agrin isoforms, have 
additional impact on agrin’s structural and functional complexity. The x-splice site is located 
in front of the second serine-threonine-rich region and alternative insertion of either 12 amino 
acids, 3 amino acids or no insertion have been described (x12, x3 or x0; (Hoch et al., 1993)). 
The y-splice site is located within the second laminin-globular (LG) domain and no insertion 
(y0) or a 4 amino acid insertion (y4) is possible. The y4-splice insert is required to enable 
heparin (heparan sulphate glycan) binding and modulates agrin’s interaction with the α-
subunit of the dystroglycan complex (Gesemann et al., 1996). The dystroglycan complex is 
composed of an extracellular α-subunit and a transmembrane β-subunit and was shown to 
connect the ECM to the intracellular actin cytoskeleton (Henry and Campbell, 1996). Binding 
to heparan sulphate proteoglycans as well as interaction with dystroglycan have been shown 
to contribute to agrin’s function at the NMJ (Bezakova and Ruegg, 2003). The z-splice site is 
located within the third LG domain (LG-3) and no insertion (z0) or alternative inserts of either 
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8, 11 or 19 amino acids (z8, z11, z19) have been described (Ferns et al., 1992; Tsim et al., 1992; 
Ferns et al., 1993; Hoch et al., 1993; Ngo et al., 2007). It was shown that agrin’s NMJ 
function relied strictly on isoforms that contained any positive insert at the molecules z-splice 
site (Bezakova and Ruegg, 2003).  
Agrin variants are expressed in a wide variety of tissues, including the lung, muscle, 
peripheral nervous system (PNS) and CNS. Non-neuronal tissues as well as CNS glial cells 
are believed to exclusively express secreted variants, whereas the transmembrane isoforms are 
predominantly expressed by CNS neurons (Bezakova and Ruegg, 2003). Also C-terminal 
splicing is regulated in a tissue-dependent manner. Although the x12-splice variant 
predominates in all tissues (Hoch et al., 1993), z-insert containing variants are exclusively 
expressed by PNS and CNS neurons as well as by adult Schwann cells. The y4 insert-
containing splice variants are mainly expressed by PNS and CNS neurons as well as by CNS 
glia (Bezakova and Ruegg, 2003). 
. The receptor mediating agrin’s function in postsynaptic development was identified as 
the ‘muscle-specific’ receptor tyrosine kinase (MuSK). Mice with a targeted disruption of the 
gene for MuSK developed profound defects in NMJ formation, similar to agrin-deficient 
animals (DeChiara et al., 1996; Glass et al., 1996). The MuSK-mediated effects on post-
synaptic development were shown to be maximally induced by a 95-kDa C-terminal agrin 
fragment. Although several hundred-fold less potent, a 21-kDa C-terminal agrin fragment, 
consisting of only the last LG-3 domain with any positive z-splice site insertion, is sufficient 
to induce the maximal numbers of AChR clusters on the muscle surface in vitro. This 
suggests that agrin interacts with its receptor at the NMJ via the LG-3 domain, additionally 
supported by further N-terminal domains of agrin (Bezakova and Ruegg, 2003). However, a 
direct interaction between MuSK and agrin was never shown and has led to the hypothesis 
that agrin binds to a MuSK receptor complex via a so far unidentified ‘myotube-associated 
specificity component’ (MASC) (Glass et al., 1996; Glass et al., 1997).      
 In the murine CNS, agrin is broadly expressed by neuronal as well as non-neuronal 
cells and localises to perisynaptic as well as extrasynaptic sites (Fig. 16; (Stephan et al., 
2008)). Its expression is developmentally regulated with peak expression around birth (Cohen 
et al., 1997; Halfter et al., 1997; Li et al., 1997; Smith and Hilgenberg, 2002). Owing to its 
complex structure, broad expression pattern and interaction with a wide variety of molecules 
(Burgess et al., 2002), agrin has been implicated in a multitude of processes in the CNS, 
including neurite outgrowth and blood-brain barrier function (Kroger and Schroder, 2002; 
Smith and Hilgenberg, 2002). Agrin has also been shown to function in PNS interneuronal 
synapses (Gingras and Ferns, 2001; Gingras et al., 2002; Bezakova and Ruegg, 2003; Gingras 
et al., 2007) but its involvement in CNS synapse development and function are just emerging. 
Initial studies, mainly performed with cultured neurons, created a controversial picture by 
supporting a role for agrin in CNS synapse development (Ferreira, 1999; Bose et al., 2000) as 
well as contradicting its contribution to this process (Li et al., 1999; Serpinskaya et al., 1999). 
However, it has recently been reported that agrin-deficient mice, rescued from perinatal death 
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by transgenic expression of agrin in motorneurons, exhibited a reduced number of synapses in 
the cerebral cortex. The signalling events contributing to agrin’s role in the formation and/or 
maintenance of CNS synapses potentially involve the mitogen-activated protein (MAP) 
kinase signalling pathway (Ksiazek et al., 2007). The receptor mediating this function is not 
known but MuSK, whose expression in the CNS was recently reported (Cheusova et al., 2006; 
Garcia-Osta et al., 2006; Ksiazek et al., 2007), was suggested as a potential candidate 
(Ksiazek et al., 2007). Other recent findings suggest that agrin may be involved in the 
generation of dendritic filopodia, structures considered to be precursors of dendritic spines, 
and thus in spine synapse formation (section 1.1.2). Both antibody-mediated clustering of 
agrin and the overexpression of agrin in neurons stimulated the formation of dendritic as well 
as axonal filopodia (Annies et al., 2006; McCroskery et al., 2006), dependent on the N-
terminal domain of transmembrane agrin variants (McCroskery et al., 2006). 
 
Figure 16. Subcellular localisation of agrin in 
hippocampus and cerebral cortex of wildtype 
mice. A, B, Silver intensified gold particles 
indicating agrin immuno-reactivity were found 
at perisynaptic as well as extrasynaptic 
locations in the neuropil of the hippocampal 
CA1 area and the cerebral cortex. C, The basal 
lamina of blood vessels in the stratum radiatum 
in the CA1 area of the hippocampus was 
strongly labelled with agrin-specific antibodies. 
The complete absence of gold particles in the 
adjacent tissue indicates a high specificity of 
the antibody. Arrows point to postsynaptic 
densities. Scale bars: 0.2 μm. Figure and text 
taken and modified from (Stephan et al., 2008). 
 
 
First evidence for a direct role of agrin in CNS synapse function emerged when a 
synaptic receptor for agrin was discovered in cultured cortical neurons (Hoover et al., 2003). 
Similar to signalling processes at the NMJ, a 20-kDa C-terminal agrin fragment was shown to 
be sufficient for receptor-binding although independent of z-splice insertions. This striking 
difference suggests that the agrin-binding component of the neuronal CNS receptor is distinct 
to its receptor at the NMJ (Hoover et al., 2003). Binding of the 20-kDa agrin fragment to its 
receptor resulted in increased intracellular Ca2+-levels and subsequent stimulation of CaMKII 
and MAP kinase activity, eventually resulting in the stimulation of early immediate gene 
expression, i.e., c-fos and cAMP-response element-binding protein (Ji et al., 1998; Hilgenberg 
and Smith, 2004). This synaptic agrin receptor was finally identified as the α3-subtype of the 
Na+/K+ ATPase and inhibition of its ATPase function by binding of the C-terminal agrin 
fragment was shown to evoke synaptic depolarisation (Hilgenberg et al., 2006).  
Taken together, the molecular mechanisms of agrin function in the CNS appear to be 
fundamentally distinct from those found at the NMJ, covering a wide variety of distinct 
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processes including synapse formation/maintenance and synapse function. However, further 
research is required to elucidate the exact mechanisms by which agrin elicits its varied CNS 
functions. 
 
1.3.2 Agrin is a substrate of neurotrypsin 
 Neurotrypsin is a serine-protease mainly expressed in the nervous system and serves 
an important role in cognitive functions (section 1.2.2.3). The NMJ is considered as a model 
system for neuron-neuron synapses (Sanes and Lichtman, 1999), owing to its size, 
accessibility and simplicity. To initially determine a potential synaptic function for 
neurotrypsin, transgenic mice were generated that overexpressed neurotrypsin in 
motorneurons and analysed for potential NMJ phenotypes. It was found that these mice 
developed a phenotype that strongly resembled the phenotype found in the diaphragm of 
agrin-deficient mice (section 1.3.1, Fig. 14; Bolliger, M. et al., unpublished observations). 
Because both neurotrypsin and agrin are endogenously expressed in motorneurons in vivo it 
was speculated that agrin is a substrate of neurotrypsin. 
 Co-expression of neurotrypsin and agrin in transiently transfected cos7 cells indeed 
confirmed that agrin is a substrate of neurotrypsin. Neurotrypsin-dependent cleavage of agrin 
occurs at two homologous sites, termed α- and β-cleavage sites and results in the release of an 
intermediate 90-kDa and a C-terminal 22-kDa fragment from the N-terminal moiety of agrin 
((Reif et al., 2007); see also Fig. 19). Detailed in vitro analyses confirmed the high specificity 
of neurotrypsin activity. Several highly conserved amino acids in the sequences flanking both 
cleavage sites of agrin are required for neurotrypsin-dependent cleavage. In addition, further 
exosite interactions between neurotrypsin and agrin are believed to be necessary for cleavage, 
supporting the high specificity of this interaction and suggesting only few, if any, additional 
substrates for neurotrypsin (Reif et al., 2007). Neurotrypsin localises to synapses in vivo and 
its secretion is caused by synaptic activity ((Molinari et al., 2002; Frischknecht et al., 2008; 
Stephan et al., 2008); section 1.2.2.3). Furthermore, the development of nonsyndromic MR 
upon functional inactivation of neurotrypsin places it as an important regulator of adaptive 
reorganisations of the synaptic circuitry ((Molinari et al., 2002); section 1.2.2.3). Given 
agrin’s emerging important role in the formation, maintenance and function of CNS synapses 
(section 1.3.1), it was tempting to speculate that agrin is a substrate of neurotrypsin also in the 
CNS, potentially regulating agrin’s synaptic functions. 
 
1.4 Aim of this study 
Agrin is a substrate of neurotrypsin in vitro and at the NMJ in vivo (section 1.3.2). The 
aim of this study was to analyse the possible functional interaction of neurotrypsin and agrin 
in the CNS. This was supposed to be achieved by two fundamentally different approaches. 1) 
By performing a detailed biochemical in situ analysis of the potential neurotrypsin-dependent 
cleavage of agrin in the murine CNS. 2) By determining its potential functional implications 
with cell biological analyses in vitro.  
2. Material and Methods  34 
 
2. Material and Methods 
2.1 In situ analyses in the murine brain 
2.1.1 Generation of transgenic mice.* To generate the pThy1-loxP-STOP-loxP-neurotrypsin 
constructs, either mouse or human neurotrypsin cDNA was subcloned into the XhoI site of the 
murine Thy1.2 genomic expression cassette (Caroni, 1997). The loxP-flanked transcription 
termination cassette from the pBS302 vector (Invitrogen AG, Basel, Switzerland) was 
inserted between the Thy1 promoter and the translational start codon of neurotrypsin. To 
generate the pThy1-neurotrypsin construct containing the serine-to-alanine mutation, a PCR 
fragment was amplified using mouse neurotrypsin cDNA as a template and 5'-
CGTGTGGACAGCTGCCAGGGAGACGCTGGAGGA-3' and 5'-CTCAAGCTTAGTTAC-
AGACTGGTGACACTTTTTATC-3' as primers. This fragment was reintroduced into the 
vector containing full-length mouse neurotrypsin. The mutated neurotrypsin cDNA was 
excised and subcloned into the XhoI site of the Thy1.2 cassette. The two resulting vectors 
were digested with PvuI, and the fragments were purified from agarose gels for pronuclear 
injections into fertilised oocytes according to standard protocols (Rulicke, 2004). Zygotes 
were produced by mating B6C3F1 hybrids. The offspring of transgenic founders of each 
transgenic line (mouse neurotrypsin, Tg(Prss12)533.1Zbz; human neurotrypsin, 
Tg(PRSS12)491.1Zbz; inactive mouse neurotrypsin, Tg(Prss12S785A)785.1Zbz were mated 
with C57BL/6-Tg(CMV-cre) mice (Schwenk et al., 1995) to delete the floxed transcription 
termination cassette (Sauer, 1998) and activate the dormant transgene. Subsequent offspring 
of constitutively overexpressing mice were backcrossed for more than 10 generations to 
C57BL/6 to produce congenic lines. For genotyping, animals were screened by PCR on 
genomic DNA using the primers 5'-CCCATCCACATGGATAATGTGAA-3' and 5'-
CCCATGTTCTGAGATATTGGAAG-3' (and see section 2.2.11). Neurotrypsin deficient 
mice were generated as described before (Reif et al., 2007). In brief, a targeting vector, 
containing the genomic DNA segment comprising exons 10 and 11 of murine neurotrypsin, 
was generated by inserting a loxP site 0.22 kb upstream of neurotrypsin exon 10 and a floxed 
neomycin resistance sequence 0.12 kb downstream of neurotrypsin exon 11. In addition, 
homology arms of 7.5 kb and 3.5 kb were added at the 5’- and 3’- regions, respectively. For 
negative selection, a diphtheria toxin cassette was inserted at the 3’ end. The linearised 
targeting vector was electroporated into C57BL/6-derived embryonic stem cells. Stem cell 
lines with homologous recombination were injected into blastocysts and a germ-line chimeric 
male was crossed with C57BL/6 females to generate heterozygous animals. These animals 
were crossed with CMV-Cre mice to excise the floxed region, resulting in a truncated 
neurotrypsin gene lacking the region encoding the proteolytic domain. Agrin-deficient 
animals, lacking the region from exon 6 to 33 of the agrin gene, were obtained from J. Sanes 
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and generated as described previously (Lin et al., 2001). All experimental protocols were 
approved by the Veterinary Department of the Canton of Zurich, Switzerland. 
* mice were generated by Serguei V. Kozlov, Paolo Cinelli or Andreas Zurlinden (all Department of 
Biochemistry, University of Zurich, Zurich, Switzerland) with additional help by Thomas Rülicke (Institute of 
Laboratory Animal Science, University of Zurich, Zurich, Switzerland), unless otherwise stated. Animal 
breedings were maintained by Beat Kunz and Daniel Blaser (Department of Biochemistry, University of Zurich, 
Zurich, Switzerland). 
 
2.1.2 Antibodies. The rabbit antiserum SZ177 was raised against two synthetic peptides 
corresponding to Asp22-Gln40 and Leu45-Phe57 of mouse neurotrypsin (CAA73646) and goat 
antiserum G93 was raised against full-length mouse neurotrypsin (Reif et al., 2007). Rabbit 
antiserum R132 (C-90-1) and goat antiserum G91 (C-90-2) were raised against the C-90-kDa 
fragment of agrin. Goat antiserum G92 (C-22-1) and rabbit antiserum R139 (C-22-2) were 
raised against the C-22-kDa fragment of agrin (Reif et al., 2007). The C-90 and C-22 anti-
agrin sera were purified by affinity chromatography. Western blotting: Depending on the goal 
of the analysis, either the anti-C-22 or the anti-C-90 antibodies were used. The anti-C-22 
antibodies were used to make sure that the detected signals corresponded to full-length agrin, 
because they were directed versus the most C-terminal domain of agrin. Because of their 
higher affinity, the anti-C-90 antibodies were superior to the anti-C-22 antibodies when 
detection of low amounts of antigen was the primary goal. In Western blotting experiments, 
both the anti-C-90 and the anti-C-22 antibodies detected the variants of full-length agrin in an 
identical band pattern (Fig. 19). The slight differences in the relative intensity of the upper, 
middle, and lower variants obtained with the anti-C-22, compared to the anti-C-90 antibodies, 
most likely reflected a differential preference of the antibodies for distinct variants of agrin 
rather than contributions from neurotrypsin-dependent cleavage fragments, although 
fragments that originate from cleavage only at the β site are expected to co-localise with the 
full-length forms of agrin on Western blots in the Mr range above 250 kDa. Co-expression of 
agrin and neurotrypsin in HeLa cells resulted in the release of not only the 22-kDa and the 90-
kDa, but also the 110-kDa fragment that originated from partial cleavage at the α site (Reif et 
al., 2007). This pattern demonstrated that neurotrypsin-dependent cleavage at the β site was 
not a necessary condition for cleavage at the α site and suggested that agrin cleavage at the α 
site preceded β site-cleavage, or that cleavage occurred at both sites in parallel. Therefore, we 
assumed that the large agrin fragment generated by partial cleavage at the β site and, thus, 
lacking only the 22-kDa fragment, occurred only in negligible amounts if at all. The anti-C-
22-1 antibody was used for detection of full-length agrin in the initial analyses of 
neurotrypsin-dependent agrin cleavage in brain homogenates of both neurotrypsin-
overexpressing and neurotrypsin-deficient mice (Fig. 21), in order to exclude detection of 
partially cleaved agrin variants. As these analyses were done with P9 mouse brain tissue, the 
agrin signals were sufficiently strong to be detected by this relatively low affinity antibody. In 
contrast, for all experiments that required sensitive detection of weak signals, including the 
2. Material and Methods  36 
 
analysis of the time course of agrin cleavage (Fig. 20) and the analyses of synaptosomal 
preparations from wild-type or transgenic animals overexpressing neurotrypsin (Fig. 23, 24), 
the anti-C-90-1 antibody that has a higher affinity was used. Immunocytochemistry: Mainly 
the anti-C-90 antibodies were used for immunofluorescence detection of agrin variants, 
because of their higher affinity.  
 
Table 1: Antibodies 
 
name/antigen 
antibody
species 
type concentration/dilution 
for Western blotting 
concentration/dilution for 
immunocytochemistry 
SZ177 rabbit serum 1:1000 1:200 
G93 goat serum 1:2,000 1:2,000 
R132 (C-90-1) rabbit serum 1:1,000 -- 
R132 (C-90-1) rabbit affinity purified 1 μg/ml 1 μg/ml 
G91 (C-90-2) goat serum -- 1:10,000 
G91 (C-90-2) goat affinity purified 1 μg/ml -- 
G92 (C-22-1) goat affinity purified 2.5 μg/ml -- 
R139 (C-22-2) rabbit affinity purified 2.5 μg/ml -- 
R149 (NtA) rabbit serum 1:1000 1:1000 
PSD-95 mouse IgG 1:2,000 -- 
beta-actin mouse IgG 1:7,000 -- 
synaptophysin rabbit serum -- 1:200 
synaptophysin mouse IgG 1:1000 1:1,000 
MAP-2 mouse IgG -- 1:1,000 
Lamp-1 mouse IgG -- 1:200 
Peroxidise-conjugated 
secondary anti-mouse 
goat IgG 1:20,000 -- 
Peroxidise-conjugated 
secondary anti-goat 
rabbit IgG 1:30,000 -- 
Peroxidise-conjugated 
secondary anti-rabbit 
goat IgG 1:20,000 -- 
FITC/Cy3-labeled 
secondary antibodies 
donkey IgG -- 1:400 
AMCA/Cy5-labeled 
secondary antibodies 
donkey IgG -- 1:200 
 
Rabbit antiserum R149 was raised against the N-terminal domain of the secreted agrin 
isoform (anti-NtA antibody). The monoclonal anti-β-actin antibody (clone AC-74) and the 
monoclonal antibody against microtubuli-associated protein 2 (MAP-2, clone HM-2) were 
purchased from Sigma-Aldrich Co. (Saint Louis, MO, USA). The monoclonal anti-PSD-95 
antibody (clone10) was purchased from BD Biosciences (Allschwil, Switzerland). The 
polyclonal antibody against synaptophysin (A00010) was purchased from DAKO GmbH 
(Hamburg, Germany) and the monoclonal antibody against synaptophysin (MAB5258) was 
purchased from Chemicon International (Millipore AG, Zug, Switzerland). The monoclonal 
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antibody against human lysosomal membrane-associated protein 1 (Lamp-1) was kindly 
provided by Dr. Jack Rohrer (University of Zurich, Zurich, Switzerland). The peroxidase-
conjugated secondary antibodies for immunoblotting were purchased from Sigma Aldrich Co. 
(Saint Louis, MO, USA). The Fluorescence-labeled secondary antibodies for 
immunocytochemistry were purchased from Jackson ImmunoResearch Europe Ltd. 
(Newmarket, Suffolk, UK). 
 
2.1.3 Brain tissue preparation. Embryonic tissue:  Embryos were removed from pregnant 
mice (C57BL/6 wild type, agrin-deficient or neurotrypsin-deficient mice) at defined time 
points and whole brains were dissected under a stereomicroscope (Wild, Heerbrugg, 
Switzerland), using micro-scissors and Dumont Tweezers #55 (World Precision Instruments 
Inc., Sarasota, FL, USA). Isolated brains were mmediately transferred into 35 mm dishes 
(Corning B.V. Life Sciences, Schiphol-Rijk, The Netherlands) containing Hank’s balanced 
salt solution (HBSS, Invitrogen AG, Basel, Switzerland) or phosphate-buffered saline (PBS; 
137 mM NaCl, 2.7 mM KCl, 8 mM Na2HPO4, 1.5 mM KH2PO4, pH 7.4). Forebrain/midbrain 
sections were further isolated and processed as stated below.  
Tissue from postnatal animals: Whole brains of C57BL/6 wild-type mice, 
neurotrypsin-deficient mice, mice overexpressing catalytically active human neurotrypsin or 
catalytically inactive mouse neurotrypsin were carefully removed from the animals scull. The 
anterior part of the brain, obtained by vertical dissection directly behind the cortex, was 
labelled the forebrain/midbrain section. Forebrain/midbrain tissue was further processed by 
homogenisation in a glass-teflon homogeniser (1,000 rpm, 10 strokes) in ice-cold buffer A 
(320 mM Sucrose, 5 mM HEPES, pH 7.5, containing protease inhibitors (1:100 dilution, P-
8340, Sigma Aldrich Co., Saint Louis, MO, USA)). After brief centrifugation of the 
homogenates at 1,000 x g, 4 °C, supernatants were collected and protein concentrations were 
measured by a Bradford assay (Bio-Rad Laboratories, Inc., Hercules, CA, USA). 
 
2.1.4 SDS-PAGE and Western blotting. Samples with equal protein concentrations were 
resolved by SDS-PAGE on 4-12 % NUPAGE gels using MOPS running buffer or on 10-20 % 
NOVEX Tricine gels (both from Invitrogen AG, Basel, Switzerland), following the 
manufacturers instructions. These pre-cast gels were mainly used for optimised full-length 
agrin separation and simultaneous detection of full-length agrin variants and agrin cleavage 
fragments. Alternatively, samples with equal protein concentrations were resolved by SDS-
PAGE on conventional, discontinuous 10 % or 12.5 % gels (Laemmli, 1970). Proteins were 
subsequently blotted to polyvinylidene fluorid membranes (Immobilon P membrane, 
Millipore AG, Zug, Switzerland). Mainly for full-length agrin detection and neurotrypsin 
detection in brain tissues, proteins were transferred by wet blotting in a Criterion blotter (Bio-
Rad Laboratories, Inc., Hercules, CA, USA) using 0.5 x blotting buffer (12.5 mM Tris, 91 
mM Glycine, 10 % Methanol) or 1x NUPAGE transfer buffer (Invitrogen AG, Basel, 
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Switzerland) at 20 volts for 16-24 hours at 4 °C. Otherwise, proteins were semi-dry blotted in 
a Trans-Blot SD Transfer Cell (Bio-Rad Laboratories, Inc., Hercules, CA, USA) using 1 x 
blotting buffer (25 mM Tris, 192 mM Glycine, 20 % Methanol) at 24 Volts for 1 hour at room 
temperature. The membranes were stained with Ponceau-solution (2 % Ponceau-S, 30 % 
trichloric acid, 30 % sulfosalicylic acid), destained in distilled water and dried to finalise 
blocking of the membranes. Primary antibodies were diluted in Tris-buffered saline (TBS; 10 
mM Tris/HCl, 150 mM NaCl, pH 8.0) containing 0.1 % Tween-20 (TBST) and 2.5 % 
Western blocking reagent (Roche Diagnostics (Schweiz) AG, Rotkreuz, Switzerland), and 
incubated with the membranes for 60 min. After washing with TBST, the blots were 
incubated with peroxidase-conjugated secondary antibodies for 45 min, and washed again. 
Immunoreactive protein bands were detected using ChemiGlow (Alpha Innotech GmbH, 
Kasendorf, Germany) and a LAS-3000 Fujifilm imager (Fujifilm Europe GmbH, Düsseldorf, 
Germany). For reprobing, membranes were incubated twice for 30 min in stripping solution 1 
(0.1 % SDS, 1 % Tween-20, in 200 mM glycine-HCl, pH 2.2) or trice for each 10 min in 
stripping solution 2 (200 mM NaOH) and afterwards extensively washed in TBST before 
incubation with primary antibodies. 
 
2.1.5 Heparitinase digestion. The forebrain/midbrain regions of one P6 C57BL/6 mouse 
were homogenised with a glass-teflon homogeniser (1,000 rpm, 10 strokes) in enzyme buffer 
(20 mM Tris, 0.1 mg/ml BSA, 4 mM CaCl2, protease inhibitors, pH 7.5). After brief 
centrifugation of the homogenate at 1,000 x g, the supernatant was collected and the protein 
concentration was measured by a Bradford assay (Bio-Rad Laboratories, Inc., Hercules, CA, 
USA). Aliquots of 150 µg protein were incubated with 1 U heparitinase (heparinase III, 
reconstituted in enzyme buffer, Sigma-Aldrich Co., Saint Louis, MO, USA) for either 2 or 5 
hours at 37 °C. For the control sample, 150 µg protein were incubated in enzyme buffer alone. 
Reactions were stopped by freezing the samples in liquid nitrogen. Samples were finally 
analysed by SDS-PAGE and Western blotting for full-length agrin detection (section 2.1.4). 
 
2.1.6 Preparation of synaptosomes. The data presented were obtained with synaptosomal 
preparations from P12 animals or older. Preparations from brain tissue of younger animals 
yielded synaptosomal samples of minor purity, as confirmed by electron microscopy, and 
were therefore not considered. Therefore, synaptosomes were prepared from P12 to P15 
neurotrypsin-overexpressing transgenic mice or from P13-P16 neurotrypsin-deficient mice 
and their corresponding wild-type littermates as described before (Phelan and Gordon, 1997). 
In brief, the forebrain/midbrain regions from 6 mice were homogenised with a glass-teflon 
homogeniser (800 rpm, 12 strokes) in buffer A (320 mM Sucrose, 5 mM HEPES, pH 7.5, 
containing protease inhibitors (1:100 dilution, P-8340, Sigma Aldrich Co., Saint Louis, MO, 
USA)) and centrifuged at 1,000 x g for 5 minutes. The resulting supernatant was further 
centrifuged at 12,000 x g for 20 minutes to produce the crude synaptosomal pellet. To reduce 
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the content in mitochondria, only the upper part of the pellet was resuspended and re-
homogenised in buffer A using a handheld glass-homogeniser (5 strokes) and the 
centrifugation at 12,000 x g was repeated. Again, only the upper part of the pellet was 
resuspended and re-homogenised in buffer A, loaded on a 7.5 %/12 % Ficoll step gradient and 
centrifuged at 68,000 x g for 1 hour. The synaptosomes, concentrated at the 7.5 % /12 % 
Ficoll gradient interphase, were well separated from a mainly myelin-containing band in the 
upper part of the 7.5 % Ficoll phase and the mainly mitochondria-containing pellet. The 
synaptosomal fraction was collected by puncturing the tube with a 18 g needle and further 
analysed by Western blotting or electron microscopy. To prepare samples for electron 
microscopy, purified synaptosomes were washed and resuspended in Krebs solution (20 mM 
HEPES, 145 mM NaCl, 5 mM KCl, 1.3 mM MgCl2, 1.2 mM NaH2PO4, 10 mM Glucose, pH 
7.5), incubated for 10 minutes at 37 °C and fixed overnight at 4 °C in 4 % formaldehyde and 
0.05 % glutaraldehyde in phosphate buffer (PB, 0.1 M, pH 7.4). 
 
2.1.7 Electron microscopy of the synaptosomal fraction.** After several washes of the 
purified and fixed synaptosomes (see above) in PB the samples were osmicated in 1 % OsO4 
in PB for 30 minutes, washed thoroughly with PB and dehydrated in increasing 
concentrations of ethanol. Subsequently, fractions were embedded in Epon resins (Epon 812, 
Fluka, Buchs, Switzerland). Ultrathin sections from synaptosomes were imaged using a 
digital camera (Gatan 791 multiscan; Gatan Inc., Pleasanton, CA, USA) attached to a EM10C 
electron microscope (Zeiss, Oberkochen, Germany). 
** Electron microscopy experiments were performed by José María Mateos. 
 
2.1.8 Mass spectrometric analysis. Both agrin C-90 fragments were affinity purified from 
P25 to P50 neurotrypsin-overexpressing transgenic mouse brains. At this age, both bands 
appear with almost equal intensity and, due to overexpression of active neurotrypsin, in 
substantial amounts. In addition, at ages above P15, bands detected in mouse brain tissue 
appear well separated (Fig. 20A). In brief, forebrain/midbrain tissue (section 2.1.3) from 53 
brains was homogenised in purification buffer (20 mM HEPES, 80 mM NaCl, pH 7.5, 
including protease inhibitors (1:100 dilution, P-8340, Sigma Aldrich Co., Saint Louis, MO, 
USA)) with a 15 % tissue to buffer ratio. The soluble fraction, obtained by ultracentrifugation 
at 100,000 x g for 1 hour at 4 °C (Sorvall T865 rotor, Thermo Fisher Scientific Inc., Waltham, 
MA, USA), was used for heparin-sepharose CL-6B affinity chromatography (Amersham 
Biosciences, GE Healthcare UK Ltd., Buckinghamshire, UK). Proteins were eluted with 1M 
NaCl, in 20mM HEPES, pH 7.5, and the eluate was concentrated with VIVASPIN20 
centrifuge cartridge concentrators (MWCO: 50 kDa; Sartorius AG, Goettingen, Germany). 
Samples were further purified by immunoaffinity chromatography, using immobilised 
affinity-purified antibody R132. Bound proteins were eluted by boiling the affinity-matrix in 
10 % SDS/PBS (137 mM NaCl, 2.7 mM KCl, 8 mM Na2HPO4, 1.5 mM KH2PO4, pH 7.4, 
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containing 10 % (w/v) SDS). The eluted proteins were concentrated by methanol/chloroform 
protein precipitation (Wessel and Flugge, 1984), resuspended in Laemmli buffer (Laemmli, 
1970) and separated by 10 % SDS-PAGE to yield maximal partition of the upper and lower 
90-kDa agrin bands. Separated proteins were visualised using the colloidal blue staining kit 
(Invitrogen AG, Basel, Switzerland). Bands corresponding to both upper and lower 90-kDa 
agrin (see results, Fig. 20) were analysed by LC-ESI-MS/MS analysis on a Qutof Ultima API 
(Waters S.A.S., Saint-Quentine, France) at the Functional Genomics Center Zurich, 
University and ETH Zurich, Switzerland. 
 
2.1.9 Quantification and statistical analysis. Western blots were recorded with a LAS-3000 
Fujifilm imager (Fujifilm Europe GmbH, Düsseldorf, Germany) and densitometric analyses 
of the protein bands were performed using AIDA software (Raytest GmbH, Straubenhardt, 
Germany). I was careful to avoid measurement of saturated signals. For analysis of P9 mouse 
brain homogenates, at least 3 animals per genotype were analysed and compared to signals of 
at least 3 different corresponding wild-type littermates. Signals of two independent blots per 
genotype were quantified and used for statistical analyses. For densitometric analyses of 
synaptosomal preparations, five separate preparations were analysed. For all analyses, agrin 
signals were first normalised to actin signals of the corresponding sample, serving as an 
internal loading control. Then, adjusted values obtained from transgenic or neurotrypsin-
deficient samples of each experiment were compared to the corresponding adjusted signals 
from the samples of wild-type littermates, whereby the wild-type signal was set to 100 
percent. Data are presented as mean ± S.E.M. Statistical analyses were performed using 
unpaired Student’s t-test (Sigmaplot, Systat Software, Inc., San Jose, CA, USA). 
 
2.2 Molecular biology techniques 
2.2.1 Generation of competent bacteria. Heat shock Ca2+ competent E. coli DH-5α or XL-1 
blue bacteria were generated as follows: 20 ml sterile LB-medium (10 g bacterial peptone, 5 
g yeast extract, 5 g NaCl in 1 l distilled H2O) was inoculated with bacteria and grown 
overnight at 37 °C. Then, 4 ml preculture were added to 400 ml LB-medium and incubated at 
37 °C, 180 rpm shaking until an OD600 of about 0.375 (Kontron Spectrophotometer Uvikon 
810, Kontron AG, Eching, Germany). The culture was then distributed to 8 x 50 ml tubes 
(Sarstedt AG & Co., Nümbrecht, Germany) and kept on ice for 10 min. Bacteria were 
afterwards pelleted at 3,000 rpm, 7 min, 4 °C (Sorvall RT6000D, Thermo Fisher Scientific 
Inc., Waltham, MA, USA), supernatant was discarded and pellets were resuspended in each 
10 ml ice-cold CaCl2 solution (60 mM CaCl2, 15 % glycerol, 10 mM PIPES, pH7.0). Bacteria 
solutions were pooled to 2 x 50 ml tubes and kept on ice for 1 hour. Cells were pelleted at 
3,000 rpm, 5 min, 4 °C, resuspended in each 10 ml ice-cold CaCl2 solution and pooled to a 50 
ml tube. Cells were pelleted again as described above and the final pellet was resuspended in 
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2 ml ice-cold CaCl2 solution, distributed into pre-chilled sterile 1.5 ml tubes (Eppendorf AG, 
Hamburg, Germany), frozen immediately on dry ice and stored at -80 °C.  
Electro competent E. coli BM25.8 bacteria were generated as follows: 50 ml sterile LB-
medium (see above but containing 10 μg/ml Kanamycin) was inoculated with bacteria and 
grown overnight at 37 °C. Then, the preculture was added to 800 ml LB-medium and 
incubated at 37 °C, 180 rpm shaking until an OD600 of about 0.5 (Kontron Spectrophotometer 
Uvikon 810, Kontron AG, Eching, Germany). The culture was then chilled on ice for about 
20 min, distributed to 16 x 50 ml prechilled tubes (Sarstedt AG & Co., Nümbrecht, Germany) 
and centrifuged at 4500 rpm, 10 min, 4 °C to pellet bacteria. The supernatant was discarded, 
cells were resuspended in 10 ml/tube ice-cold sterile distilled water and bacteria solutions 
were pooled to 4 x 50 ml tubes. Cells were pelleted again at 4500 rpm, 10 min, 4 °C, 
resuspended in 10 ml/tube sterile ice-cold 10 % glycerol/distilled water and pooled to one 50 
ml tube. Cells were pelleted once more at 3000 rpm, 4 °C, 10 min, finally resuspended in 2 ml 
sterile 10 % glycerol/distilled water, distributed to pre-chilled sterile 1.5 ml tubes (Eppendorf 
AG, Hamburg, Germany), frozen immediately in liquid nitrogen and stored at -80 °C. 
 
2.2.2 Transformation of bacteria. Heat-shock Ca2+ competent bacteria: 50 μl Competent E. 
coli DH5α or XL-1 blue bacteria (section 2.2.1) were thawed on ice, mixed with either 5 μl 
ligation sample (section 2.2.7) or 10 ng vector DNA and kept on ice for further 30 min. Heat 
shock transformation was achieved by incubation of the samples for 1 min at 42 °C. 
Afterwards, 800 μl LB-medium (10 g bacterial peptone, 5 g yeast extract, 5 g NaCl in 1 l 
distilled H2O) were added to the transformation sample and the bacteria were further 
incubated for 30 min at 37 °C, shaking. Bacteria were pelleted at 1,000 g for 3 min and 
resuspended in 100 μl supernatant. The final suspension was then plated onto LB/Agar-plates 
(10 g bacterial Peptone, 5 g yeast extract, 5 g NaCl, 13 g Agar in 1 l H20) containing suitable 
antibiotics for selective growth of transformed bacteria and incubated overnight at 37 °C. 
Electro competent bacteria: 100 μl electro-competent E. coli (e.g., E. coli BM25.8; section 
2.2.1) bacteria were thawed on ice, mixed with respective plasmid DNA and transferred to 
pre-chilled electroporation cuvettes (0.1 cm gap, Bio-Rad Laboratories, Inc., Hercules, CA, 
USA). Electroporation was performed in a Gene Pulser (Bio-Rad Laboratories, Inc., Hercules, 
CA, USA) at 1.6 V, 200 μOhm, 25 μFD (960 μFD extended). Immediately afterwards, the 
sample was diluted with 800 μl LB medium (10 g bacterial peptone, 5 g yeast extract, 5 g 
NaCl in 1 l distilled H2O) within the cuvette, transferred to an 1.5 ml tube (Eppendorf AG, 
Hamburg, Germany) and further incubated shaking for 30 min at 37 °C. Cells were pelleted 
(1000 x g, 3 min), resuspended in 100 μl supernatant and plated onto LB/Agar-plates (10 g 
bacterial Peptone, 5 g yeast extract, 5 g NaCl, 13 g Agar in 1 l H20) containing suitable 
antibiotics for selective growth of transformed bacteria and incubated overnight at 37 °C. 
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2.2.3 Working concentrations of antibiotics. The following antibiotics (Invitrogen AG, 
Basel, Switzerland) were applied for selective growth of transformed bacteria, dependent on 
the respective plasmid properties: Ampicilline (100 μg/ml; 60 μg/ml in combination with 30 
μg/ml Zeocin for pAd selection); Zeocin (30 μg/ml); Kanamycin (10 μg/ml);  
 
2.2.4 Mini-preparation and Midi-preparation production of vector-constructs. For low 
yield vector amplification and analyses of plasmid clones, mini-preparations were performed 
using the QFX microprep kit (QE Healthcare UK Ltd., Buckinghamshire, England). Briefly, 3 
ml of LB-medium (10 g bacterial peptone, 5 g yeast extract, 5 g NaCl in 1 l distilled H2O), 
containing suitable antibiotics for selective growth of transformed bacteria, were inoculated in 
15 ml Falcon tubes (BD Biosciences, Allschwil, Switzerland) with bacteria from a colony 
grown on a LB/Agar plate (section 2.2.2) or from a glycerol stock (see below) and incubated 
for 16 hours at 37 °C, shaking. Bacteria were pelleted and isolation, purification and elution 
of plasmid DNA were performed according to the manufacturers protocol. Purified plasmid 
DNA was analysed by restriction digest analysis (section 2.2.5) and DNA sequencing 
(Microsynth AG, Balgach, Switzerland). Plasmid DNA was stored at -20 °C and mini-
cultures of positive clones were stored as glycerol stocks (final 20 % glycerol) in Cryo tubes 
(Nunc GmbH & Co. KG, Wiesbaden, Germany) at -80 °C. 
To produce highly pure and high yield plasmid DNA, midi-preparations were 
performed with the Qiafilter midi kit (Qiagen AG, Hombrechtikon, Switzerland). In brief, 50 
ml of LB-medium, containing suitable antibiotics for selective growth of positive bacteria 
clones, were inoculated in 50 ml tubes (Sarstedt AG & Co., Nümbrecht, Germany) with 
bacteria from a mini-culture (see above) or from a glycerol stock (see above) and incubated 
for 16 hours at 37 °C, shaking. Bacteria were pelleted and isolation, purification and elution 
of plasmid DNA were performed according to the manufacturers protocol. Purified plasmid 
DNA was analysed by restriction digest analysis and DNA sequencing (Microsynth AG, 
Balgach, Switzerland) and stored at -20 °C. 
 
2.2.5 Restriction digest analyses and gel extraction of DNA samples. Restriction enzymes 
were obtained from New England Biolabs (Ipswich, MA, USA), Promega AG (Dübendorf, 
Switzerland) or Fermentas International Inc (Burlington, Ontario, Canada) and digests of PCR 
products or plasmid DNA were performed according to standard manufacturers protocols in 
1.5 ml tubes (Eppendorf AG, Hamburg, Germany). DNA was purified using the ‘PCR 
product purification kit’ (Qiagen AG, Hombrechtikon, Switzerland). Alternatively, if 
separation of digested fragments was desired, samples were constituted with 6x loading buffer 
(10 mM Tris/HCl pH 7.5, 30% glycerol, 0.1 % Xilene cyanol, 0.1 % bromphenol blue) and 
separated by agarose gel electrophoresis (0.8-2 % agarose in TAE buffer (40 mM Tris-acetate, 
2 mM Na2EDTA, pH 8.5), containing 1 μg/ml ethidium bromide). Desired bands were 
excised from the gel and finally eluted in TE buffer (10 mM Tris/HCl pH 7.5, 1 mM EDTA) 
43  2. Material and Methods 
 
using the ‘gel extraction kit’ (Qiagen AG, Hombrechtikon, Switzerland). In case of fragments 
bigger than 10 kb, the ‘QiaExII kit’ (Qiagen AG, Hombrechtikon, Switzerland) was used for 
gel-extraction and purification of DNA fragments.  
 
2.2.6 Ethanol precipitation. To change buffer conditions for further enzymatic processing of 
plasmid DNA or to concentrate DNA, the DNA was precipitated by adding 10 mM EDTA, 
300 mM sodium acetate and 100 % ethanol (precooled to -20 °C; final concentration: 70 %). 
Samples were incubated for 60 min or overnight at -20 °C and DNA was subsequently 
pelleted in a table-top centrifuge (Eppendorf AG, Hamburg, Germany) at 14,000 rpm for 20 
min at 4 °C. The pellet was washed once with 70 % ethanol, centrifuged for 2 min at 14,000 
rpm and air-dried for 10 minutes at room temperature. Finally, DNA was resuspended  in TE 
buffer (10 mM Tris/HCl pH 7.5, 1 mM EDTA) or elution buffer (Qiagen AG, 
Hombrechtikon, Switzerland) by incubating the sample for 10 min at 50 °C, shaking.  
 
2.2.7 Ligation. Ligation of double stranded DNA ends was performed using the DNA ligation 
kit ‘mighty mix’ (Takara Bio Inc., Shiga, Japan) according to the standard manufacturers 
protocol. Briefly, linearised plasmid vector backbone DNA and DNA fragment inserts were 
mixed in a molecular ratio of 1:3 in total 5 μl volume and incubated with 5 μl of Takara 
ligation mix for 30 min at 16 °C in a Thermocycler T3 (Biometra biomedizinische Analytik 
GmbH, Göttingen, Germany). Ligation samples were stored at -20 °C or directly used for 
transformation of competent bacteria (section 2.2.2). In case of electro-shock transformation 
of electro competent bacteria, ligation samples were dialysed and therefore desalted on MF-
Millipore Membranes (VSWP01300, 0.025 μm, 13 mm; Millipore AG, Zug, Switzerland) 
floating on distilled H2O in a Petri dish (Sarstedt AG & Co., Nümbrecht, Germany) for 30 
minutes, prior to transformation. 
 
2.2.8 Generation of neurotrypsin and membrane targeted eGFP expression constructs. 
The following neurotrypsin (all mus musculus) expression constructs were generated in our 
lab: Wild-type neurotrypsin, catalytically inactive neurotrypsin (mutation of the catalytic 
serine, at amino acid position 711, to alanine) and either catalytically active or inactive 
variants of neurotrypsin-enhanced green fluorescent protein (eGFP (Cubitt et al., 1995; Heim 
et al., 1995), Clontech, Takara Bio Inc., Shiga, Japan) fusion proteins. These variants were 
generated by fusing the eGFP cDNA sequence in-frame to the 3’-end of neurotrypsin. The 
respective coding sequences were subcloned into the pCDNA3.1(-)A vector (Invitrogen AG, 
Basel, Switzerland) or into the transfer vector for adenovirus production (pCMVtransfer; 
section 2.3; (Frischknecht et al., 2008)). 
A construct coding for amino acids 1-41 of myristoylated alanine-rich C-kinase 
substrate (MARCKS; homo sapiens) fused at its 3’-end in-frame via a linker (coding for the 
two amino acids glycine and serine) to eGFP (MARCKS-eGFP) was kindly provided by P. 
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Caroni (FMI Basel, Basel, Switzerland). This construct targets eGFP to cellular membranes 
(De Paola et al., 2003). The MARCKS-eGFP sequence was excised with XhoI and subcloned 
into the pCDNA3.1(+) vector (Invitrogen AG, Basel, Switzerland) or into the transfer vector 
for  adenovirus production (pCMVtransfer; section 2.3). 
 
2.2.9 Generation of agrin expression constructs. The transmembrane agrin-x12, y4, z8 
isoform (SN-agrin (rattus norvegicus), kindly provided by M. Rüegg, Biozentrum, Basel, 
Switzerland), was selected, because SN-agrin is strongly expressed in CNS neurons both in 
vitro and in vivo (O'Connor et al., 1995; Lesuisse et al., 2000). In addition, this isoform has 
been used in most of the studies analysing agrin functions in CNS neurons (Hilgenberg et al., 
1999; Bose et al., 2000; Gingras et al., 2002; Hilgenberg et al., 2002; Hoover et al., 2003). 
eGFP-tagged variants of neurotrypsin were generated in our lab (section 2.2.8). Therefore, a 
wild-type SN-agrin expression construct and, for simultaneous microscopic analyses of co-
expressed neurotrypsin and agrin variants in living neurons, monomeric red-fluorescent 
protein (mRFP (Campbell et al., 2002)) tagged SN-agrin variants were produced. These 
constructs contained mRFP in-frame either at agrin’s N-terminus or its C-terminus. 
Concerning the analysis of neurotrypsin-dependent cleavage of agrin, these mRFP-agrin and 
agrin-mRFP constructs were believed to also enable the tracking of agrin parts after 
neurotrypsin-dependent cleavage. In addition, SN-agrin expression constructs were generated 
that are not cleavable by neurotrypsin (SN-agrin-mutant). Several modified parts of SN-agrin, 
carrying a mutation in the P1-position of the α cleavage site (arginine to alanine mutation) or 
the β cleavage site (lysine to alanine mutation), respectively (Reif et al., 2007), were 
assembled to yield the final SN-agrin-mutant construct. Again, untagged as well as mRFP-
tagged variants were generated. Furthermore, as a control for experiments performed to 
analyse SN-agrin’s function to generate filopodia, the secreted variant of the agrin-x12, y4, z8 
isoform (LN-agrin) was generated. All constructs were assembled in the pCDNA 3.1(+) 
vector (Invitrogen AG, Basel, Switzerland) for ectopic expression in transiently transfected 
eukaryotic cells and identically subcloned into the transfer vector for adenovirus production 
(pCMVtransfer; section 2.3), unless otherwise stated.  
SN-agrin-mRFP: Two fragments of about 3.5 kb, covering the total SN-agrin sequence and 
lacking the original agrin stop codon, were generated by PCR using the PfuUltra hot start 
DNA Polymerase (Stratagene, La Jolla, CA, USA) and pCDNA3.1-SN-agrin (M. Rüegg, 
Biozentrum, Basel, Switzerland) as template DNA for final assembly in the pCDNA3.1(+) 
vector. The first fragment, flanked by NotI and NdeI restriction sites, was ligated with the 
second fragment, flanked by NdeI and BglII restriction sites, at the agrin-internal NdeI site. 
mRFP was modified and amplified by PCR from the vector pRSETB-mRFP (kindly provided 
by J. Rohrer, University of Zurich, Zurich, Switzerland) for in-frame ligation to the modified 
3’-end of SN-agrin via its BglII restriction site (see above). The whole construct was inserted 
into the multiple cloning site of the linearised pCDNA 3.1(+) vector via NotI and XbaI 
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restriction sites. The final construct was analysed by sequencing (Microsynth AG, Balgach, 
Switzerland) and also subcloned into the pCMVtransfer vector via NotI and XbaI restriction 
sites. 
Wild-type SN-agrin: The 5’ PCR fragment used for SN-agrin-mRFP generation (see above) 
was ligated with a NdeI to XbaI fragment, obtained by restriction digest from pCDNA3.1-SN-
agrin template DNA (M. Rüegg, Biozentrum, Basel, Switzerland), and inserted via NotI and 
XbaI restriction sites into pCDNA3.1(+). This step was performed to generate matching 
restriction sites for virus-vector assembly. Due to usage of the NdeI/XbaI restriction fragment 
from the original template vector, this construct contained an approximately 1,000 bp long 
stretch of the original agrin 3’ UTR sequence at its 3’-end.  
mRFP-SN-agrin: An approximately 3.5 kb fragment covering the 5’ SN-agrin sequence and 
lacking the original agrin translation initiation codon was generated by PCR using the 
PfuUltra hot start DNA Polymerase (Stratagene, La Jolla, CA, USA) and pCDNA3.1-SN-
agrin (M. Rüegg, Biozentrum, Basel, Switzerland) as template DNA. This construct, flanked 
by NotI and NdeI restriction sites, was ligated with the 3’ agrin NdeI to XbaI fragment, 
obtained by restriction digest from pCDNA3.1-SN-agrin template DNA (M. Rüegg, 
Biozentrum, Basel, Switzerland), into pCDNA 3.1(+) via its NotI and XbaI restriction sites. 
mRFP was modified and amplified by PCR from the vector pRSETB-mRFP (kindly provided 
by J. Rohrer, University of Zurich, Zurich, Switzerland), in this case lacking the original 
mRFP stop codon and containing NotI restriction sites at both ends. This fragment was then 
ligated in-frame with the modified 5’-end of SN-agrin via the NotI site of the previously 
assembled agrin construct. The final construct was analysed by sequencing (Microsynth AG, 
Balgach, Switzerland). Lastly, this construct was subcloned into the multiple cloning site of 
the pCMVtransfer vector via PmeI restriction sites flanking the mRFP-SN-agrin construct. 
Due to usage of the NdeI/XbaI restriction fragment from the original template vector, this 
construct contained an approximately 1,000 bp long stretch of the original agrin 3’ UTR 
sequence. As the insert size for functional virus assembly is limited to 8 kb, the construct was 
subsequently shortened by performing a partial restriction digest with NheI and XbaI enzymes 
to remove approximately 600 bp of the 3’UTR sequence of agrin. 
Mutant SN-agrin (SN-agrin-mutant): Distinct mutant variants of the SN-agrin-x12, y4, z8 
isoform, uncleavable for neurotrypsin at either the α or the β site (the P1 cleavage positions 
mutated to alanine, respectively; (Reif et al., 2007)) were generated in our lab. To yield a 
completely uncleavable agrin variant for pCDNA3.1(+) based as well as adenovirus based 
expression, the different fragments of these mutated variants were assembled. For this, an 
EcoRV/HindIII fragment of an agrin variant mutated at the β site was subcloned into the 
previously cloned pCDNA3.1(+) wild-type SN-agrin variant described above. The mutation at 
the α-site was subsequently inserted by ligation of a NdeI/EcoRV-fragment from a mutant 
clone into the aforementioned wild-type SN-agrin clone, already carrying the mutation at the 
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β site. For adenovirus production, this final construct was subcloned via NotI and XbaI 
restriction sites into the pCMVtransfer vector to generate pCMVtransfer SN-agrin-mutant. 
SN-agrin-mutant-mRFP: A HindIII fragment, containing the whole 5’ agrin sequence 
including the mutated β site sequence from the SN-agrin-mutant clone, was ligated into the 
SN-agrin-mRFP vectors, lacking the original region flanked by HindIII restriction sites.  
mRFP-SN-agrin-mutant: A SalI fragment of mRFP-SN-agrin, containing the mRFP sequence 
as well as approximately the first 1,000 bp of the 5’ region of SN-agrin, was ligated into the 
previously generated SN-agrin-mutant vectors. 
LN-agrin: The cDNA encoding the N-terminal domain (NtA; mus musculus) of the secreted 
isoform of agrin was cloned by A. Zurlinden in our lab. This cDNA was subcloned into the 
SN-agrin construct (rattus norvegicus) via a SmaI restriction site, leading to a secreted variant 
of wild-type agrin-x12, y4, z8 carrying the coding information for the LN domain instead of 
the SN domain. This construct was exclusively generated in the pCDNA3.1(+) expression 
vector. 
 
For all agrin PCR reactions the following reaction mix was prepared, using the PfuUltra hot 
start DNA Polymerase (Stratagene, La Jolla, CA, USA) to yield long transcripts with very 
low error rates: 10 ng template DNA, 1x PCR-buffer, 0.25 mM dNTPs, 0.5 μM forward 
primer, 0.5 μM reverse primer and 2.5 U polymerase. For all mRFP PCR reactions the 
following reaction mix was prepared, using the ‘expand high fidelity PCR system’ (Roche 
Diagnostics (Schweiz) AG, Rotkreuz, Switzerland): 10 ng template DNA, 1x PCR-buffer, 
0.25 mM dNTPs, 0.5 μM forward primer, 0.5 μM reverse primer and 2.5 U polymerase. The 
primer sequences and the PCR program used for each reaction are indicated below. 
Corresponding restriction enzyme recognition sites within the primer are indicated in green 
and mutations introduced into the agrin coding sequence are marked in red. All reactions were 
performed in a Thermocycler T3 (Biometra biomedizinische Analytik GmbH, Göttingen, 
Germany): 
 
SN-agrin-mRFP generation: 
agrin-PCR 
5p-Agrin-NotI 5’-AAG CGG CCG CTG TAT GTA TCA TGC CTC-3’ 
3p-mid-Agrin-NdeI 5’-TGC CAT ATG TCA CAC CGT C-3’ 
5p-mid-Agrin-NdeI 5’-TGA CAT ATG GCA ATG AAT GC-3’ 
3p-mut-Agrin-BglII 5’-TTA GAT CTG TGG CAG CTA AGG GAG TG-3’ 
PCR program: 1x (2’, 95 °C), 30x (30’’, 95 °C; 30’’ 51 °C; 3.5’, 72 °C), 1x (10’ 72 °C) 
 
mRFP-PCR 
5p-mRFP-pRSETB-BglII 5’-AAA GAT CTG GTC CGA TTG CCT CCT CC-3’ 
3p-mRFP-pRSETB-XbaI 5’-AAT CTA GAT TGT TAG CAG CCG GAT CAA GC-3’ 
PCR program: 1x (3’, 95 °C), 20x (30’’, 94 °C; 30’’ 56 °C; 60’’, 72 °C), 1x (7’ 72 °C) 
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5’ of wild-type SN-agrin generation: 
agrin-PCR 
5p-Agrin-NotI 5’-AAG CGG CCG CTG TAT GTA TCA TGC CTC-3’ 
3p-mid-Agrin-NdeI 5’-TGC CAT ATG TCA CAC CGT C-3’ 
PCR program: 1x (2’, 95 °C), 30x (30’’, 95 °C; 30’’ 51 °C; 3.5’, 72 °C), 1x (10’ 72 °C) 
 
mRFP-SN-agrin generation: 
agrin-PCR 
5p-mut-Agrin -NotI 5’-AAG CGG CCG CTG TAT CTA TCT TGC CTC-3’ 
3p-mid-Agrin-NdeI 5’-TGC CAT ATG TCA CAC CGT C-3’ 
PCR program: 1x (2’, 95 °C), 30x (30’’, 95 °C; 30’’ 51 °C; 3.5’, 72 °C), 1x (10’ 72 °C) 
mRFP-PCR 
5p-mRFP-pRSETB-NotI 5’-AAG CGG CCG CTG TAT CTA TCT TGC CTC-3’ 
3p-w/o-stop-mRFP-pRSETB-NotI 5’-TTG CGG CCG CTG CTG AGG CGC CGG TGG AG-3’ 
PCR program: 1x (3’, 95 °C), 20x (30’’, 94 °C; 30’’ 56 °C; 60’’, 72 °C), 1x (7’ 72 °C) 
 
Subsequent to the PCR reaction, samples were constituted with 6x loading buffer (10 mM 
Tris/HCl pH 7.5, 30% glycerol, 0.1 % Xilene cyanol, 0.1 % bromphenol blue) and analysed 
by agarose gel electrophoresis (0.8-2 % agarose in TAE buffer (40 mM Tris-acetate, 2 mM 
Na2EDTA, pH 8.5), containing 1 μg/ml ethidium bromide). Positive bands were excised from 
the gel and purified as stated in section 2.2.5. Eluted PCR fragments were subsequently 
prepared for ligation by digesting with the appropriate restriction enzymes indicated in the 
text, according to manufacturers protocols (section 2.2.5).  
 
2.2.10 Detection of endogenously expressed agrin and neurotrypsin transcripts in 
cultured cells. To confirm the endogenous neuronal expression of neurotrypsin and agrin 
variants in vitro, messenger RNA (mRNA) was isolated from either cultured neurons (see 
section 2.4.1) or from cultured cortical astrocytes (see section 2.4.3), used as feeder cells for 
neuronal cultures (section 2.2.10.1). Isolated mRNA was then re-transcribed into 
complementary DNA (cDNA; section 2.2.10.2) and finally analysed by PCR for neurotrypsin 
and agrin transcripts detection (section 2.2.10.3). 
 
2.2.10.1 RNA isolation from cultured hippocampal neurons and cortical astrocytes. 
Cultured hippocampal neurons (section 2.4.1) were grown in high density (400,000 cells/dish) 
on poly L-lysine coated (0.1 mg/ml) 35 mm plates (Corning B.V. Life Sciences, Schiphol-
Rijk, The Netherlands) in the presence of Cytosine arabinoside (ARA-C, 15 μM, Sigma 
Aldrich Co., Saint Louis, MO, USA) to suppress glia cell growth. Alternatively, cortical 
astrocytes (section 2.4.3), usually employed as glia-feeder cells for hippocampal neuron 
cultures (section 2.4.1), were grown in 35 mm dishes (Corning B.V. Life Sciences, Schiphol-
Rijk, The Netherlands). Total mRNA was isolated using TRI-reagent (Sigma Aldrich Co., 
Saint Louis, MO, USA) according to standard manufacturers protocol. Briefly, cells were 
washed twice with ice-cold PBS (137 mM NaCl, 2.7 mM KCl, 8 mM Na2HPO4, 1.5 mM 
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KH2PO4, pH 7.4) and lysed in 130 μl/well TRI-reagent. Homogenous lysate was incubated for 
5 min at room temperature, 25 μl chloroform were added and the sample was shaken 
vigorously for 15 sec. The mixture was incubated for further 2 to 15 min at room temperature 
and finally centrifuged at 12,000 g for 15 min at 4 °C to produce a red organic phase 
(proteins), the DNA-containing interphase and the upper aqueous phase containing RNAs. 
The RNA-containing aqueous phase was mixed in a new tube with 62.5 μl isopropanol, 
incubated for 5-10 min at room temperature and centrifuged at 12,000 g for 10 min at 4 °C. 
The resulting RNA-containing pellet was washed with 75 % ethanol (7,500 g, 5 min, 4 °C). 
The RNA pellet was subsequently dried for 5-10 min at room temperature and resuspended in 
15 μl diethylpyrocarbonate-treated H2O (DEPC-H2O) at 55 °C for 10 min with a micropipette  
 
2.2.10.2 cDNA synthesis from isolated RNA. The isolated RNA (section 2.2.10.1) was re-
transcribed into cDNA using the ThermoScriptTM RT-PCR System (Invitrogen AG, Basel, 
Switzerland) according to manufacturers protocols. Briefly, 1 µg isolated RNA was 
supplemented with 2.5 μM oligo-dT-primer (neurotrypsin detection) or 2.5 μM 
hexanucleotide-primer (agrin detection) and 2 mM dNTPs in a 0.2 ml PCR tube (Eppendorf 
AG, Hamburg, Germany) and denatured for 5 min at 65 °C. The master reaction mix (1x 
cDNA-synthesis buffer, 5mM DTT, 40 U  RNase OUTTM, 15 U ThermoScriptTM in DEPC-
H2O) was subsequently added. Only samples containing hexanucleotid-primer were incubated 
for 10 min at 25 °C prior to cDNA synthesis, all other samples were kept on ice. Then, cDNA 
synthesis was performed by incubating the samples for 50 min at 51 °C. The synthesis 
reaction was terminated by incubation of the samples for 5 min at 85 °C and template RNA 
was finally digested with 2 U RNAse H for 20 min at 37 °C. Samples were stored at -20 °C. 
 
2.2.10.3 PCR detection of neurotrypsin and agrin transcripts. Finally, isolated cDNA 
(section 2.2.10.2) was analysed by PCR using the ‘expand high fidelity PCR system’ (Roche 
Diagnostics (Schweiz) AG, Rotkreuz, Switzerland) with neurotrypsin and agrin-transcript 
specific primers. For all PCR reactions the following reaction mix was prepared: 2 μl cDNA-
sample (section 2.2.10.2; or 10 ng vector DNA in neurotrypsin and agrin control reactions), 
1x PCR-buffer, 1 mM dNTPs, 0.5 μM forward primer, 0.5 μM reverse primer, 5 μl DMSO 
and 2.5 U polymerase mix. The primer sequences and the PCR program used for each mouse 
line are indicated below (for all analyses, GAPDH was used as a positive control for PCR 
amplification). All reactions were performed as hot start PCR in a Thermocycler T3 
(Biometra biomedizinische Analytik GmbH, Göttingen, Germany): 
 
Neurotrypsin (mus musculus) transcript detection: 
Kringle-Fw 5’-CCG ACG ATT CCA CGC CGC-3’     
BI 5’-CTG TGG TAG ACA ATC TCC-3’ 
GAPDH-Fw 5’-TGC CAT CAA CGA CCC CTTC-3’ 
GAPDH-back 5’-GGA TGA TGT TCT GGG CTG C-3’ 
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PCR program: 1x (3’, 95 °C), 35x (30’’, 94 °C; 30’’ 51 °C; 60’’, 72 °C), 1x (7’ 72 °C) 
 
Transmembrane agrin (mus musculus) isoform transcript detection: 
5pAgrin-SN-N-term 5’-TGC AAC ATC TGC TTG ATC C-3’ 
3pAgrinRT-N-term 5’-TGT AGC TCA CAC TCG TTG C-3’ 
GAPDH-Fw 5’-TGC CAT CAA CGA CCC CTTC-3’ 
GAPDH-back 5’-GGA TGA TGT TCT GGG CTG C-3’ 
PCR program: 1x (3’, 95 °C), 35x (30’’, 94 °C; 30’’ 51 °C; 60’’, 72 °C), 1x (7’ 72 °C) 
 
 
Secreted agrin (mus musculus) isoform transcript detection: 
5pAgrin-LN-N-term 5’-AGA TCC TCA ACG TGG ACC-3’ 
3pAgrinRT-N-term 5’-TGT AGC TCA CAC TCG TTG-3’ 
GAPDH-Fw 5’-TGC CAT CAA CGA CCC CTTC-3’ 
GAPDH-back 5’-GGA TGA TGT TCT GGG CTG C-3’ 
PCR program: 1x (3’, 95 °C), 35x (30’’, 94 °C; 30’’ 51 °C; 60’’, 72 °C), 1x (7’ 72 °C) 
 
Subsequent to the PCR reaction, samples were constituted with 6x loading buffer (10 mM 
Tris/HCl pH 7.5, 30% glycerol, 0.1 % Xilene cyanol, 0.1 % bromphenol blue) and analysed 
by agarose gel electrophoresis (2 % agarose in TAE buffer (40 mM Tris-acetate, 2 mM 
Na2EDTA, pH 8.5), containing 1 μg/ml ethidium bromide). 
 
2.2.11 PCR genotyping. Genomic DNA was isolated by alkaline lysis from tail biopsies of 
embryos or postnatal animals. For this, a 0.5 cm tail biopsy was incubated for 45 min at 96 °C 
in 300 μl alkaline lysis reagent (25 mM NaOH; 0.2 mM Na-EDTA, pH 12.0). The reaction 
was stopped by adding 300 μl neutralising reagent (400 mM Tris-HCl, pH 5.0). Genotyping 
was performed with Taq polymerase (Sigma Aldrich Co., Saint Louis, MO, USA) according 
to the standard manufacturers protocol. For all PCR reactions the following reaction mix was 
prepared: 100 ng extracted DNA-sample, 1x PCR-buffer, 0.25 mM dNTPs, 1.5 mM MgCl2, 
0.5 μM forward primer, 0.5 μM reverse primer and 0.5 U Taq-Polymerase. The primer 
sequences and the PCR program used for each mouse line are indicated below (for all but 
neurotrypsin-deficient and agrin-deficient animals, TAG was used as a positive control for 
PCR amplification). All reactions were performed as hot start PCR in a Thermocycler T3 
(Biometra biomedizinische Analytik GmbH, Göttingen, Germany): 
 
Neurotrypsin (homo sapiens) overexpressing mice: 
hNTSIIfor 5’-GCA ATG TGC CAG ATT CAG CAG-3’ 
Thy1back 5’-CCC ATG TTC TGA GAT ATT GGA AG-3’ 
TAG-83for 5’-GGA GGA GAG AGA CCC CGT GAA A-3’ 
TAG-82back 5’-ACA CGA AGT GAC GCC CAA TCC GT-3’ 
PCR program: 1x (3’, 95 °C), 40x (45’’, 95 °C; 45’’ 63 °C; 60’’, 72 °C), 1x (5’ 72 °C) 
 
Neurotrypsin (mus musculus) overexpressing mice: 
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THY1-300 5’-AGT GCT GGA ATC AAA GGT GTG AGC-3’  
mNTbegR 5’-AGG TCG AGG GAC CTA ATA ACT TCG-3’  
mNTIIfor 5’-CAA TGT GCC AGA CTA AGC ACC-3’  
THY1-back 5’-CCC ATG TTC TGA GAT ATT GGA AG-3’ 
TAG-83for 5’-GGA GGA GAG AGA CCC CGT GAA A-3’  
TAG-82back 5’-ACA CGA AGT GAC GCC CAA TCC GT-3’ 
PCR program: 1x (3’, 95 °C), 40x (45’’, 95 °C; 45’’ 56 °C; 60’’, 72 °C), 1x (5’ 72 °C) 
 
 
 
Mice overexpressing a catalytically inactive variant of neurotrypsin (mus musculus): 
mNTIIfor 5’-CAA TGT GCC AGA CTA AGC ACC-3’ 
Thy1back 5’-CCC ATG TTC TGA GAT ATT GGA AG-3’ 
TAG-83for 5’-GGA GGA GAG AGA CCC CGT GAA A-3’ 
TAG-82back 5’-ACA CGA AGT GAC GCC CAA TCC GT-3’ 
PCR program: 1x (3’, 95 °C), 40x (45’’, 95 °C; 45’’ 56 °C; 60’’, 72 °C), 1x (5’ 72 °C) 
 
Neurotrypsin-deficient mice: 
NTKOF01 5’-CAG AGC TCC TGG CGC TCA TC-3’ 
NTKOR02 5’-GGA AGA CAA TAG CAG GCA TGC TG-3’ 
NTKOR03 5’-CTC GCA GCT CAG CCC AAC TG-3’ 
PCR products of NTKOF01 and NTKOR02 indicated a neurotrypsin-deficient genotype and products of 
NTKOF01 and NTKOR03 indicated the wild-type allele. 
PCR program: 1x (3’, 95 °C), 40x (45’’, 95 °C; 45’’ 62 °C; 60’’, 72 °C), 1x (5’ 72 °C) 
 
Agrin-deficient mice: 
PGK-Neo (77730) 5- TCG CAA GTT CTA ATT CCA-3’ 
AS Int-33 (30234) 5-GGG CAG GGC TAA CAC CAA-3’ 
Ex31fw 5-CAG GGG ATA GTT GAG AAG-3’ 
Ex32rev 5-GCT GGG ATC TCA TTG GTC-3’  
PCR products of 77730 and 30234 indicated the mutant allele and products of Ex31fw and Ex32rev indicated the 
wild-type allele. 
PCR program: 1x (3’, 95 °C), 40x (45’’, 95 °C; 45’’ 56 °C; 45’’, 72 °C), 1x (5’ 72 °C) 
 
Subsequent to the PCR reaction, samples were constituted with 6x loading buffer (10 mM 
Tris/HCl pH 7.5, 30% glycerol, 0.1 % Xilene cyanol, 0.1 % bromphenol blue) and analysed 
by agarose gel electrophoresis (2 % agarose in TAE buffer (40 mM Tris-acetate, 2 mM 
Na2EDTA, pH 8.5), containing 1 μg/ml ethidium bromide). 
 
2.3 Adenovirus production and application 
To achieve efficient ectopic expression of neurotrypsin and agrin variants in cultured 
hippocampal neurons, recombinant adenoviruses were generated. Cultured neurons are 
difficult to transfect and transfection methods commonly applied for ectopic expression of 
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recombinant proteins in cultured cells, including calcium phosphate precipitation or lipid-
mediated transfection using, e.g., lipofectamine (Invitrogen AG, Basel, Switzerland), result in 
very low transfection levels of neurons. In contrast, high transfection rates of neurons may be 
achieved by using recombinant viral systems (Washbourne and McAllister, 2002). The main 
advantages of the use of recombinant adenoviruses for ectopic expression analyses in cultured 
neurons, when compared to most other viral vector systems, is their low toxicity, their 
comparably easy construction and the potential insert size of DNA fragments of up to 8 kb. 
Adenoviruses do not integrate into the genome and, therefore, they do not cause any gene 
inactivation or misregulation of oncogenes. In addition, adenoviruses have the potential to 
also infect post-mitotic cells. Though, the usage of the adenoviral system has some potential 
drawbacks. Neurons are not natural hosts for the adenovirus and, therefore, very high 
multiplicities of infection (MOI, viral titers; such as MOIs of 10 to 100) are required for 
effective infection of a large number of cells. In contrast, e.g., herpes simplex viruses 
efficiently infect neurons with low MOIs (MOI as low as 1). However, recombinant 
adenoviruses have been successfully used for infection of neurons in dissociated cultures, 
slice cultures and in vivo (Akli et al., 1993; Wilkemeyer et al., 1996; Giger et al., 1997) as the 
usage even of MOI up to 100 did not cause toxic effects. The main limitation of the 
adenoviral system is that glial cells are much more efficiently infected than neurons. This can 
lead to difficulties when neurons in mixed neuronal cultures need to be targeted.  
The adenoviral expression vectors used in this work were derived from the human 
adenovirus 5 (Acc. Nr. M73260). These vectors lack the ER1 (base pairs 343-3532) and ER3 
(base pairs 28140- 30821) regions of the viral genome, both to decrease the biohazard 
potential of the otherwise highly infective virions and to enable integration of up to 8 kb 
foreign DNA, e.g., an expression construct.  ER1 codes for viral transactivators, which are 
necessary for initiation of viral DNA replication and the expression of remaining viral 
proteins. These adenoviruses are therefore incapable of replication in conventional cells. 
However, these viruses can be amplified in cell lines that express the ER1 gene products such 
as HEK293 cells (section 2.3.1). ER3 codes for several gene products that interfere with the 
human immune answer. It also codes for the adenovirus death protein (ADP), which is 
required for the efficient cell lysis and release of virus from infected cells (Tollefson et al., 
1996). The infection potential of ER3 virus mutants of cultured cells is indistinguishably from 
wild-type virus variants and therefore, in combination with the E1 deletion, enables the 
production of recombinant viruses with low biohazard potential. However, virus producing 
HEK293 cells lyse more slowly. Yet, this has no influence on virus amplification in HEK293 
cells since the commonly used protocols recommend to release amplified virus from infected 
cells by employing freezing and thawing or sonication methods (section 2.3.1).  
 
2.3.1 Generation and production of recombinant adenoviruses expressing agrin and 
membrane targeted eGFP constructs. A previously described adenoviral expression system 
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(Mohanty et al., 2005), utilising type 5, E1/E3-deficient adenoviruses, was used to enable 
convenient and efficient ectopic expression of neurotrypsin variants, eGFP, membrane-
targeted eGFP (MARCKS-eGFP) and agrin variants in cultured neurons. The necessary tools 
for virus production, including the transfer vector as well as the receiver vector carrying most 
of the adenoviral genome (Fig. 18A) were kindly provided by T. Trüb (University of Zurich, 
Zurich, Switzerland). The mouse neurotrypsin(-eGFP) and eGFP expression constructs were 
generated in our lab as described before ((Frischknecht et al., 2008) and section 2.2.8). To 
analyse the neurotrypsin-agrin interaction in cultured neurons in detail, I generated the 
following adenoviruses (AV) also expressing the respective construct under the control of the 
CMV promoter (Fig. 18A): AV-rat transmembrane agrin-x12, y4, z8 (AV-SN-agrin), AV-
mRFP-SN-agrin ((Campbell et al., 2002), fused in-frame to the 5’-end of SN-agrin-x12, y4, 
z8), AV-SN-agrin-mRFP (mRFP fused in-frame to the 3’-end of SN-agrin-x12, y4, z8), AV-
SN-agrin-mutant (the corresponding amino acids in the P1 positions of the respective alpha 
and beta cleavage sites of neurotrypsin (Reif et al., 2007) within SN-agrin-x12, y4, z8 were 
mutated to alanine, section 2.2.9), AV-mRFP-SN-agrin-mutant (mRFP fused in-frame to the 
5’-end of SN-agrin-mutant), AV-SN-agrin-mutant-mRFP (mRFP fused in-frame to the 3’-end 
of SN-agrin-mutant) and AV-MARCKS-eGFP (eGFP fused in frame to the 3’-end of amino 
acids 1-41 of the MARCKS protein ((De Paola et al., 2003), section 2.2.8).  
 
 
Figure 17: Overview of produced adenoviruses. The following recombinant adenoviruses were generated 
(section 2.3.1): Adenoviruses expressing wild-type transmembrane (SN)-agrin-x12, y4, z8 (rattus norvegicus). 
An untagged variant as well as variants, carrying mRFP either at agrin’s N- or its C-terminus were produced. 
Alternatively, the same constructs were generated with a mutant variant of SN-agrin, not cleavable by 
neurotrypsin (SN-agrin-mutant y4, z8). Adenoviruses expressing eGFP alone, or expressing a myristoylated 
alanine-rich C-kinase substrate (homo sapiens; MARCKS)-eGFP fusion protein that targets eGFP to the cellular 
membranes. Adenoviruses expressing neurotrypsin (mus musculus) or a catalytically inactive variant of 
neurotrypsin (neurotrypsin S/A; mus musculus). Again, untagged or C-terminally eGFP-tagged variants of 
neurotrypsin were generated. * produced by Miriam Viesti and Anna Fejtova 
 
Recombinant adenoviruses were generated as previously described (Mohanty et al., 
2005). Briefly, the expression cassettes for each construct were inserted in-frame behind the 
CMV promoter cassette of the corresponding transfer vector (pCMVtransfer, Fig. 18A) as 
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described in sections 2.2.8-9. Cre-mediated recombination (Sternberg and Hamilton, 1981) of 
the pCMVtransfer-expression construct with a vector that contained the main part of the 
adenovirus genome (pAd) was then performed in the E. coli strain BM25.8 to obtain finally 
assembled virus expression construct DNA (Fig. 18A). These finally assembled constructs 
were retransformed (section 2.2.1) into the E. coli DH5α strain and subsequently amplified by 
mini-preparation analysis according to the manufacturers standard protocol (section 2.2.4). 
Positive clones, identified by restriction digest analysis, were linearised by PacI digestion for 
final transfection into the HEK293 helper cell line to produce virus particles (Fig. 18A).  
 
 
Figure 18: Production and purification of recombinant adenoviruses. A, Schematic overview of the protocol 
applied for adenovirus vector production. The cDNA of the expression-construct was cloned into the multiple 
cloning site 3’ of the CMV-promoter cassette of the pTransfer (pCMVtransfer) vector. Co-transformation of E. 
coli BM25.8 bacteria with the pCMVtransfer vector construct and the pReceiver vector, carrying the main part 
of the virus genome, resulted in Cre-LoxP mediated generation of the final E1, E3-deficient recombinant 
adenovirus vector (pAd). Due to the endogenous expression of the adenoviral E1 genes, essential for virus 
amplification, HEK293 cells were employed for the production of the E1, E3-deficient adenoviruses. Initial virus 
particles were produced by transfection of HEK293 cells with the linearised pAd vector. High titer adenovirus 
stocks were generated by subsequent rounds of HEK293 cell infection with freshly generated virions. B, 
Purification of high titer virus particles. Several rounds of CsCl density gradient centrifugation (steps1-3) 
resulted in the concentration and purification of adenovirus particles (arrows).  
 
Line 293 of human embryonic kidney cells (HEK293) is characterised as a constantly 
dividing cell-line expressing the E1 genes of the adenovirus genome, responsible for virus 
amplification and cell lysis (Graham et al., 1977). This cell-line was therefore used for the 
production of the E1/E3-deficient adenoviruses. HEK293 cells growing on 6-well cell culture 
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plates (Nunc GmbH & Co. KG, Wiesbaden, Germany) were transfected with a PacI-linearised 
adenoviral vectors (pAd, Fig. 18A), using Lipofectamine 2000 according to the manufacturers 
standard protocol (Invitrogen, Basel, Switzerland; see below). Successfully transfected cells 
produced infectious viruses that were expanded by subsequent infection of fresh cells. For 
large-scale virus production, overinfected cells were collected and resuspended in collection 
buffer (10 mM Tris-HCl, pH 8.1, containing 150 mM NaCl and 1 mM MgCl2). The viral 
particles were released by three cycles of freezing and thawing and 5 min sonication on ice. 
Finally, the viruses were purified by several rounds of CsCl density gradient centrifugation, 
using one CsCl step gradient and two continuous CsCl gradients. The CsCl step gradient 
contained from bottom to top 2 ml 534.66 g/l (1.40 g/cm3) CsCl in TD buffer (137 mM NaCl, 
6 mM KCl, 0.7 mM Na2HPO4, 25 mM Tris-HCl, pH 7.5), 2 ml 331.7 g/l (1.25 g/cm3) CsCl in 
TD buffer, and 6 ml of virus containing cell lysate. The banded virus from the step gradient 
(Fig. 18B, step 1) was isolated with an 20 g injection needle and mixed with 466.67 g/l (1.35 
g/cm3) CsCl in TD buffer and centrifuged in a Beckman SW41 rotor (Beckmann Coulter Intl. 
SA, Nyon, Switzerland) at 30,000 rpm for 16 hours (Fig. 18B, step 2). The virus was 
collected and once more purified on the continuous gradient (Fig. 18B, step 3). After 
purification the virus was dialysed in Slide-A-Lyzer dialysis cassettes (0.5-3ml, 10,000 
MWCO; Pierce, Rockford, IL, USA) against TD buffer, transferred to Cryo tubes (Nunc 
GmbH & Co. KG, Wiesbaden, Germany), subsequently frozen in liquid nitrogen and stored at 
-80 °C. Virus titers were determined by plaque assays on HEK293 cells (Payment and Trudel, 
1993) or by cytopathic effect assays on HEK293. Titers were calculated according to the 
Spearman-Kärber formula (Spearman, 1908; Kärber, 1931; Miller, 1973). 
 
2.3.2 Infection of cultured cells. The infection potential and construct expression of purified 
virus was first tested with cos7 cells. Therefore, purified virus was added in varying 
concentrations to the cell-culture medium and cos7 cells were analysed 24-36 hours post-
infection by Western blotting (section 2.4.8) and immunocytochemistry (section 2.4.10). All 
constructed adenoviruses successfully infected cos7 cells, even viruses from low titer virus 
preparations. Cultured neurons growing on poly-L-lysine coated coverslips (section 2.4.1) 
were infected at varying stages of development. Therefore, purified virus was added in 
varying concentrations to the culture medium and virus-mediated ectopic expression in 
cultured neurons was analysed 3-5 days post-infection by immunocytochemistry (section 
2.4.10). Usually, 1-5 μl of virus preparations with a titer around 5 LogTCID50/ml, determined 
by cytopathic effect assays on HEK293 cells (section 2.3.1), were sufficient to efficiently 
infect cultured neurons at varying developmental stages. 
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2.4 Cell culture techniques 
2.4.1 Preparation of dissociated hippocampal neuron cultures. Primary dissociated 
hippocampal cultures were prepared from embryonic day 18 NMRI mice as previously 
described (Banker, 1980; Goslin, 1998; Kaech and Banker, 2006). Briefly, cell suspensions, 
obtained after trypsin treatment and careful trituration of excised hippocampal tissue, were 
plated onto round glass coverslips (diameter 18 mm; corrected thickness (0.17 mm ± 0.1 mm), 
Menzel-Glaeser, Braunschweig, Germany) coated with 0.5 mg/ml poly-L-lysine (Sigma, 
Saint Louis, MO, USA). After 1-2 hours at 37 °C, the coverslips were transferred into 12-well 
plates (Nunc GmbH & Co. KG, Wiesbaden, Germany) containing a 70-80 % confluent 
monolayer of astrocytes (section 2.4.3) and 1 ml DMEM supplemented with B27, 5 mM 
glutamine, 1 mM sodium pyruvate, 0.5 mg/ml Albumax and 1/100 antibiotic/antimycotic 
solution (100x). Cultures were maintained at 37 °C in a humidified incubator with an 
atmosphere of 95 % air and 5 % CO2. All chemicals used for neuronal cultures were obtained 
from Invitrogen AG (Basel, Switzerland), unless otherwise indicated. 
 
2.4.2 Preparation of cultured hippocampal neurons from transgenic animals 
overexpressing active mouse neurotrypsin.  As an attempt to establish a neuronal culture 
system with endogenous overexpression of active neurotrypsin, hippocampal neuron cultures 
were prepared from heterozygous transgenic animals constitutively overexpressing active 
mouse neurotrypsin (line Tg(Prss12)533.1Zbz). Prior to culture preparation, E18-mouse 
embryos were removed from a pregnant transgenic mother, decapitated and the corresponding 
heads were kept in HBSS solution (Invitrogen AG, Basel, Switzerland) on ice while the 
respective embryos were genotyped to identify transgene-positive animals (section 2.2.11). 
Finally, primary dissociated hippocampal cultures were prepared from transgene positive 
embryonic brains as described in section 2.4.1. Unfortunately, neuronal cultures generated 
from transgenic animals did not overexpress neurotrypsin and were therefore not further 
analysed. Most likely, Thy1-promoter mediated expression of the transgene (section 2.1.1), 
starting around postnatal day 5 in vivo (Radrizzani et al., 1995), is not activated in neuronal 
cultures prepared from prenatal brains (confirmed by internal communication with P. Caroni, 
FMI Basel, Switzerland). 
 
2.4.3 Preparation of glia-feeder cultures. Cortical astrocytes were isolated from postnatal 
day 2 NMRI mice and expanded in culture as previously described (Banker, 1980; Goslin, 
1998). In brief, a cell suspension obtained after trypsin treatment and trituration of excised 
cortical tissue was plated onto 10 cm culture dishes (Corning B.V. Life Sciences, Schiphol-
Rijk, The Netherlands) and cultured in DMEM supplemented with 10 % FCS and 1/100 
antibiotic/antimycotic solution (1/100). The culture-medium was replaced one day after the 
preparation and cells were grown till 90 % confluency and then splitted to 4 x 10 cm culture 
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dishes for further expansion. Cultures were maintained at 37 °C in a humidified incubator 
with an atmosphere of 95 % air and 5 % CO2. All chemicals used for glia cultures were 
obtained from Invitrogen AG (Basel, Switzerland), unless otherwise indicated. 
 
2.4.4 Preparation of glia-feeder cultures from agrin-deficient animals. In the central 
nervous system, agrin is expressed by neurons as well as glial cells. Glial cells are known to 
express secreted agrin isoforms that may be deposited along neurons in a neuron-glia co-
culture system. To exclusively detect neuronal expressed agrin in neuronal cultures, glia-
feeder cultures were generated from agrin-deficient animals (Lin et al., 2001). Agrin-deficient 
animals die at birth due to respiratory failure and agrin-deficient glia were therefore isolated 
from cortices of E19 embryos. Prior to astrocyte preparation, E19 mouse embryos were 
removed from a pregnant mother, heterozygous for the agrin null-allele and mated with a 
heterozygous male. The embryos were decapitated and the corresponding heads were kept in 
HBSS solution (Invitrogen AG, Basel, Switzerland) on ice while the respective embryos were 
genotyped to identify agrin-deficient animals (section 2.2.11). Finally, cortical glia cultures 
were prepared from agrin-deficient embryonic brains as described in section 2.4.3. 
 
2.4.5 Culturing cos7 and HEK293 cells. Cos7 is a continuously dividing cell-line, derived 
from kidney cells of the African green monkey (Chlorocebus aethiops), because of expression 
of the SV40 T-antigen of the SV40 virus. Cos7 cells are conventionally used for a wide range 
of cell culture applications and especially suitable for microscopic analyses of (ectopically) 
expressed proteins due to their flat and sprawled adherent growth on plastic or glass surfaces. 
Line 293 of human embryonic kidney cells (HEK293) is characterised as a constantly 
dividing cell-line expressing the adenoviral E1 genes (Graham et al., 1977) and was used in 
this study for adenovirus production (section 2.3). Cos7 as well as HEK293 cells were 
generally grown in 10 cm culture dishes (Corning B.V. Life Sciences, Schiphol-Rijk, The 
Netherlands) in DMEM supplemented with 10 % fetal calf serum (FCS) at 37 °C in a 
humidified incubator with an atmosphere of 95 % air and 5-10 % CO2. Cells were regularly 
passaged when grown confluent. Briefly, cells were washed once with HBSS (Invitrogen AG, 
Basel, Switzerland) and detached with trypsin solution (Invitrogen AG, Basel, Switzerland) 
diluted 1/10 in HBSS (without Mg2+ and Ca2+, Invitrogen AG, Basel, Switzerland). Usually, 
1/10 of cells were transferred to new 10 cm dishes and further incubated with DMEM/10 % 
FCS at 37 °C in a humidified incubator with an atmosphere of 95 % air and 5-10 % CO2. For 
storage purposes, cells were frozen in DMEM/10 % FCS containing 10 % DMSO (Sigma 
Aldrich Co., Saint Louis, MO, USA)  and stored at -80 °C. 
 
2.4.6 Transient transfection of cos7 cells on glass coverslips. Cos7 cells were grown to 30-
40 % confluency on poly-L-lysin (0.1 mg/ml, P-1524, Sigma Aldrich Co., Saint Louis, MO, 
USA) coated glass coverslips (diameter 18 mm; corrected thickness of 0.17 mm ± 0.1 mm, 
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Menzel-Glaeser, Braunschweig, Germany) in 12-well culture plates (Nunc GmbH & Co. KG, 
Wiesbaden, Germany) containing 1 ml/well DMEM/10 % FCS. Transfection of cells in one 
well was performed by mixing solution A (2 μl Lipofectamine 2000 in 100 μl OptiMEM I 
(both Invitrogen AG, Basel, Switzerland)) after 5 min with solution B (total 1 μg vector DNA 
for single transfections or total 1.5 μg vector DNA for double transfections in 100 μl 
OptiMEM I). The transfection mix was then incubated at room temperature for 20-30 min. 
During the incubation period, cell culture-medium was replaced with fresh DMEM/10 % 
FCS. Finally, the transfection-mix was added drop-wise to the well and cells were further 
incubated for 24 hours at 37 °C in a humidified incubator with an atmosphere of 95 % air and 
5-10 % CO2.  
 
2.4.7 Transient transfection of cos7 and HEK293 cells in 35 mm dishes or on 6-well 
plates. Cos7 cells were grown to 80 % confluency in 35 mm dishes (Corning B.V. Life 
Sciences, Schiphol-Rijk, The Netherlands) or on 6-well culture plates (Nunc GmbH & Co. 
KG, Wiesbaden, Germany) containing 2 ml/well DMEM/10 % FCS. Transfection of cells in 
one well was performed by mixing solution A (6 μl Lipofectamine 2000 in 250 μl OptiMEM 
I (both Invitrogen AG, Basel, Switzerland)) after 5 min with solution B (total 2 μg vector 
DNA for single transfections or total 3 μg vector DNA for double transfections in 250 μl 
OptiMEM I). The transfection mix was then incubated at room temperature for 20-30 min. 
During the incubation period, cell culture-medium was replaced with fresh DMEM/10 % 
FCS. Finally, the transfection-mix was added drop-wise to the well and cells were further 
incubated for a minimum of 36 hours at 37 °C in a humidified incubator with an atmosphere 
of 95 % air and 5-10 % CO2.  
 
2.4.8 Processing of cultured cells for Western blotting. Supernatants (cell-culture medium) 
of untransfected or transiently transfected cos7 cells, growing in 6-well plates (Nunc GmbH 
& Co. KG, Wiesbaden, Germany), were transferred to a 2 ml tube (Eppendorf AG, Hamburg, 
Germany), containing protease inhibitors (1/100 dilution, P-8340, Sigma Aldrich Co., Saint 
Louis, MO, USA). Cell debris was removed by centrifugation in a tabletop centrifuge for 10 
min, 14,000 rpm, 4 °C and resulting supernatants were transferred to fresh tubes, frozen in 
liquid nitrogen and stored at -80 °C. Cells adhering to the culture dish were washed once in 
ice-cold PBS (137 mM NaCl, 2.7 mM KCl, 8 mM Na2HPO4, 1.5 mM KH2PO4, pH 7.4), 
scraped off in 300 μl lysis buffer (20 mM Tris/HCl, pH7.5; 150 mM NaCl, 5 mM EDTA, 1 % 
(w/v) CHAPS and 0.1 % (w/v) SDS), transferred to 1.5 ml tubes (Eppendorf AG, Hamburg, 
Germany) and incubated for a minimum of 30 min on ice before frozen in liquid nitrogen and 
stored at -80 °C. SDS-PAGE/Western blot analyses were performed as described in section 
2.1.4. 
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2.4.9 Functional analyses of filopodia induction by agrin on cos7 cells. The overexpression 
of transmembrane agrin causes filopodia-like membrane extensions in a variety of different 
cell types, including neurons and cos7 cells. To analyse a possible impact of neurotrypsin-
activity on this function of agrin, I performed immunofluorescence analyses of transiently 
transfected cos7 cells, transfected with plasmids expressing either agrin and/or neurotrypsin 
variants. Fixed and permeabilised cells were stained with specific primary antibodies against 
agrin or neurotrypsin and fluorescently-labeled secondary antibodies (section 2.4.10). 
Additionally, filamentous actin (F-actin) structures within the cell and within motile surface 
elements, like filopodia, were specifically visualised with fluorescently labelled Phalloidin 
(Molecular Probes, Invitrogen AG, Basel, Switzerland). Alternatively, membrane structures 
were visualised by (co-)transfection of cells with MARCKS-eGFP (section 2.2.8). 
Quantification of the effect of neurotrypsin on agrin’s ability to cause filopodia was 
performed by a rough estimation of filopodia positive and negative cells for each set of 
transfections. The appearance of an excess of filopodia-like structures at multiple sites of the 
cellular surface identified cos7 cells as filopodia-positive. In contrast, filopodia-negative cells 
had a similar appearance as the average control cell with little or no filopodia.    
 
2.4.10 Immunocytochemistry. Cells growing on poly-L-lysine coated coverslips (see 
sections 2.4.1, 2.4.2 and 2.4.6) were washed in HBSS (Invitrogen AG, Basel, Switzerland) for 
5 min at room temperature and fixed in fixation solution (4 % paraformaldehyde in PBS, 137 
mM NaCl, 2.7 mM KCl, 8 mM Na2HPO4, 1.5 mM KH2PO4, pH 7.4) for 5-10 min at room 
temperature. Samples were subsequently blocked with blocking solution (10 % FCS/PBS, 0.1 
% glycine and 0.05 % NaN3) either for at least 1 hour at room temperature or for at least 12 
hours at 4 °C. Protein detection was performed by incubation of the cells in primary antibody 
incubation solution (3 % FCS/PBS), containing primary antibodies. This step was performed 
on Parafilm M (Brand GmbH & Co. KG, Wertheim, Germany) in a wet chamber, preferably 
overnight at 4 °C or alternatively for 2 hours at room temperature. Cells were washed 3 times 
10 min with PBS and incubated on Parafilm M in a wet chamber with secondary antibody 
incubation solution, containing fluorescence-labelled secondary antibodies, detecting the 
primary antibodies. If necessary, fluorescence-labeled Phalloidin (1:25; Molecular probes, 
Invitrogen AG, Basel Switzerland) was included in the secondary antibody incubation 
solution to visualise the actin-cytoskeleton, including motile cell-surface elements like 
filopodia. In general, for detection of intracellular epitopes, 0.5 % Saponin was included in 
any antibody incubation solution to permeabilise cells. Cells were finally washed with PBS 
for at least 3 times 10 min and mounted with Vectashield (Vector Laboratories, Burligame, 
CA, USA). Mounted samples were sealed with conventional nail polish and stored at 4 °C in 
the darkness. Cells were analysed using a Leica SP2 confocal microscope and Leica LCS 
software (Leica Mikrosysteme Vertrieb GmbH, Wetzlar, Germany). Recorded images were 
carefully processed using Photoshop CS2 (Adobe Systems Inc., San Jose, CA, USA).  
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3.1 Analysis of the neurotrypsin-agrin interaction in the murine brain. 
3.1.1 Agrin is a substrate of neurotrypsin in the murine CNS.  
Agrin is a substrate of neurotrypsin in vitro (Reif et al., 2007) and neurotrypsin-dependent 
cleavage of agrin was observed at the NMJ in vivo (Bolliger, M. et al., unpublished 
observations). To confirm that agrin is a substrate of neurotrypsin also in the CNS, I analysed 
mouse brain homogenates of neurotrypsin-deficient mice (Ntd), agrin-deficient mice and their 
corresponding wild-type littermates by Western blotting. So far, analyses of neurotrypsin-
deficient mice did not reveal an apparent phenotype and corresponding brain homogenates 
from postnatal day 4 (P4) pups were analysed. In contrast, agrin-deficient mice die at birth 
due to respiratory failure and, thus, brain homogenates of 19 days old embryos (E19) were 
analysed. Both 90-kDa and 22-kDa agrin cleavage fragments were indeed detected in brain 
homogenates of wild-type mice but did not appear in samples of Ntd animals when analysed 
with each two different polyclonal antibodies directed against the 90-kDa or the C-terminal 
22-kDa fragment, respectively (Fig. 19B). The week signals detected with the anti-C-22-agrin 
antibodies in between 20 and 25 kDa in samples of Ntd animals represented unspecific 
signals, as signals of similar intensity also appeared in tissue from corresponding agrin-
deficient animals (Fig. 19C). Confirming the better quality and higher affinity of the anti-C-
90-agrin antibodies, no signals for the 90-kDa fragment were detected in brain homogenates 
of agrin-deficient mice. Therefore, these data confirmed that the C-terminal 90-kDa and 22-
kDa agrin fragments are generated in the murine brain and that their appearance is exclusively 
dependent on neurotrypsin activity. Furthermore, this SDS-PAGE analysis, based on a Bis-
Tris buffer adjusted to neutral pH and gradient gels, enabled the detection of full-length agrin 
as three distinct groups of bands between 220 and 500 kDa. We termed these three distinct 
groups of bands upper, middle and lower full-length agrin variants. Both the anti-C-90 and the 
anti-C-22 antibodies detected these variants of full-length agrin in an identical band pattern. 
The slight differences in the relative intensity of the upper, middle, and lower variants 
obtained with the anti-C-22, compared to the anti-C-90 antibodies, most likely reflected a 
differential preference of the antibodies for distinct variants of agrin rather than contributions 
from neurotrypsin-dependent cleavage fragments (see material and methods, section 2.1.2). 
All three full-length agrin bands appeared in brain homogenate of wild-type as well as Ntd 
mice. However, in particular the upper and middle full-length bands appeared stronger in 
tissue from Ntd mice (Fig. 19B). The increase of full-length agrin signals most likely reflects 
the lack of neurotrypsin-dependent cleavage of agrin and therefore an accumulation of 
unprocessed agrin variants in the brains of Ntd mice (see section 3.1.3). The identity of the 
three distinct groups of bands as variants of agrin was confirmed by Western blot analyses of 
brain homogenates from agrin-deficient mice, compared to brain homogenates from their 
wild-type littermates (Fig. 19C). All three groups of full-length agrin bands were exclusively 
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present in wild-type tissue when detected with the high affine anti-C-90-agrin antibodies. 
Similar results were obtained with the anti-C-22-agrin antibodies. However, these less affine 
antibodies also detected a weaker and unspecific band at the level of the bottom full-length 
agrin variants in tissue from agrin-deficient mice.  
 
Figure 19. The C-90 and C-22 agrin fragments are exclusively generated by neurotrypsin in the mouse CNS. A, 
Schematic overview of agrin’s protein structure (modified from (Hoch et al., 1993; Bezakova and Ruegg, 2003)). 
Alternative splicing leads to the expression of a variety of transmembrane (SN) or secreted (LN) agrin variants, 
containing variable inserts of several amino acids at the x, y, and z splice sites. Binding sites within the C-
terminal moiety of agrin are indicated. Neurotrypsin-dependent cleavage of agrin (indicated by arrows) generates 
two C-terminal fragments of 90 kDa and 22kDa. NtA - N-terminal agrin domain; TM - transmembrane domain; 
F - follistatin-like domains; GAG - glycosaminoglycan side chains; LE - laminin-epidermal growth factor 
(EGF)-like domains; S/T - serine-threonine-rich region; SEA - sperm protein, enterokinase and agrin domain; 
EG - EGF-like domains; LG - laminin-globular domains. B, Comparison of different polyclonal antibodies 
generated against the respective neurotrypsin cleavage fragments of agrin. Western Blot analyses of P4 mouse 
brain homogenates from neurotrypsin deficient (Ntd) animals compared to brain homogenates obtained from 
their wildtype (wt) littermates. Molecular mass references are indicated in kDa. Both antibodies directed against 
the C-90 agrin fragment (C-90-1; C-90-2) detected a double band at 90 kDa in wildtype tissue but not in tissue 
from Ntd animals. Similarly, the antibodies directed against the C-22 agrin fragment (C-22-1; C-22-2) detected a 
specific double band at around 22 and 24 kDa in wildtype tissue on top of unspecific bands visible in 
neurotrypsin-deficient samples (compare to C). These findings indicated that the C-90 and C-22 agrin fragments 
were exclusively generated by neurotrypsin activity. In addition to the detection of their respective cleaved 
antigens, all antibodies similarly detected three distinct groups of bands above 200 kDa, most likely indicating 
differentially glycanated variants of full-length agrin. These groups of bands were termed upper (a), middle (b) 
and lower (c) variants of full-length agrin. C, Confirmation of the specificity of the different polyclonal 
antibodies generated against the respective neurotrypsin cleavage fragments of agrin. Western Blot analyses of 
E19 mouse brain homogenates from agrin-deficient (Agrin-d) animals or their wildtype littermates (wt). The 
three groups of bands above 200 kDa as well as the bands at around 90 kDa (C-90-1) and 22-kDa (C-22-1; C-22-
2) indeed correspond to agrin as these bands appear in wildtype but not in Agrin-d tissue. The C-90-1 antibody 
was by far the most specific and strongest antibody tested as it detected strong bands only in wt but not in Agrin-
d tissue. Both the C-22 antibodies were comparably less affine and also detected unspecific signals, mainly at the 
level of the lower full-length agrin variants but also faintly at the level for both 22-kDa fragment bands. 
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On Western blots made from standard SDS-PAGE gels, the variant forms of agrin 
were not resolved, but appeared as a broad smear ranging from 220 to 500 kDa. This feature 
was suggested to reflect the existence of differently glycanated agrin variants (Bezakova and 
Ruegg, 2003). Differential glycanation as the molecular basis underlying all of these resolved 
agrin variants was indeed confirmed by heparitinase digestion of brain homogenates, which 
resulted in a shift of all upper and middle bands to the level of the lower bands (Fig. 20B). 
Based on these results we concluded that the lower group of bands reflected agrin variants 
without or with little glycanation, while the middle and upper groups were composed of 
variants with intermediate and strong glycanation. 
 
3.1.2 Expression of neurotrypsin and agrin, as well as neurotrypsin-dependent agrin 
cleavage predominate during neural development.  
To obtain a detailed view of neurotrypsin-dependent processing of agrin, I analysed 
the expression pattern of neurotrypsin together with full-length agrin and the neurotrypsin-
dependent fragments of agrin by Western blotting of brain homogenates from mice of various 
developmental and adult stages. The analysis of samples from E14 through P730 
demonstrated that neurotrypsin protein expression was developmentally regulated with peak 
expression between E18 and P10 (Fig. 20A). This is in accordance with previously reported 
mRNA expression profiles, indicating that neurotrypsin expression is strongest around the 
first postnatal week in a variety of CNS regions ((Wolfer et al., 2001); Fig. 12). The 
expression of full-length agrin was similarly developmentally regulated, also with maximal 
expression between E18 and P10 (Fig. 20A). Subsequently, expression declined until P30, but 
persisted at a low level throughout adult life. Similar overall expression profiles of agrin 
mRNA have been reported previously (Cohen et al., 1997; Li et al., 1997). The analysis 
allowing resolution of the glycanation-dependent variants of agrin (section 3.1.1) revealed 
that the stage-dependent regulation of agrin expression was most pronounced for the upper 
group of variants, representing the most heavily glycanated forms of agrin. These variants 
exhibited the most pronounced developmental rise as well as a stronger decline during 
adulthood. In contrast, the expression of the middle and lower groups of agrin variants was 
only slightly enhanced during development and less reduced during adulthood.  
The abundance of the neurotrypsin-dependent agrin fragments roughly reflected the 
temporal expression pattern of full-length agrin and neurotrypsin. Both neurotrypsin-
dependent fragments of agrin were detected as double bands (Fig. 20A). The two bands of the 
90-kDa fragment showed a differential regulation between E14 and P15. The upper 90-kDa 
band was strongest in the samples from E14 brain and its intensity declined in the first 
postnatal days. In contrast, the lower 90-kDa band was strongest between E18 and P15. 
Beyond P15, both bands persisted throughout adult life at equal but weak levels. To confirm 
their identity, I purified both 90-kDa bands by immunoaffinity isolation from mouse brain 
homogenates, subjected them to tryptic digestion, and analysed the peptides by mass 
spectrometry. Several sequences of agrin-derived peptides, covering the 90-kDa fragment,  
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Figure 20. Expression of 
neurotrypsin and agrin, as well 
as neurotrypsin-dependent agrin 
cleavage are developmentally 
regulated. A, Western blot 
analyses of mouse brain 
homogenates obtained from 
animals of E14 to P730. Peak 
expression of neurotrypsin and 
agrin was found during the first 
postnatal week. The protein 
bands above 220 kDa, detected 
with the anti-C-90 agrin 
antibody, represent differentially 
glycosylated variants of full-
length agrin. They can be 
categorised into three distinct 
groups, termed upper (a), middle 
(b) and lower (c) variants of 
agrin. Neuro-trypsin-dependent cleavage of agrin also appeared strongest around the first postnatal week. Both 
cleavage products of agrin appeared as double bands. Molecular mass references are indicated in kDa. B, 
Heparitinase digestion of P6 mouse brain homogenates. In control samples, full-length agrin was detected as 
three distinct groups of bands, running above 220 kDa (1: control). Digestion with heparitinase III resulted in the 
disappearance of the upper and middle variants, characterising them as glycanated variants of agrin (2: 2 h 
digestion, 3: 5 h digestion). C, Mass spectrometric analysis of the purified 90-kDa fragments from brains of P25-
P50 mice overexpressing active neurotrypsin confirmed that both bands correspond to the C-terminal region of 
agrin. The detected tryptic peptides of the isolated protein bands (grey: upper 90 kDa band; black: lower 90-kDa 
band) were aligned within the designated C-terminal region of agrin ranging from amino acid (aa) 996 to aa 
1754 (NCBI protein accession no. AAA40703.1). The identified peptides were: 1-SIESTLDDLFR (pos. 1061-
1071), 2-ALETEGLLLYNGNAR (pos. 1293-1307), 3-FDTGSGPAVLTSLVPVEPGR (pos. 1325-1344), 4-
GPSGLLLYNGQK (pos. 1563-1574), 5-EPLYVGGAPDFSK (pos. 1656-1668), 6-GHQLLTQEHVLR (pos 1690-1701). 
 
were found in both bands (Fig. 20C). The two bands of the 22-kDa fragment, detected with 
the C-22-1 antibody exhibiting higher affinity compared to the C-22-2 antibody used in our 
previously published study ((Reif et al., 2007), were of equal relative intensity at all time 
points with much stronger signals for the lower band (Fig. 20A). Highest levels of the 22-kDa 
fragment were found between E14 and P8. The decline in the intensity of the 22-kDa 
fragment between P8 and P15 correlated well with a drop in expression of both full-length 
agrin and neurotrypsin. Similar to the 90-kDa fragment, the 22-kDa fragment remained 
detectable throughout adult life. In contrast, the high levels of the 22-kDa fragment detected 
already at E14 do not correlate well with the relatively low expression levels of neurotrypsin. 
This discrepancy could be due to particularities in the spatial locations of agrin and 
neurotrypsin at early developmental stages, which are not reflected in the results of Western 
blot analyses based on homogenates of whole brains. The molecular basis underlying the 
differential electrophoretic mobility of the two variants of the 90-kDa and the 22-kDa 
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fragments of agrin is currently not clear. Based on the highly specific nature of the proteolytic 
activity of neurotrypsin (Reif et al., 2007), differential proteolytic cleavage is unlikely. 
Rather, the variants of the two agrin fragments may reflect different splice variants of agrin or 
differential post-translational modifications (Bezakova and Ruegg, 2003), such as potential O-
linked glycosylation as predicted for the region of agrin giving rise to the 90-kDa fragment 
(Parkhomovskiy et al., 2000; Xia and Martin, 2002). 
 
3.1.3 The glycanated variants of CNS agrin are preferred substrates of neurotrypsin.  
To analyse the neurotrypsin-dependent cleavage of agrin in detail, I performed 
quantitative densitometry of Western blots of mouse brain homogenates. Brain samples were 
prepared at P9 from neurotrypsin-deficient (Ntd) mice, mice overexpressing catalytically 
active (Nto-act) or a catalytically inactive (Nto-inact) neurotrypsin and compared with brain 
samples from their wild-type littermates. The analyses of Nto-inact mice were included as a 
control to confirm that the catalytic activity of neurotrypsin is strictly required for 
neurotrypsin-dependent cleavage of agrin (see below). Representative Western blots of 
neurotrypsin, and full-length agrin, detected with the anti-C-22 antibody, as well as its 90-kDa 
and 22-kDa fragments are shown in Figure 21A-D. Western blotting of neurotrypsin 
confirmed its absence in Ntd mice and its excess in neurotrypsin-overexpressing mice (Fig. 
21A). Neither the 90-kDa nor the 22-kDa fragment of agrin was found in samples from Ntd 
mice, confirming their origin from neurotrypsin-dependent cleavage of agrin (Fig. 21C-F). 
Accordingly, both fragments were increased in samples from Nto-act mice (Fig. 21C-F). 
Densitometry revealed that overexpression of active neurotrypsin resulted in a significant 
four-fold increase of the 90-kDa fragment (392.0 ± 44.1 % (mean ± S.E.M.) of wild type; Fig. 
21E). In contrast, the 22-kDa fragments showed an increment of only 1.5-fold (148.4 ± 7.9 % 
of wild type; Fig. 21F). This discrepancy may be explained by higher diffusive properties of 
the 22-kDa fragments or different stabilities of the respective fragments. In samples from 
transgenic Nto-inact mice the signal intensities of both agrin fragments did not significantly 
differ from those of wild-type mice (92.6 ± 5.0 % of wild type for the 90-kDa fragment and 
111.7 ± 7.2 % of wild type for the 22-kDa fragment; Fig. 21E, F. The neurotrypsin-dependent 
increase of the agrin fragments in samples from Nto-act mice coincided with a decrease of 
full-length agrin (Fig. 21G-I). I measured the signal intensities of the upper, middle and lower 
groups of full-length agrin in samples from Nto-act, Nto-inact, and Ntd mice using an 
antibody against the 22-kDa fragment and normalised the results to the corresponding signals 
of wild-type littermates. The results indicated that the protein levels for upper and middle full-
length agrin were significantly decreased in the brain of Nto-act mice (59.1 ± 4.4 % and 75.2 
± 8.7 % of wild-type, respectively; Fig. 21G), unaltered in Nto-inact mouse brains (103.6 ± 
2.7 % and 103.7 ± 0.3 % of wild type, respectively; Fig. 21H), and increased in the brain of 
Ntd mice (216.4 ± 23.2 % and 156.4 ± 14.0 % of wild type, respectively; Fig. 21I). In 
contrast, no alterations of the lower group of full-length agrin were measured in all analysed 
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tissues (Nto-act 99.0 ± 6.2 %, Nto-inact 97.9 ± 2.2 %, and Ntd 99.4 ± 10.2 % of wild type; 
Fig. 21G-I).  
 
 
Figure 21. Neurotrypsin exclusively 
cleaves glycanated agrin variants in 
the mouse brain, generating the 90-
kDa and 22-kDa fragments A-D, 
Representative images of Western 
blots from P9 mice confirm that agrin 
is a substrate of neurotrypsin. Brain 
homogenates from neurotrypsin-
deficient (Ntd), human neurotrypsin-
overexpressing (Nto-act) mice or from 
mice that overexpress a catalytically 
inactive variant of mouse neurotrypsin 
(Nto-inact) were compared to brain 
homogenates from their wildtype (wt) 
littermates. Molecular mass references 
are indicated in kDa. A, Neurotrypsin 
detected in samples of Ntd, Nto-act, 
and Nto-inact brain homogenates. 
Endogenous neurotrypsin was 
detected as a single band at 85 kDa 
(arrowhead) in samples of all geno- 
types except Ntd (circle). In contrast 
to mouse neurotrypsin, human neuro-
trypsin contains an additional SRCR domain, resulting in an approximate Mr of 95 kDa. Transgenic human 
neurotrypsin was detected in samples of Nto-act mice as a double band at around 95 kDa (asterisk) with a much 
stronger signal for the upper band. This human neurotrypsin-specific double band was situated on top of a weak 
unspecific band visible in samples of all genotypes, including Ntd. Transgenic inactive mouse neurotrypsin was 
detected at 85 kDa, superimposed over endogenous neurotrypsin (triangle). B-D, Cleavage of the variants of full-
length agrin (upper (a), middle (b) and lower (c) full-length agrin variants, C-22 antibody) as well as the 
appearance of the 90-kDa and the 22-kDa fragments, detected in brain homogenates of Ntd, Nto-act, and Nto-
inact mice. E, F, Quantitative densitometric Western blot analyses of the appearance of the 90-kDa and the 22-
kDa fragments, respectively, revealed that these fragments were only generated by active neurotrypsin. G-I, 
Quantitative analyses of full-length agrin signals, detected with the C-22 antibody, confirmed that neurotrypsin 
exclusively cleaved the upper and middle variants of agrin, with preference for the most heavily glycanated 
upper variants. Signal intensities of the upper, middle and lower agrin variants in samples from Nto-act (G), Nto-
inact (H) and Ntd (I) mice. Signal intensities of Ntd, Nto-act or Nto-inact samples, normalised to signals of the 
corresponding wildtype littermate controls (wildtype values set to 100 %), are shown. Data represent mean 
values ± S.E.M. For each genotype, two Western blots with samples of at least three different animals per 
genotype were analysed (n ≥ 6). × = no signal detected; * = P<0.05; ** = P<0.01; *** = P<0.001. 
 
I also measured the signal intensities of the upper, middle and lower groups of full-
length agrin in samples from Nto-act, Nto-inact and Ntd mice using the anti-C-90 antibodies. 
Again, results obtained by quantitative densitometry of Western blots were normalised to the 
corresponding signals of wild-type littermates (Fig. 22). A representative Western blot of full-
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length agrin, detected with the anti-C-90-1 antibody, is depicted in Figure 22A. The data 
obtained with the anti-C-90-agrin antibodies mainly supported the results obtained with the 
anti-C-22 antibody (see above) and confirmed that the protein levels for upper and middle 
full-length agrin were significantly decreased in the brain of Nto-act mice (68.3 ± 2.2 % and 
71.2 ± 5.8 % of wild type, respectively; Fig. 22B, anti-C-90-1 antibody) and unaltered in Nto-
inact mouse brains (104.1 ± 4.1 % and 105.2 ± 4.2 % of wild type, respectively; Fig. 22C, 
anti-C-90-1 antibody). Furthermore, no alterations of the lower group of full-length agrin 
were measured in the analysed tissues of Nto-act (99.7 ± 1.6 %, Fig. 22B, anti-C-90-1 
antibody) and Nto-inact (104.9 ± 3.2 %, Fig. 22C, anti-C-90-1 antibody) animals. However, 
slight differences were observed with brain homogenates of Ntd mice when results obtained 
with the anti-C-90 antibodies (Fig. 22D, E) were compared to the data presented with the anti-
C-22 antibody (Fig. 21I). When detected with the respective C-90 antibodies, bottom full-
length agrin levels were reduced in brain homogenates of Ntd mice to 83.0  ± 2.8 % (C-90-1 
antibody, Fig. 22D) or 65.5 ± 12.9 % (C-90-2 antibody, Fig. 22E) of wild-type levels. This 
was in strong contrast to experiments performed with the anti-C-22 antibody (Fig. 21I), where 
no differences of bottom full-length agrin levels were detected between samples of Ntd and 
wild-type animals. Also, the increase of upper and middle full-length agrin signals in brain 
homogenates of Ntd mice, detected with the anti-C-90 antibodies, was less prominent when 
compared to results obtained with the C-22 antibody. The levels for the upper variants were 
slightly increased in samples of Ntd mice (anti-C-90-1 antibody, 110.4 ± 1.0 %; anti-C-90-2 
antibody, 129.2 ± 9.4 % of wild type, respectively; Fig. 22D, E) and changes concerning the 
middle variants were even less pronounced (anti-C-90-1 antibody, 102.7 ± 2.2 %; anti-C-90-2 
antibody, 111.7 ± 1.7 % of wild type, respectively; Fig. 22D, E). Differences in signal 
detection between the anti-C-22 and the anti-C-90 antibodies were apparent in Ntd samples 
only. Interestingly, utilisation of different anti-C-90-agrin antibody concentrations resulted in 
the measurement of varying full-length agrin signal intensities (data not shown). It is currently 
inexplicable why these variations were only measured with samples of Ntd animals. These 
findings suggest that difficulties with anti-C-90 antibody detection in Ntd samples led to the 
determination of different results. However, if levels for bottom full-length agrin signals in 
samples of Ntd mice, detected with the anti-C-90 antibodies, are adjusted to wild-type levels, 
the corresponding increase of upper and middle full-length agrin signals would closely 
resemble the anti-C-22 antibody data. Thus, the data obtained with the anti-C-90 antibodies 
mainly supported the results determined with the anti-C-22 antibody. 
Taken together, these results demonstrated that only the glycanated variants of full-
length agrin are cleaved by neurotrypsin. Furthermore, I registered a tendency for preferential 
cleavage of the variants of the upper group, as their increase in Ntd and decrease in Nto-act 
mice was stronger compared to the variants of the middle group. However, the differences 
were not statistically significant.  
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Figure 22. Neurotrypsin exclusively cleaves glycanated agrin variants in the mouse brain, generating the 90-kDa 
and 22-kDa fragments. A, Representative image of a Western blot from P9 mice, developed with the antibody 
directed against the C-90 agrin fragment, detecting full-length agrin (upper (a), middle (b) and lower (c) full-
length agrin variants). Brain homogenates from neurotrypsin-deficient (Ntd), human neurotrypsin-over-
expressing (Nto-act) mice or from mice that overexpress a catalytically inactive variant of mouse neurotrypsin 
(Nto-inact) were compared to brain homogenates from their wildtype (wt) littermates. Molecular mass references 
are indicated in kDa. B-E, Also the quantitative analysis of full-length agrin signals, detected with the anti-C-90-
agrin antibodies (C-90-1; C-90-2), confirms that neurotrypsin exclusively cleaves the glycanated variants of 
agrin (compare to Fig. 21). However, slight differences between C-90 and C-22 antibodies were detected with 
Ntd samples (see main text). Signal intensities of the upper, middle and lower agrin variants in samples from 
Nto-act (B, C-90-1), Nto-inact (C, C-90-1) and Ntd (D, C-90-1; E, C-90-2 antibody) mice are shown, normalised 
to signals of the corresponding wildtype littermate controls (wildtype values set to 100 %). Data represent mean 
values ± S.E.M. For each genotype, two Western blots with samples of at least three different animals per 
genotype were analysed (n ≥ 6). × = no signal detected; * = P<0.05; ** = P<0.01; *** = P<0.001. 
 
3.1.4 The most heavily glycanated variants of agrin are enriched in synaptosomes.  
Neurotrypsin localises to presynaptic terminals in vivo (Molinari et al., 2002; Stephan 
et al., 2008) and results obtained with cultured hippocampal neurons indicated its activity-
dependent release from synaptic terminals (Frischknecht et al., 2008). Experiments with 
fluorescently tagged neurotrypsin indicated that neurotrypsin lingered in the synaptic 
extracellular space after activity-dependent externalisation from presynaptic intracellular 
stores. Therefore, we speculated about a local proteolytic role of neurotrypsin in the synaptic 
or perisynaptic region. To test this hypothesis, I prepared synaptosomes from brains of wild-
type mice (P12 to P15) and their content of neurotrypsin, agrin, and neurotrypsin-dependent 
agrin fragments was visualised by SDS-PAGE and Western blotting (Fig. 23A, C). The 
quality of the synaptosomal preparations was evaluated by electron microscopy and Western 
blotting. The morphological analysis confirmed the integrity of the synaptosomal fraction that 
was strongly enriched in synaptic structures, mainly consistent of resealed presynaptic 
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membranes associated with post- and perisynaptic structures (Fig. 23B). Western blotting of 
the initial brain homogenate (S1), the soluble fraction (S2), and the synaptosomal fraction 
(SS, Fig. 23A), using an antibody against the postsynaptic density protein PSD-95 as a 
synaptic marker, also demonstrated the synaptic enrichment of these synaptosomal 
preparations (Fig. 23C, 24A, 25A). Endogenous neurotrypsin was found in the synaptosomal 
as well as in the other fractions of the preparation (Fig. 23C, 24A, 25A). This observation is in 
accordance with our immunohistological localisation studies of neurotrypsin, as well as with 
our live imaging studies of intracellular trafficking of neurotrypsin. Both studies indicated 
that, besides its synaptic localisation, a fraction of neurotrypsin is localised to intracellular 
compartments ranging from the rough endoplasmatic reticulum through the Golgi apparatus to 
 
 
Figure 23. The upper variants are the 
predominant isoforms of agrin in 
synaptosomes. A, Schematic repre-
sentation of the fractionation protocol 
used to prepare synaptosomes. B, 
Electron micrographs of a repre-
sentative synaptosomal sample con-
firmed the integrity of the prepar-
ations. Presynaptic structures were 
prominent (asterisk) and in many 
cases attached postsynaptic struc-
tures were found (arrow). Scale bars: 
0.2 μm. C, Representative Western 
blots of a synaptosomal preparation 
from brains of 12- to15-days-old 
wildtype mice. Post-synaptic-density 
protein 95 (PSD-95) was strongly 
enriched in the synaptosomal fraction 
(SS) and served as a control for the 
quality of the preparation. Endoge-
nous neurotrypsin was found in the 
synaptosomal as well as in the other
fractions of the preparation (soluble fraction 1 of the brain homogenate (S1), soluble fraction 2 (S2)). Mainly the 
upper agrin variants were detected in synaptosomes, whereas all three groups of agrin variants were detected 
with similar intensities in the other fractions of the preparation (upper (a), middle (b) and lower (c) variants). D, 
E, Quantitative densitometric Western blot analyses of synaptosomal preparations confirmed upper variants as 
the predominant isoforms of agrin in synaptosomes. Based on normalisation to lower full-length agrin, only the 
upper (D) but not the middle variants (E) were found enriched in the synaptosomal fraction of wildtype mice. 
Data represent mean values ± S.E.M (n = 5). ** = P<0.01. 
 
axonal transport vesicles. However, the synaptosomal preparation protocol utilises 
homogenisation and therefore tissue disruption to yield a fraction enriched in synaptosomes. 
The intermediate fractions of the preparation therefore partially contain synaptic material. 
Hence, neurotrypsin detected in the soluble fraction (S2) represents a heterogenous pool of 
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non-synaptic as well as synaptic origin. Likewise, all three groups of full-length agrin were 
detected in all fractions (Fig. 23C). However, their relative amounts varied between the 
distinct fractions. As the distribution of all three groups of full-length agrin appeared to be 
different in the distinct fractions, I quantified the full-length variants of agrin in each fraction 
by densitometry of the Western blots and normalised the upper and middle group of variants 
to the lower group. These analyses revealed that the upper group was the predominant form of 
full-length agrin in all analysed fractions. I measured in homogenate (S1) and in the soluble 
fraction (S2) approximately two times more upper than lower full-length agrin (ratios to lower 
group of 1.95 ± 0.25 and 1.70 ± 0.25 (mean ± S.E.M.), respectively; Fig. 23D). In 
synaptosomes, the upper variant was more than five-fold enriched (ratio to lower group of 
5.25 ± 1.11; Fig. 23D). In contrast, the relative amounts of the middle group were nearly 
identical with those of the lower group of variants in all fractions (Fig. 23E, ratio for S1 = 
0.96 ± 0.05, for S2 = 1.01 ± 0.05, for SS = 1.16 ± 0.27). These results indicated that the upper 
group of agrin variants is the predominant agrin variant in synaptosomes. In addition, both 
neurotrypsin-dependent cleavage fragments of agrin appeared in all analysed fractions, 
including synaptosomes (Fig. 23C).  
 
3.1.5 Neurotrypsin-mediated cleavage of agrin is localised at synapses.  
The synaptic localisation of neurotrypsin (Molinari et al., 2002; Stephan et al., 2008), 
its activity-dependent externalisation from presynaptic terminals (Frischknecht et al., 2008), 
and the appearance of the neurotrypsin-dependent agrin fragments in synaptosomes (Fig. 23) 
suggested a local proteolytic activity of neurotrypsin at synapses. To test this hypothesis, I 
compared the extent of neurotrypsin-dependent cleavage of agrin in synaptosomes and other 
subcellular brain fractions of neurotrypsin-overexpressing mice (Nto-act) and their wild-type 
littermates (P12 to P15; Fig. 24A). Evaluation by electron microscopy revealed no 
morphological differences between synaptosomes from wild-type littermates and Nto-act 
mice (data not shown). In addition, Western blotting confirmed the overexpression of human 
neurotrypsin in Nto-act mouse brains with a distribution similar to endogenous neurotrypsin 
(Fig. 24A).  
The comparison of full-length agrin signals in synaptosomes and the other subcellular 
fractions from wild-type and Nto-act mice revealed both the predominant cleavage of agrin in 
the synaptosomal fraction and the preferred cleavage of the upper group of full-length agrin 
(Fig. 24A, arrow). The synaptosomal upper group of full-length agrin was identified as the 
predominant target for neurotrypsin at synapses, because its levels were reduced to 40.1 ± 4.7 
% in samples of Nto-act mice (Fig. 24B), while its reduction was only to 64.5 ± 3.3 % in the 
soluble fraction and to 62.2 ± 4.7 % in the homogenate of neurotrypsin-overexpressing mice. 
Neurotrypsin-dependent cleavage of full-length agrin was not as strong for the middle group 
as found for the upper group of bands, but the tendency was conserved (Fig. 24C). Signals for 
the middle variants of agrin signals were reduced to approximately 80 % of wild-type levels 
(79.3 ± 5.8 % and 79.8 ± 6.1 %) in the homogenate and soluble fraction, respectively, and to 
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Figure 24. Neurotrypsin preferentially cleaves synaptic agrin. A, Western blot analysis of a representative 
synaptosomal preparation from brains of 12- to 15-days-old mice overexpressing active human neurotrypsin 
(Nto-act) compared to their wildtype (wt) littermate samples. Postsynaptic-density protein 95 (PSD-95) was 
strongly enriched in the synaptosomal fraction (SS) and served as a control for the quality of the preparation. 
Endogenous (murine) neurotrypsin (arrowhead) as well as overexpressed human neurotrypsin (asterisk) were 
found in the synaptosomal (SS) fraction, but as expected they were also detected in the other fractions of the 
preparation (soluble fraction 1 of the brain homogenate (S1), soluble fraction 2 (S2)). Human neurotrypsin was 
detected as a double band of approximately 100 kDa on top of an unspecific band that was also visible in the 
wildtype samples. The overexpression of neurotrypsin led to a major decline of upper full-length agrin, 
especially in synaptosomes (arrow; upper (a), middle (b) and lower (c) full-length agrin variants) and a 
corresponding increase of the 90-kDa and the 22-kDa fragments in all fractions. Molecular mass references are 
indicated in kDa. B-E, Quantitative Western blot analyses of synaptosomal preparations from postnatal day 12 to 
15 Nto-act mouse brains compared to their wildtype littermates. B, C, Upper agrin variants (B) as well as middle 
agrin variants (C) were more efficiently cleaved in all analysed fractions of transgenic animals. For both the 
upper and middle agrin variants cleavage was strongest in the synaptosomal fraction. D, E, The levels of both the 
90-kDa (D) and the 22-kDa (E) fragment were increased in all analysed fractions compared to wildtype levels. 
This increase was strongest in the synaptosomal fraction. Signal intensities of samples from Nto-act mice were 
normalised to corresponding signals of the wt littermate control samples (wt values set to 100 %). Data represent 
mean values ± S.E.M (n = 5).  * = P<0.05; ** = P<0.01; *** = P<0.001. 
 
approximately 50 % (48.2 ± 11.9 %) in the synaptosomal fraction. These results were 
supported by synaptosomal analyses of neurotrypsin-deficient (Ntd) mice and their wild-type 
littermates (P13 to P16; Fig. 25). Upper and middle full-length agrin signals were increased in 
all analysed fractions obtained from Ntd mice when compared to wild-type littermate controls 
(Fig. 25A-C, anti-C-22 antibody; Fig. 25A, D, E, anti-C-90 antibody). A pronounced increase 
of full-length agrin levels was also detected in the synaptosomal fraction, when analysed with 
both the anti-C-22 and the anti-C-90 antibodies (Fig. 25A, arrows). As a tendency, upper and 
middle full-length agrin levels increased strongest in synaptosomal samples from Ntd mice 
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Figure 25. Neurotrypsin preferentially cleaves synaptic agrin. A, Western blot analysis of a representative 
synaptosomal preparation from brains of 13- to 16-days-old neurotrypsin-deficient mice (Ntd) compared to their 
wildtype (wt) littermate samples. Postsynaptic-density protein 95 (PSD-95) was strongly enriched in the 
synaptosomal fraction (SS) and served as a control for the quality of the preparation. Endogenous neurotrypsin 
(arrowhead) was found in the synaptosomal (SS) fraction as well as in the other fractions of the preparation 
(soluble fraction 1 of brain homogenate (S1), soluble fraction 2 (S2)) of wildtype animals only. The signals for 
upper full-length agrin were increased in the absence of neurotrypsin, especially in synaptosomes (arrow; upper 
(a), middle (b) and lower (c) full-length agrin variants). Molecular mass references are indicated in kDa. B-E, 
Quantitative Western blot analyses of synaptosomal preparations from postnatal day 13 to 16 Ntd mouse brains 
compared to their wildtype littermates. Signals for upper agrin variants (B, C-22-2 antibody; D, C-90-1 
antibody) as well as for middle agrin variants (C, C-22-2 antibody; E, C-90-1 antibody) were stronger in all 
analysed fractions of Ntd animals, compared to wildtype levels. These findings indicate, in accordance to the 
data presented in Fig. 24, that neurotrypsin-dependent cleavage of agrin also takes place at the synapse. The 
finding of preferred cleavage of synaptic agrin was supported by results obtained with the C-22 antibody. Here, 
the increase of signals for both the upper and middle agrin variants was strongest in the synaptosomal fraction of 
Ntd animals. When detection of full-length agrin was performed with the C-90 antibody, this tendency was only 
observed for middle agrin variants. However, due to the low number of experiments performed, the data 
presented states only tendencies. Signal intensities of samples from Ntd mice were normalised to corresponding 
signals of the wt littermate control samples (wt values set to 100 %). Data represent mean values of one (C-90-1 
antibody) or two independent experiments (C-22-2 antibody). 
 
(Fig. 25B-E). However, due to the little number of possible experiments with tissue from Ntd 
animals, statistical analyses could not be performed and it was therefore impossible to verify 
these tendencies. Signal intensities of the lower group of agrin variants were not altered 
between wild-type and transgenic samples or between wild-type and Ntd samples (data not 
shown). In accordance with the results from the analysis in P9 mouse brains (section 3.1.3; 
Fig. 21, 22), lower full-length agrin is not a substrate of neurotrypsin in any of the analysed 
fractions. 
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In parallel with the predominant cleavage of agrin in synaptosomes, I found that the 
increase of agrin fragments due to neurotrypsin-overexpression was strongest in the 
synaptosomal fraction for both fragments. The increase of the 90-kDa agrin fragment due to 
neurotrypsin overexpression was over 25-fold (2787.8 ± 791.4 % (mean ± S.E.M.) of wild 
type; Fig. 24D) in the synaptosomal fraction, but only 5 to 6-fold in brain homogenate and the 
soluble fraction (594.5 ±89.2 % and 543.9 ±53.0 %, respectively; Fig. 24D). A similar but 
less pronounced synaptosomal enrichment was found for the 22-kDa fragment. The 22-kDa 
fragment was enriched two-fold (197.4 ± 25.1 %; Fig. 24E) in the synaptosomal fraction of 
Nto-act mice and appeared in the homogenate and the soluble fraction at about 130 percent of 
wild-type levels (132.6 ± 12.0 % and 127.6 ± 6.9 %, respectively; Fig. 24E).  
Taken together, I found that the upper group represents the main form of full-length 
agrin in synaptosomes and that this group of variants was predominantly cleaved by 
neurotrypsin. A similar enrichment in synaptosomes was not found for the middle group of 
agrin variants, but their cleavage was also localised predominantly in synaptosomes. These 
data therefore indicated that neurotrypsin-dependent cleavage of agrin is concentrated at 
synapses. 
 
3.2 In vitro analysis of the neurotrypsin-agrin interaction in dissociated 
hippocampal neuron cultures and in cos7 cells. 
3.2.1 Neurotrypsin and agrin are endogenously expressed by cultured dissociated 
hippocampal neurons as well as by cultured astrocytes. 
Neurotrypsin cleaves synaptic agrin in vivo (section 3.1) but the functional 
implications of this interaction are largely unknown. To reduce system complexity, the 
interaction of neurotrypsin and agrin was further analysed in vitro. The well characterised 
dissociated hippocampal neuron cultures (Banker, 1980; Goslin, 1998; Kaech and Banker, 
2006) has proven a useful and suitable in vitro system for studying neuronal characteristics of 
neurotrypsin. Initial live-cell imaging experiments with these cultures revealed synaptic 
targeting of ectopically expressed neurotrypsin and its activity-dependent release from 
presynaptic terminals (Frischknecht et al., 2008). Further analyses with cultured hippocampal 
neurons were supposed to be performed to elucidate the neuronal effects of the neurotrypsin-
dependent cleavage of agrin to support the in vivo findings. 
To determine the endogenous expression levels for neurotrypsin as well as agrin 
transcripts, reverse transcriptase polymerase chain reaction (RT-PCR) was performed from 
dissociated hippocampal neuron cultures grown in high density as well as from cultured 
cortical glial cells. To confirm the integrity of the isolated mRNA in each preparation, primers 
specific for glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) were used as a positive 
control. Neurotrypsin-transcripts were detected in 6 days and 13 days old dissociated 
hippocampal neuron cultures (DIV6 and DIV13, respectively; Fig. 26A). However, minor 
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glial cell contaminations may also be present in these cultures and therefore I performed RT-
PCR also from cultured cortical glial cells. Neurotrypsin transcript expression was indeed 
detected in cultured glia, even if in vivo expression of neurotrypsin is believed to be restricted 
to neurons (Wolfer et al., 2001). Hence, this RT-PCR result for neurotrypsin transcript 
expression in cultured glia indicates that the general protein expression patterns may diverge 
in vitro and in vivo. Similar, however, less surprising results were obtained when the 
endogenous expression of agrin variants was assessed. Transcripts of transmembrane agrin 
(SN, Fig. 26B1) and secreted agrin (LN, Fig. 26B2) variants were detected in dissociated 
hippocampal neuron cultures at both analysed time points (DIV6 and DIV13, respectively; 
Fig. 8B) as well as in cultured cortical glia. These results suggested that the in vitro 
expression of both agrin variants is similar to their reported in vivo expression pattern (Kroger 
and Schroder, 2002). Thus, both neurotrypsin as well as agrin transcript expression was 
detected in hippocampal neuron cultures. However, these data rendered it impossible to 
definitely determine if neurotrypsin and agrin variants are expressed by cultured neurons or if 
their detection in neuronal cultures was due to minor glial contaminations. 
 
 
Figure 26. Neurotrypsin and agrin transcripts are expressed in hippocampal neuron cultures as well as cortical 
glial cell cultures. Reverse transcriptase polymerase chain reaction (RT-PCR) performed from total RNA 
isolated from high density dissociated mouse hippocampal neuronal cultures or from mouse cortical glial 
cultures. A, Neurotrypsin-specific mRNA was amplified using specific primers hybridising in transcript regions 
encoded by different exons. As a positive control (+), a plasmid containing the cDNA for mouse neurotrypsin 
was used as template DNA. Expression of neurotrypsin transcripts was confirmed in neurons that were grown for 
6 or 13 days in vitro (DIV6 and DIV13, respectively) as well as in cultured glial cells. B, Transmembrane agrin 
or secreted agrin transcripts were amplified by using a common 3’ primer that hybridises in the first, for all 
agrin-isoforms common, exon and a specific 5’ primer that hybridises in the specific 5’ regions of the respective 
transcript-variants. Expression of both variants was confirmed in DIV6 and DIV13 neurons as well as in cultured 
glial cells. In parallel to the neurotrypsin and agrin-specific PCR reactions, the integrity of the isolated mRNA 
was analysed with GAPDH-primers (GAPDH). 
 
 The endogenous expression of neurotrypsin and agrin in cultured hippocampal 
neurons was further analysed by immunocytochemistry using neurotrypsin and agrin specific 
antibodies. Hippocampal neurons were grown on poly-L-lysine coated glass coverslips and 
co-cultured above a separated layer of cortical glia-feeder cells used to support neuronal 
growth and survival. This co-culture system enabled the growth of neurons in low densities 
(Goslin, 1998) to allow the detailed analyses of expressed proteins, in particular their 
subcellular localisations in single cells. DIV8 (Fig. 27A-F) or DIV15 (Fig. 27G-L) dissociated 
hippocampal neuron cultures were fixed and agrin was detected with the anti-C-90-agrin  
73  3. Results 
 
Figure 27. Agrin protein is expressed by neurons as well as glial cells. Confocal microscopy analyses of 
dissociated hippocampal neurons cultured for either 8 or 15 days in vitro (DIV8, A-F; DIV15, G-L, 
respectively). Neuronal cultures were generated from wildtype NMRI animals and cultured on glia-feeder cells 
generated either from agrin-deficient animals (D-F; J-L) or from corresponding wildtype littermates (A-C; G-I). 
A, D, G, J, Agrin protein ex-pression was visualised with the affinity purified anti-C-90 agrin antibody (C-90-1). 
B, E, H, K, Microtubuli associated protein 2 (MAP-2) was used as a marker to visualise dendritic processes of 
3. Results  74 
cultured neurons. C, F, I, L, Agrin and MAP-2 specific signals were merged to better identify subcellular 
localisations of agrin (overlay). Independent of the age of the cultures, agrin signals were dense and evenly
distributed over coverslips cultured above wildtype glia-feeder cells (DIV8, A-C; DIV15, G-I). Agrin signals 
were especially strong within and around glial cells (A, C arrows), occasionally growing in between cultured 
neurons on the coverslips. In contrast, neuronal cell bodies were devoid of agrin signals (asterisks). However, 
agrin signals detected on coverslips cultured above agrin-deficient glia-feeder cells (DIV8, D-F; DIV15, J-L) 
were mainly localised to neuronal cell-bodies and neurites growing on the coverslips. Especially pronounced 
signals were observed along axons (arrowheads), identified as neurites devoid of MAP-2 signals. These findings 
strongly suggested that glia-feeder cells secrete high amounts of agrin variants that are deposited on the neuron-
containing coverslips localised above the glia-feeder cell layer. By culturing neurons on agrin-deficient glia-
feeder cells, thus abolishing the main source for glia-derived agrin variants, the neuronal expression pattern of 
agrin can be monitored. These experiments indicated that neuronal agrin is localised to all neurites but especially 
enriched in axons. Scale bars: 50 µm. 
← 
antibody using confocal microscopy. To differentiate between axonal and dendritic processes 
and therefore to determine the subcellular localisation of agrin-specific signals, cells were co-
stained with an antibody against the dendritic marker microtubule-associated protein 2 (MAP-
2). When neurons were co-cultured with wild-type glia-feeder cells, agrin-specific signals 
were almost uniformly distributed over the whole coverslip at both analysed time-points 
(DIV8, Fig. 27A-C); DIV15, Fig. 27G-I). Signals were merely absent within cell-bodies and 
neurites of neurons. In glial cells, occasionally growing in between the cultured neurons, 
however, strong agrin-specific signals were detected (Fig. 27A, C, arrows). Interestingly, 
coated coverslips incubated without neurons on glia-feeder cells also showed uniformly 
distributed agrin-specific signals (data not shown). Glial cells express a variety of agrin 
variants as confirmed by RT-PCR (see above). Therefore, glia-feeder cells may secrete agrin 
variants that are deposited on the coverslips accommodating the neurons. To solely detect 
neuronal agrin and, therefore, to exclude the detection of glia-feeder cell-derived secreted 
agrin variants, neurons were cultured on glia-feeder cells obtained from agrin-deficient mice 
(DIV8, Fig. 27D-F; DIV15, Fig. 27J-L). Indeed, cultures devoid of glia-feeder derived agrin 
variants showed a redistribution of agrin signals. Here, neuron-derived agrin was detected 
within and around neuronal cell-bodies and neurites of both DIV8 and DIV15 neurons. Co-
staining with MAP-2 revealed that agrin signals were mainly detected in a punctuate pattern 
within and around dendrites and very strong concentrated within axons (arrowheads). These 
results confirmed that agrin is expressed by neurons as well as by glial cells. Furthermore, 
neuron-derived agrin localised to dendrites and axons, in accordance with previously 
published data (Neuhuber and Daniels, 2003), whereas secreted variants of glia-feeder origin 
were broadly deposited on the coverslip. 
In contrast, neurotrypsin protein was not detected in dissociated hippocampal neuron 
cultures with any of the neurotrypsin-specific polyclonal antibodies generated in our lab. Only 
unspecific signals were detected with these antibodies, judged by the appearance of identical 
signals obtained from experiments performed with corresponding preimmune sera (data not 
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shown). We were so far not able to produce a highly specific antibody against neurotrypsin 
and low level expression of endogenous neurotrypsin may have been missed with the 
currently available low affinity antibodies. 
 
 
Figure 28. Efficient and successful adenovirus-mediated ectopic expression of agrin and eGFP variants in cos7 
cells. Confocal microscopy analyses of cos7 cells infected with recombinant adenoviruses expressing the 
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respective constructs indicated in panel A. B, Differential interference contrast image of a representative sample 
of cos7 cells growing on coverslips. Ectopically expressed proteins were identified either by antibody staining 
(agrin detection in F, I, K, anti-C-90 antibody) or by detection of signals emitted by the corresponding 
fluorescent protein of the respective fusion proteins (mRFP-signals, G, H, J; eGFP-signals, C, D, E). C, 
Neurotrypsin, C-terminally tagged with eGFP (neurotrypsin-eGFP), was mainly detected in a dotted pattern 
within the cell. These signals most likely resemble, as anticipated, mainly transport-vesicles filled with 
neurotrypsin-eGFP fusion proteins. D, Adenovirus-mediated expression of eGFP resulted in a uniformly 
distribution of eGFP in the cytoplasm and sometimes the nucleus of infected cells. E, Adenovirus-expressed 
myristoylated alanine-rich C-kinase substrate (MARCKS)-eGFP fusion proteins were successfully and 
efficiently targeted to cellular membranous compartments, including the plasma membrane. F, The expression 
pattern of wildtype transmembrane agrin-x12, y4, z8 (SN-agrin), with strong localisation mainly at the plasma 
membrane, confirms the successful and efficient adenovirus-mediated expression of SN-agrin. This was also 
confirmed for the SN-agrin fusion proteins, carrying mRFP either at agrin’s C-terminus (SN-agrin-mRFP, G) or 
at its N-terminus (mRFP-SN-agrin, H). The same was true for the mutant versions of SN-agrin, not cleavable by 
neurotrypsin: SN-agrin-mutant (I), SN-agrin-mutant-mRFP (J) and mRFP-SN-agrin-mutant (not shown). All 
mRFP-agrin fusion proteins were prominently detected at the plasma membrane but also some intracellular 
signals (arrows) were detectable. However, both N-terminally mRFP-tagged agrin fusion protein variants were 
mistargeted to mainly intracellular sites of some but not all infected cells (as an example: mRFP-SN-agrin-
mutant, K). Scale bars: 25 μm (B); 30 μm (J); 40 μm (C, D); 47 μm (E-I, K). 
← 
 
3.2.2 Recombinant adenoviruses efficiently express functional transmembrane agrin 
variants in cos7 cells. 
Neurotrypsin and agrin variants are endogenously expressed in dissociated 
hippocampal neuron cultures but due to presumably low level expression of neurotrypsin and 
the expression of a variety of agrin variants by glia as well as neurons, it was impossible to 
perform detailed analyses of the neurotrypsin-agrin interaction with the endogenously 
expressed proteins.  
To enable the efficient expression and detection of neurotrypsin as well as defined 
agrin variants in cultured neurons, we chose to perform adenovirus-mediated ectopic 
expression of neurotrypsin and transmembrane agrin variants. Adenovirus-mediated neuronal 
expression of neurotrypsin variants, including neurotrypsin fused at its C-terminus to 
enhanced green fluorescent protein (eGFP), were already successfully established in our lab. 
Studies with ectopically expressed neurotrypsin fusion proteins indicated that neurotrypsin-
(eGFP) variants are correctly targeted to axons and presynaptic terminals in dissociated 
hippocampal neuron cultures (Frischknecht et al., 2008). This was in accordance with the 
presynaptic localisation of endogenous neurotrypsin in vivo (Molinari et al., 2002; Stephan et 
al., 2008). In parallel to the generation of neurotrypsin expressing virus variants, a control 
adenovirus, expressing eGFP alone, was constructed in our lab. To determine the functional 
interaction of neurotrypsin and agrin, I generated recombinant adenoviruses, expressing 
variants of the transmembrane agrin-x12, y4, z8 isoform (SN-agrin). This isoform is strongly 
expressed in (hippocampal) neurons both in vivo and in vitro (O'Connor et al., 1995; Lesuisse 
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et al., 2000) and has been used in most of the analyses concerning agrin functions in CNS 
neurons (Hilgenberg et al., 1999; Bose et al., 2000; Gingras et al., 2002; Hilgenberg et al., 
2002; Hoover et al., 2003). In addition, due to its expression at the plasma membrane, the 
transmembrane isoform of agrin may be easier to track when compared to secreted variants. 
Besides a wild-type agrin variant, I generated a SN-agrin expression construct that is not 
cleaved by neurotrypsin due to mutations of the respective amino acids in the P1 positions of 
the cleavage sites targeted by neurotrypsin (SN-agrin-mutant). In addition, expression 
constructs of SN-agrin and SN-agrin-mutant, either N-terminally or C-terminally tagged with 
monomeric red fluorescent protein (mRFP), were generated. Due to the physical properties of 
eGFP and mRFP, their fluorescent signals are easily separable using appropriate equipment, 
therefore allowing the simultaneous detection of co-expressed neurotrypsin-eGFP and mRFP-
tagged SN-agrin variants even in live neurons. Concerning the analysis of neurotrypsin-
dependent cleavage of agrin, the mRFP-agrin and agrin-mRFP constructs were believed to 
enable the tracking of agrin parts after neurotrypsin-dependent cleavage. SN-agrin was shown 
to generate filopodia-like processes on dendrites as well as axons of cultured neurons (Annies 
et al., 2006; McCroskery et al., 2006) and recent findings suggest that also the C-terminus of 
agrin is involved in structural changes of the dendritic surface (unpublished observations). In 
prospect of also analysing the impact of neurotrypsin activity on these functions of agrin, I 
generated another adenovirus, expressing a myristoylated alanine-rich C-kinase substrate 
(MARCKS)-eGFP fusion protein. This variant targets eGFP to all membranous compartments 
of the cell, including the plasma membrane (De Paola et al., 2003), and is therefore suitable to 
visualise morphological cell-surface alterations, including those mediated by agrin. 
 Initial expression analyses of constructed virus variants in infected cos7 cells 
confirmed the efficient and functional expression of almost all constructs. Adenovirus-
mediated expression of neurotrypsin was detected in a punctuate pattern throughout the 
cytoplasm, expectedly representing mainly transport vesicles filled with the extracellular 
protease (Fig. 28C). The infection of cos7 cells with an adenovirus-eGFP construct led to the 
strong expression of eGFP within the cytoplasm and the nucleus (Fig. 28D). In contrast, cells 
infected with MARCKS-eGFP adenoviruses (Fig. 28E) revealed strong punctuated 
intracellular eGFP signals, presumably resembling a range of different intracellular 
membranous compartments, and strong continuous signals at the plasma membrane. Also the 
SN-agrin (Fig. 28F), SN-agrin-mutant (Fig. 28I), SN-agrin-mRFP (Fig. 28G) and SN-agrin-
mutant-mRFP (Fig. 28J) variants were successfully expressed at the plasma membrane and 
detectable by either anti-C-90-agrin immunostaining or mRFP fluorescence of the respective 
fusion proteins. However, both N-terminally tagged SN-agrin or SN-agrin-mutant variants 
were only in some infected cells efficiently targeted to the plasma membrane (e.g., mRFP-
SN-agrin in Fig. 28H). In contrast, many infected cells revealed strong intracellular 
expression of these constructs, in addition to its plasma membrane localisation. An example 
of cos7 cells expressing mistargeted mRFP-SN-agrin-mutant fusion proteins is shown in 
Figure 28K. Similar mistargeting was also observed with constructs alternatively carrying an 
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unrelated enhanced cyan fluorescent protein (eCFP) at the N-terminus of SN-agrin (data not 
shown). These results indicated that N-terminal fusion to SN-agrin in general may interfere 
with its proper targeting within the cell. However, it is unclear why mistargeting seemed to be 
cell-dependent as normal expression of these N-terminal fusion proteins was detectable in 
some infected cells. Though, even when correct and efficient targeting of agrin-mRFP and 
mRFP-agrin fusion constructs was observed by their predominant expression at the plasma-
membrane, additional strong punctuate intracellular signals were detected in most of the 
infected cells (Fig. 28G, H, arrows). In contrast, only weak intracellular signals were detected 
in wild-type SN-agrin expressing cells. The additional intracellular signals appearing in cells 
expressing agrin-mRFP and mRFP-agrin variants were generally much stronger visualised by 
mRFP fluorescence, compared to anti-C-90-agrin antibody mediated fusion protein detection. 
Other immunofluorescence experiments performed in our lab indicated that the anti-C-90 
antibody recognises intracellular agrin far weaker than its extracellular localised epitopes. 
Thus, it might be that the mRFP signal of the respective fusion proteins allows a far better 
detection of intracellular agrin than signals obtained by anti-agrin immunofluorescence, 
enabling a more sensitive detection of immature agrin variants in golgi- or transport-vesicle-
like structures. However, the appearance of additional intracellular signals might alternatively 
indicate mistargeting of, e.g., incorrect folded and therefore potentially toxic fusion proteins. 
To exclude that the appearance of these additional intracellular signals were caused by 
mistargeting of mRFP-tagged agrin variants to lysosomes, a co-localisation study with a 
lysosomal marker (anti-lysosomal-associated membrane protein 1 (Lamp-1) antibody) was 
performed. Yet, only a minor fraction of SN-agrin-mRFP (Fig. 29A) or mRFP-SN-agrin (Fig. 
29B) signals, detected by mRFP fluorescence, co-localised with Lamp-1 positive structures. 
Another explanation for the appearance of additional mRFP-positive intracellular structures 
may be the detection of endocytosed C-terminal agrin-mRFP parts released from the N-
terminal moiety of agrin or N-terminal mRFP-SN-agrin parts released from the C-terminal 
part of agrin.  
Agrin is efficiently cleaved by neurotrypsin (Reif et al., 2007) and Western blot 
analyses of infected cos7 cells were performed to further determine the functionality of the 
generated viruses. As a control, supernatant samples of transfected cos7 cells expressing SN-
agrin alone or co-expressing SN-agrin and mouse neurotrypsin (mNT; Fig. 29C, D) were 
analysed. The anti-C-90-agrin antibody detected in the supernatant of agrin and neurotrypsin 
co-expressing cells the characteristic C-terminal agrin cleavage fragments, generated by 
neurotrypsin, with a molecular mass of around 130-kDa and 90-kDa (Fig. 29C). Only minor 
amounts of the 130-kDa fragment (arrowhead), resembling C-terminal agrin solely cleaved at 
the α-site, were detected. In contrast, the 90-kDa fragment appeared much stronger, 
confirming that neurotrypsin-dependent cleavage of agrin occurs predominantly at both α- 
and the β-cleavage sites (Reif et al., 2007). Interestingly, a band at around 130 kDa was 
visible also in single transfected cells expressing SN-agrin alone, indicating endogenous low 
level agrin cleavage (Fig. 29C, arrowhead). It is possible that cos7 cells endogenously express 
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Figure 29. Adenovirus-agrin variants as well as adenovirus-neurotrypsin variants were functionally expressed in 
cos7 cells. A, B, Confocal microscopy analyses of cos7 cells infected with transmembrane agrin-x12, y4, z8 
(SN-agrin) variants carrying mRFP either at agrin’s C-terminus (SN-agrin-mRFP, A) or its N-terminus (mRFP-
SN-agrin, B). mRFP-agrin fusion proteins were visualised by mRFP fluorescence. To determine correct targeting 
of the mRFP-agrin fusion proteins  the cell, the intracellular localisation of fusion proteins was analysed. 
Mistargeting of ectopically expressed proteins to lysosomes may indicate toxic or at least aberrant protein 
properties. Therefore, lysosomes were co-visualised with an antibody against the lysosomal marker lysosomal-
associated membrane protein 1 (Lamp-1). However, in addition to strong signals detected at the plasma 
membrane of cells, mRFP-positive intracellular signals (red) are not co-localising with LAMP-1 positive 
organells (green). This suggests the proper integrity and functional targeting of the mRFP-agrin fusion proteins 
within the cell. Scale bars: 10 μm (A); 7 μm (B) C, D, Western blot analysis of samples from cos7 cells 
transfected with SN-agrin alone or co-transfected with SN-agrin and mouse neurotrypsin (mNT). Molecular 
mass references are indicated in kDa. C, Agrin signals were detected with the anti-C-90 agrin antibody in 
supernatant samples. In contrast to cells expressing agrin alone (agrin), the co-expression of agrin and 
neurotrypsin (agrin+mNT) resulted in efficient processing of agrin by neurotrypsin, generating the C-90 and C-
22 agrin fragments. The additional fragment detected at around 130 kDa (arrowhead) represents C-terminal agrin 
only cleaved at the α-site (also termed 110-kDa agrin fragment corresponding to its estimated net molecular 
mass (Reif et al., 2007)). This fragment also appeared in the single transfection sample (arrowhead) and may 
here be generated by another endogenously expressed protease. D, Full-length neurotrypsin protein expression 
was detected in the corresponding lysates of cos7 cells, transfected with mouse neurotrypsin, as a single band at 
around 85 kDa. This neurotrypsin-specific band appeared above an unspecific double band also present in the 
negative control (agrin transfection only). E, F, Western blot analysis of samples from cos7 cells infected with 
adenovirus-SN-agrin variants alone or co-infected with adenovirus-SN-agrin variants and adenovirus-
neurotrypsin-eGFP. E, Agrin signals detected with the anti-C-90 agrin antibody in supernatant samples. All three 
analysed constructs (lanes 3, 4 – wildtype SN-agrin; lanes 5, 6 – SN-agrin-mRFP; lanes 7, 8 – mRFP-SN-agrin) 
were efficiently processed by co-expressed neurotrypsin-eGFP. This was indicated by the appearance of agrin 
cleavage products (compare to C) only in samples of co-infected cells (lanes 4, 6, 8) but not in single infected 
cells (lanes 3, 5, 7). Mind the band-shift of the partially processed C-terminal agrin fragment at around 130 kDa 
(cleaved by neurotrypsin only at the α-site; arrowhead) due to mRFP fusion at the C-terminus of this agrin 
construct (SN-agrin-mRFP, lane 6) to around 160 kDa. However, the faint band (asterisk) below the prominent 
160 kDa band might represent the partially cleaved C-terminal agrin fragment that has lost the mRFP due to 
proteolytic activity. As there are no antibodies against mRFP available it was impossible to determine if mRFP is 
partially cleaved off agrin’s C-terminus. F, Neurotrypsin-eGFP was detected in cell-lysates of corresponding 
infected cell-samples (lane 2, cells infected with adenovirus-neurotrypsin-eGFP alone; lanes 4, 6, 8 – co-
infection with adenovirus-agrin variants) as two bands at around 120 and 90 kDa. Both bands appeared to be 
3. Results  80 
neurotrypsin-specific as no signals were detected in the sample of uninfected control cells (lane 1). The 120-kDa 
band most likely represents full-length neurotrypsin-eGFP detection, whereas the identity of the 90-kDa band is 
unclear. 
← 
low levels of neurotrypsin, even if only ectopically expressed mouse neurotrypsin with a Mr 
of around 85 kDa was detected in cell lysates with the anti-neurotrypsin antibody employed in 
this study (Fig. 29D). The two faint bands detected at around 80 to 85 kDa in the sample of 
single transfected, SN-agrin expressing cells, most-likely represent unspecific signals. Cos7 
cells, derived from the African green monkey (Chlorocebus aethiops), are believed to express 
neurotrypsin containing an additional scavenger receptor cysteine-rich domain (SRCR 
domain), therefore altering its molecular mass to approximately 100 kDa (Xu and Su, 2005). 
However, the 90-kDa agrin cleavage product was not observed in cells expressing SN-agrin 
alone, indicating that the band appearing at around 130 kDa was most-likely generated by 
another protease. The Western blot analysis of supernatant samples of infected cos7 cells 
confirmed the successful adenovirus-mediated expression of wild-type SN-agrin, SN-agrin-
mRFP, mRFP-SN-agrin and neurotrypsin (detected in cell lysates) variants as well as their 
functional interaction (Fig. 29E, F). Substantial amounts of agrin-cleavage fragments were 
only found in samples from cells co-expressing an agrin variant and neurotrypsin-eGFP (lanes 
4, 6, 8 of Fig. 29E (anti-C-90-agrin detection) and Fig. 29F (anti-neurotrypsin(-eGFP) 
detection)). Both adenovirus-expressed SN-agrin (Fig. 29E, lanes 3, 4) and mRFP-SN-agrin 
(Fig. 29E, lanes 7, 8) were identically processed by neurotrypsin-eGFP (Fig. 29E, lanes 4, 8, 
respectively), generating the previously described 130-kDa (arrowhead) and 90-kDa agrin 
fragments (see above). The SN-agrin-mRFP variant (Fig. 29E, lanes 5, 6) was similarly and 
also efficiently processed by neurotrypsin (Fig. 29E, lane 6). Due to C-terminal fusion with 
mRFP, the original 130-kDa agrin fragment was detected at around 160 kDa (arrowhead). 
However, a weaker signal also appeared at around 130 kDa (asterisk), potentially indicating 
partially cleaved C-terminal agrin that has lost the mRFP due to proteolytic activity. As there 
are no antibodies against mRFP available it was impossible to determine if mRFP is partially 
cleaved off agrin’s C-terminus. Like detected in control samples of SN-agrin expressing cells 
(Fig. 29C), if at all, only minor amounts of virus-expressed SN-agrin variants were processed 
in singly infected cells at the α-site only (SN-agrin, Fig. 29E, lane 3; SN-agrin-mRFP, Fig. 
29E, lane 5; mRFP-SN-agrin, Fig. 29E, lane 7). 
 
3.2.3 Adenovirus-mediated ectopic expression targets transmembrane agrin to dendrites 
as well as axons in cultured dissociated hippocampal neurons. 
The generated adenovirus expression constructs were functionally expressed in cos7 
cells and efficiently processed by neurotrypsin-eGFP, confirming their potential for further 
analyses of the functional neurotrypsin-agrin interaction in cultured hippocampal neurons. I 
therefore infected cultured dissociated hippocampal neurons at DIV11 with adenoviruses 
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expressing either SN-agrin, SN-agrin-mRFP, mRFP-SN-agrin or MARCKS-eGFP. The cells 
were fixed 3 days post-infection and the expression  
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Figure 30. Transmembrane agrin is targeted to the membrane of dendrites as well as axons of cultured 
hippocampal neurons. Confocal microscopy analyses of hippocampal neurons cultured for 14 days (DIV14), 
infected with recombinant adenovirus at DIV11. Ectopically expressed proteins were identified by either 
antibody staining (agrin detection in A, D, G, anti-C-90 agrin antibody) or by detection of signals emitted by the 
corresponding fluorescent protein of the respective fusion proteins (mRFP-signals, E, H, N; eGFP-signals, J, K, 
L). Co-staining of neurons with an antibody against the dendritic marker microtubuli associated protein 2 (MAP-
2) allowed the differentiation between dendrites and axons (B, F, I, M). A-C, Adenovirus-mediated expression 
of transmembrane agrin-x12, y4, z8 (SN-agrin) targeted SN-agrin to neurites of infected neurons. The merging 
of agrin (A, anti-C-90 agrin antibody) and MAP-2 (B) specific signals (C; agrin, green; MAP-2, red) revealed 
that SN-agrin localised to dendrites (arrows) as well as to axons (arrowheads). Most agrin-positive axons 
depicted were processes from neurons whose cell bodies lay outside the depicted area. Also SN-agrin-mRFP (D-
F) and mRFP-SN-agrin (G-I) were targeted to dendrites and axons of infected cells (D, G, anti-C-90 agrin 
immunofluorescence; E, H, mRFP signals; F, I, anti-C-90 agrin (green) and anti-MAP-2 (blue) signals merged). 
J, K, Adenovirus-mediated expression of the myristoylated alanine-rich C-kinase substrate (MARCKS)-eGFP 
fusion protein in cultured neurons and astroglia (asterisk, J). MARCKS-eGFP was targeted to cellular 
membranes of infected cells, including the plasma membrane of all neurites. Due to their different morphological 
properties, the axon (arrowhead) and dendrites (arrows) can easily be differentiated (K, magnified section of J). 
L-O, Co-infection of a cultured neuron with adenovirus-MARCKS-eGFP and Adenovirus-SN-agrin-mRFP 
revealed that SN-agrin was targeted to the plasma membrane. MARCKS-eGFP was localised to the membrane 
of a dendrite, confirmed by merging MARCKS-eGFP (green; L, M) and MAP-2 (blue, M) signals. The 
cytoplasmatic MAP-2 signal filled the dendrite whereas the membrane-targeted eGFP was localised to the rim of 
the structure. The mRFP signal of the SN-agrin-mRFP fusion protein also localised to the rim of this dendrite 
(N), and exactly co-localised with MARCKS-eGFP (O; mRFP, red; eGFP, green; co-localisation, yellow), 
indicating that the SN-agrin constructs were successfully targeted to the plasma membranes of neurons. Scale 
bars: 45 μm (A-F); 50 μm (G-J); 20 μm (K); 10 μm (L-O). 
← 
patterns of the respective ectopically expressed proteins were analysed by confocal 
microscopy (Fig. 30). SN-agrin variant expression was detected by either anti-C-90-agrin 
antibody staining (SN-agrin, Fig. 30A; SN-agrin-mRFP, Fig. 30D; mRFP-SN-agrin, Fig. 
30G) or by mRFP fluorescence of the corresponding mRFP-tagged SN-agrin fusion proteins 
(SN-agrin-mRFP, Fig. 30E; mRFP-SN-agrin, Fig. 30H). Antibody-derived signals as well as 
mRFP-fluorescence signals of the respective agrin variants revealed almost identical results. 
Like in cos7 cells, however, intracellular signals in the neuronal cell-body were stronger 
detected by mRFP fluorescence, compared to anti-C-90-agrin antibody signals. Nevertheless, 
all agrin variants were identically targeted to the neuronal periphery. To differentiate between 
axonal and dendritic processes and therefore to determine the subcellular localisation of agrin-
specific signals, cells were co-stained with an antibody against the dendritic marker 
microtubule-associated protein 2 (MAP-2). Merging anti-C-90-agrin signals with MAP-2 
signals verified that ectopically expressed SN-agrin (Fig. 30C), SN-agrin-mRFP (Fig. 30F) 
and mRFP-SN-agrin (Fig. 30I) identically localised to dendrites (arrows) as well as axons 
(arrowheads). The same was true for the different SN-agrin-mutant variants, uncleavable by 
neurotrypsin (data not shown). This targeting of ectopically expressed SN-agrin to axonal as 
well as dendritic compartments resembles the previously determined expression pattern of 
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endogenous agrin in cultured neurons (section 3.2.1). It was therefore concluded that the 
adenovirus-agrin variants were efficiently expressed and correctly targeted within neurons. 
Infection of cultured neurons with MARCKS-eGFP-expressing adenoviruses resulted in 
strong eGFP fluorescence in a punctuate pattern within the cell-body and in continuous 
signals along the neuronal surfaces, extending into the neuronal periphery (Fig. 30J, K). Glia 
cells are generally more efficiently infected by adenoviruses, resulting in much higher 
adenovirus-mediated expression levels in glia when compared to neurons. Indeed, astrocytes, 
occasionally growing in between the cultured neurons, were expressing high levels of 
MARCKS-eGFP (Fig. 30J, asterisk). However, MARCKS-eGFP was efficiently targeted to 
the axonal (Fig. 30K, arrowheads) as well as dendritic (Fig. 30K, arrows) membranes of 
neurons, even labelling thin dendritic protrusions like dendritic spines. To confirm that the 
SN-agrin constructs were also efficiently targeted to the plasma membrane of neurites, 
cultured hippocampal neurons were co-infected with MARCKS-eGFP- and SN-agrin-mRFP-
expressing viruses. A dendritic segment of a co-infected cell is depicted in Figures 30L-O. 
Strong eGFP-fluorescence was detected at the rim of a dendrite (Fig. 30L), positively 
identified by MAP-2 signals filling the dendritic cytoplasm (Fig. 30M). The mRFP 
fluorescence of the SN-agrin-mRFP fusion protein also localised to the rim of this dendritic 
segment (Fig. 30N) and exactly co-localised with the MARCKS-eGFP signal  (Fig. 30O), 
confirming correct and efficient plasma-membrane targeting of the SN-agrin variants also in 
cultured neurons. 
 
3.2.4 Neurotrypsin cleaves agrin in dissociated hippocampal neuron cultures. 
 SN-agrin variants were successfully and efficiently expressed at the plasma membrane 
of axons and dendrites of cultured hippocampal neurons, utilising adenovirus mediated 
expression. In addition, adenovirus-mediated neurotrypsin expression in cultured neurons was 
previously described to target neurotrypsin predominantly to the axonal compartment 
(Frischknecht et al., 2008). Indeed, adenovirus-mediated expression of neurotrypsin-eGFP 
(Fig. 31A-C) or a catalytically inactive variant of neurotrypsin-eGFP (NT-inact-eGFP; Fig. 
31D-F) were identically detected in a punctuate pattern in the neuronal cell body as well as in 
proximal dendrites and entire axons (arrowheads) of DIV14 neurons, when analysed by 
confocal microscopy. Confirming the reported preferential targeting of neurotrypsin to axons, 
the density of signals was much higher in axons and continuous transport of a high number of 
neurotrypsin-eGFP or NT-inact-eGFP positive transport vesicles was mainly detected in the 
entire axon of infected live neurons (data not shown but see (Frischknecht et al., 2008)). 
Identical signals were obtained when neurotrypsin-eGFP was detected either by eGFP 
fluorescence (Fig. 31A) or with an antibody against neurotrypsin (Fig. 31B), therefore 
confirming the integrity of the neurotrypsin expression constructs. 
To investigate the interaction of ectopically expressed neurotrypsin and agrin variants, 
cultured dissociated hippocampal neurons were co-infected with SN-agrin-mRFP and 
neurotrypsin-eGFP or with SN-agrin-mRFP and NT-inact-eGFP at DIV11, fixed at DIV14 
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and analysed by confocal microscopy. When neurotrypsin-eGFP was co-expressed with SN-
agrin-mRFP (Fig. 31G-I), neurotrypsin expression was detected in an identical pattern when 
compared to single expression experiments (Fig. 31G). However, SN-agrin-mRFP detection, 
performed by mRFP fluorescence, was clearly altered due to neurotrypsin co-expression (Fig. 
31H). SN-agrin-mRFP signals were mainly detected in the neuronal cell-body but the 
neuronal processes were largely devoid of mRFP signals, indicating efficient neurotrypsin-
dependent cleavage of agrin. In contrast, co-expression of SN-agrin-mRFP and NT-inact-
eGFP (Fig. 31J-O) neither altered the targeting of NT-inact-eGFP (Fig. 31J, M) nor the 
original localisation of SN-agrin-mRFP (Fig. 31K, N). Besides its predominant localisation at 
the plasma membrane, SN-agrin-mRFP was also detected in a punctuate pattern within 
neurites, presumably reflecting transport vesicles (Fig. 31N, arrowheads). NT-inact-eGFP 
signals detected in the same neurite and supposedly also indicating transport vesicles (Fig. 
31M, arrowheads), were only occasionally co-localising with intracellular SN-agrin-mRFP 
signals (Fig. 31O, arrows), suggesting that neurotrypsin and SN-agrin were mainly 
transported in different transport vesicles.    
These results are in line with the previously presented data and indicate that agrin is a 
substrate of neurotrypsin in neurons, also when ectopically expressed in dissociated 
hippocampal neuron cultures. Neurotrypsin is predominantly but not exclusively expressed in 
the axonal compartment, whereas SN-agrin is targeted to axons as well as dendrites of 
cultured neurons. Co-expression experiments of SN-agrin with catalytically inactive 
neurotrypsin indicate independent trafficking of both proteins within the neuron and therefore 
supporting the hypothesis of extracellular interaction of neurotrypsin and agrin (Stephan et al., 
2008). However, further and more detailed analyses are necessary to elucidate the exact 
mechanism of their interaction. Unfortunately, problems with both the stability of produced 
virus variants and high-titer virus production made it impossible for me to proceed with these 
analyses. 
  
3.2.5 Transmembrane agrin is involved in the generation of additional filopodia-like 
protrusions on dendrites as well as axons of cultured dissociated hippocampal neurons. 
Transmembrane agrin (SN-agrin) was described to cause the increased appearance of 
dendritic as well as axonal filopodia on cultured neurons (Annies et al., 2006; McCroskery et 
al., 2006). Dendritic filopodia have been characterised as precursors of dendritic spines and 
their induction could indicate an early stage of synapse formation (Jontes and Smith, 2000; 
Matus, 2005; Knott et al., 2006; Toni et al., 2007). Assuming that SN-agrin is indeed involved 
in filopodia-dependent generation of new synapses, neurotrypsin-dependent cleavage of agrin 
may interfere with agrin’s function and might therefore implicate the neurotrypsin-agrin 
interaction in adaptive reorganisations of the synaptic circuitry.  
To confirm the published effects of SN-agrin, adenovirus-mediated ectopic expression 
of SN-agrin in dissociated hippocampal neurons cultures was visualised by immuno-
cytochemistry and analysed by confocal microscopy (Fig. 32). Cell surfaces were visualised  
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Figure 31. Neurotrypsin cleaves agrin in cultured neurons. Confocal microscopy analyses of adenovirus-
mediated ectopic expression of agrin and neurotrypsin variants in hippocampal neurons cultured for 14 days 
(DIV14), infected with recombinant adenovirus at DIV11. Ectopically expressed proteins were identified either 
by antibody staining (neurotrypsin detection with an antibody against the proline-rich basic domain, B) or by 
detection of signals emitted by the corresponding fluorescent protein of the respective fusion proteins (mRFP-
signals, H, K, N; eGFP-signals, A, D, G, J, M). Co-staining of neurons with an antibody against the dendritic 
marker microtubuli associated protein 2 (MAP-2) allowed the differentiation between dendrites and axons (C, 
E). A-C, Adenovirus-mediated expression of neurotrypsin-eGFP, either detected by eGFP fluorescence (A) or 
anti-neurotrypsin antibody staining (B), was detected in a punctuate pattern in the neuronal cell-body and within 
neurites. Co-staining with MAP-2 revealed that neurotrypsin was mainly localised to axons (arrowhead) and 
proximal dendrites (C, eGFP, green; MAP-2, blue). D-F, Adenovirus-mediated expression of a catalytically 
inactive neurotrypsin-eGFP fusion protein (NT-inact-eGFP), detected by eGFP fluorescence (D). Comparison 
with MAP-2 staining (E) and merging of eGFP and MAP-2 specific signals confirmed that also NT-inact-eGFP 
was mainly localised to axons (arrowhead) and proximal dendrites (F, eGFP, green; MAP-2, red). G-I, 
Adenovirus-mediated co-expression of neurotrypsin-eGFP and transmembrane agrin-x12, y4, z8-mRFP (SN-
agrin-mRFP) in cultured hippocampal neurons. Ectopically expressed neurotrypsin-eGFP (G, eGFP 
fluorescence) was localised to the cell body as well as neurites, whereas SN-agrin-mRFP signals (H, mRFP 
fluorescence) were mainly detectable within the cell-body of the same co-infected neuron (I, merged signals; 
mRFP, red; eGFP, green). This distribution of agrin signals was unlike its localisation in single expression 
analyses (Fig. 30) and indicated that neurotrypsin cleaves agrin also in cultured neurons, leading to the removal 
of agrin from neuronal surfaces. J-O, Adenovirus-mediated co-expression of NT-inact-eGFP (J, M, eGFP 
fluorescence) and SN-agrin-mRFP (K, N, mRFP fluorescence) in cultured hippocampal neurons (L, O, merged 
signals; mRFP, red; eGFP, green). In contrast to the co-expression of active neurotrypsin-eGFP and SN-agrin-
mRFP, co-expression of NT-inact-eGFP and SN-agrin-mRFP did not result in the redistribution of agrin signals. 
In the neuronal periphery, NT-inact-eGFP signals were detected in a dotted pattern, most-likely indicating 
transport vesicles (M, arrowheads point at some of the detectable vesicles (eGFP fluorescence)). SN-agrin-mRFP 
was detected at the plasma membrane as well as in a punctuate pattern within the neurite (N, mRFP 
fluorescence), potentially representing vesicular structures (arrowheads point at some of the detectable vesicles). 
The overlay of NT-inact-eGFP and SN-agrin-mRFP signals revealed that only a few vesicular structures 
contained both NT-inact-eGFP and SN-agrin-mRFP (arrows, O, mRFP, red; eGFP, green; co-localisation, 
yellow). Most of the visualised, potentially vesicular structures were only labelled for one of the analysed 
proteins, indicating that neurotrypsin and agrin are mainly trafficked in independent transport compartments. 
Scale bars: 50 μm (A-F, J-L); 40 μm (G-I); 10 μm (M-O). 
← 
with agrin signals covering the plasma membrane of all neurites, detected with the anti-C-90-
agrin antibody. Indeed, the overexpression of SN-agrin caused the increased appearance of 
filopodia-like protrusions on cultured dissociated hippocampal neurons. Neurons infected for 
either 4 days and analysed at DIV8 (Fig. 32A, B) or 3 days and analysed at DIV14 (Fig. 32C-
H) showed a high number of dendritic (arrows) as well as axonal filopodia. (arrowheads). In 
immature DIV8 neurons, long filopodia-like protrusions were found mainly at distal parts of 
the outgrowing dendrites (Fig. 32A, arrows) as well as on distal axons (not shown). In 
contrast, in mature DIV14 neurons, filopodia were distributed all over dendritic processes and 
were mainly detected along proximal segments of dendrites (Fig. 32C). Filopodia-like 
protrusions along proximal segments of dendrites were also detectable on differential 
interference contrast images of both uninfected DIV14 neurons (Fig. 32E, arrows) and  
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Figure 32. The overexpression of 
transmembrane agrin causes the 
increased appearance of filopodia-
like protrusions on dendrites and 
axons of cultured hippocampal 
neurons. Confocal microscopy 
analyses of dissociated hippocampal 
neurons cultured for 8 or 14 days 
(DIV8, DIV14, respectively), infect-
ed with a recombinant adenovirus-
transmembrane agrin-x12, y4, z8 
(SN-agrin) variant. Agrin signals 
were detected with the anti-C-90 
agrin antibody (A, C, G, H). Co-
staining of neurons with an antibody 
against the dendritic marker micro-
tubuli associated protein 2 (MAP-2) 
allowed the differentiation between 
dendrites and axons (B, D). A, B, 
Immature DIV8 neurons, infected 
with adenovirus-SN-agrin-mRFP for 
4 days, developed a multitude of 
filopodia-like processes (A, arrows) 
mainly along the distal parts of their 
MAP-2 positive dendrites (B). C-H, 
Mature DIV14 neurons, infected with 
adenovirus-SN-agrin-mRFP for 3 
days, developed a multitude of 
filopodia-like processes (C, arrows) 
mainly along the MAP-2 positive 
dendrites (D). This increase of 
filopodia-like protrusions (arrows) 
upon SN-agrin overexpression was 
also detected on differential inter-
ference contrast images of proximal 
dendrites (F), when compared to an 
uninfected control cell (E). In 
addition to the in-creased appearance 
of filopodia-like protrusions on 
dendrites, the overexpression of SN- 
agrin also caused the appearance of 
filopodia-like protrusions on distal 
parts of axons (G, H, arrows). Scale 
bars: 50 μm (A, B); 40 μm (C, D); 10 
μm (E, F), 15 μm (G, H).  
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SN-agrin overexpressing neurons (Fig. 32F, arrows). However, a clear increase of filopodia 
number was visible on dendrites of neurons overexpressing SN-agrin. In addition to the SN-
agrin dependent increase of dendritic filopodia, the appearance of filopodia on distal segments 
of axons was also detectable (DIV14, Fig. 32G, H, arrowheads).  
Thus, expression of SN-agrin caused the additional generation of filopodia-like 
protrusions at the neuronal surface of both immature and mature cultured neurons. Yet, with 
regards to dendritic filopodia, immature neurons mainly generated filopodia in distal regions 
of dendrites whereas mature neurons mainly developed filopodia in proximal dendritic 
regions. Therefore, one could expect that SN-agrin-mediated generation of filopodia-like 
protrusions may contribute to different functional processes, depending on the maturation 
state of the cultured neuron. Filopodia-like protrusions in immature neurons may be involved 
in processes of peripheral neurite formation. In contrast, filopodia in mature neurons may 
represent precursors of dendritic spines and, therefore, contribute to synapse generation, a 
process potentially targeted by neurotrypsin activity given its role in the establishment and 
maintenance of cognitive brain functions (Molinari et al., 2002).     
  
3.2.6 Neurotrypsin inhibits transmembrane agrin’s potential to generate filopodia-like 
protrusions in cultured cos7 cells. 
 Transmembrane agrin (SN-agrin) causes the increased appearance of filopodia-like 
protrusions on dendrites as well as axons of cultured dissociated hippocampal neurons. It was 
therefore tempting to speculate that neurotrypsin-dependent cleavage of agrin might modify 
this function of SN-agrin. Unfortunately, due to problems with virus stability and high-titer 
virus production I was not able to further analyse the effects of neurotrypsin-dependent 
cleavage on agrin’s functions in cultured neurons. However, SN-agrin expressing cos7 cells 
also develop excessive filopodia-like protrusions on their cell-surface (see below) and 
neurotrypsin was shown to efficiently cleave agrin in cos7 cells (Fig. 29C). I therefore studied 
if neurotrypsin-dependent cleavage of agrin caused modifications of SN-agrin-dependent 
generation of filopodia-like protrusions on cos7 cells.  
To determine if agrin’s induction of filopodia-like protrusions at the cos7 cell surface 
is based on similar properties as described for its function in neurons (McCroskery et al., 
2006), cos7 cells were transfected with either SN-agrin, secreted agrin (LN-agrin) or 
neurotrypsin expression constructs.  Cells were fixed and stained 24 hour post-transfection 
and analysed by confocal microscopy (Fig. 33). To visualise filopodia-like protrusions, cells 
were stained with fluorescently-labeled Phalloidin that specifically binds to filamentous actin 
structures within the cell, including motile surface elements like filopodia. Alternatively, cells 
were transfected with the membrane-targeted eGFP variant MARCKS-eGFP to visualise the 
cellular surface. Thin and long filopodia-like protrusions (arrowheads) appeared only 
infrequently on untransfected cos7 cells (Fig. 33A) or MARCKS-eGFP expressing cells (Fig. 
33B) and the surface of most cells appeared rather smooth. However, densely packed und 
rather uniformly distributed short protrusions were detected at the surface of only some 
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Figure 33. Transmembrane agrin but not secreted agrin generates additional filopodia-like structures on cos7 
cell surfaces. Confocal microscopy analyses of transiently transfected cos7 cells. To visualise motile cell-surface 
protrusions, like filopodia, the actin cytoskeleton was labelled with fluorescence-tagged Phalloidin (A, C, E, G, 
M). Alternatively, cells were transfected with a construct targeting eGFP to cellular membranes, including the 
plasma membrane (B). This myristoylated alanine-rich C-kinase substrate (MARCKS)-eGFP fusion construct 
was therefore also suitable to visualise cell surface protrusions. Untransfected cos7 cells (A) or cells transfected 
with MARCKS-eGFP (B) occasionally developed motile and thin filopodia-like protrusions at the cellular 
surface (arrowheads). C-F, Transfection of cos7 with transmembrane agrin-x12, y4, z8 (SN-agrin) causes the 
excessive appearance of filopodia-like protrusions at the cell-surface (arrows). These protrusions may 
alternatively represent branched-retraction fibres (BRF, see main text) and were visualised by staining 
ectopically expressed agrin with the anti-C-90 agrin antibody (D, F). These protrusions were positive for 
Phalloidin signals, supporting the notion that they were indeed filopodia-like structures or BRF (C, E). G-I, In 
contrast to the effects of SN-agrin, secreted agrin-x12, y4, z8 (LN-agrin) did not cause filopodia-like protrusions 
or BRF. Cells transfected with LN-agrin had a smooth surface, in average exactly resembling control conditions 
(G, Phalloidin). LN-agrin was detected in a punctuate pattern throughout the permeabilised cell with two 
different agrin-specific antibodies (H, anti-N-terminal agrin domain (NtA) antibody; I, anti-C-90 agrin 
antibody), most likely indicating endoplasmatic reticulum, golgi and secretory vesicle structures. J-L, LN-agrin 
was indeed secreted and deposited around the cell, as visualised with not permeabilised cells, by either anti-NtA-
dependent (J) or anti-C-90 agrin-dependent (K) fluorescence. To identify the cellular borders, the corresponding 
differential interference contrast image is shown in panel L. M-O, The cell surface of cos7 cells transfected with 
neurotrypsin was indistinguishable from control cells (M, Phalloidin). Ectopically expressed neurotrypsin was 
detected in a vesicular pattern within permeabilised cells (N) and deposited around cells, when not permeabilised 
cells were analysed (O). Scale bars: 25 μm (A-D, J-L); 50 μm (G-I); 55 μm (E, F), 47 μm (M-O). 
← 
untransfected or MARCKS-eGFP expressing cells (data not shown). Only around 19 % of 
control cells showed an extraordinary amount of filopodia at their surface (Table 2). In strong 
contrast, 86.8 % of cos7 cells expressing SN-agrin developed extensive filopodia-like 
protrusions at their surface (Table 2; Fig. 33C-F, arrows), visualised by both Phalloidin-
staining (Fig. 33C, E) and anti-C-90-agrin immunoreactivity (Fig. 33D, F). These protrusions 
were irregularly distributed over the whole cellular surface and appeared sometimes in 
bundles or as long and branched structures. Alternatively to the definition as filopodia, these 
sometimes very long and branched structures might resemble branched retraction fibres 
(BRF) that emerge from extensive cell movements (internal communication with A. Matus, 
FMI Basel, Switzerland; see also (Taylor and Robbins, 1963)). It is therefore unclear if the 
morphological changes on cos7 cells generated by SN-agrin are comparable to effects 
triggered by SN-agrin in neurons. Analyses of cos7 cells expressing LN-agrin confirmed that 
this effect was SN-agrin specific. The surface of LN-agrin expressing cells was mostly 
smooth and indistinguishable from untransfected cells, as confirmed by Phalloidin signals 
(Fig. 33G). LN-agrin signals were detected by both the anti-NtA-agrin antibody (Fig. 33H) 
and the anti-C-90-agrin antibody (Fig. 33I) within the permeabilised cell in a punctuate 
pattern, presumably reflecting transport vesicles. The functional expression of LN-agrin was 
supported by its efficient secretion and deposition around the cell, visualised in 
nonpermeabilised cells again by both anti-NtA-agrin (Fig. 33J) and anti-C-90-agrin 
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immunoreactivity (Fig. 33K). Also the surface of neurotrypsin-overexpressing cos7 cells was 
indistinguishable from control cells (Fig. 33M; 15.9 % of the neurotrypsin-expressing cells 
with many filopodia versus 18.9 % of control cells, Table 2). Like LN-agrin, neurotrypsin was 
detected in a punctuate pattern, potentially resembling mostly secretory vesicles (Fig. 33N), 
and was efficiently secreted and deposited around transfected cells (Fig. 33O). These results 
confirmed that exclusively the transmembrane variant of agrin causes alterations of the cos7 
cell surface, generating the excessive appearance of filopodia-like protrusions or BRF. 
 
Figure 34. Transmembrane and secreted agrin 
variants are both efficiently cleaved by 
neurotrypsin in cos7 cells. Western blot analysis 
of transfected cos7 cells to determine 
neurotrypsin-dependent (NT-act) cleavage of 
both transmembrane agrin-x12, y4, z8 (SN-
agrin) and secreted agrin-x12, y4, z8 (LN-agrin). 
As a control, co-expression of agrin variants with 
a catalytically inactive variant of neurotrypsin 
(NT-inact) was performed. Two different cell 
pools were independently transfected with either 
a neurotrypsin or an agrin variant and mixed 24 
hours post-transfection. Therefore, mainly 
extracellular cleavage of both SN-agrin and LN-
agrin was assessed. Molecular mass references 
are indicated in kDa. A, Full-length agrin 
detection with the anti-C-90 agrin antibody in 
cos7 cell-lysate samples. Both full-length 
variants of LN-agrin and SN-agrin were detected 
as three distinct groups of bands above 
250 kDa, indicating differentially glycanated forms of full-length agrin, termed upper (a), middle (b) and lower 
(c) variants of agrin. In parallel to full-length agrin detection, some additional but less intense bands appeared in 
all analysed cell lysate samples, possibly representing partially cleaved agrin variants. B, Both mouse NT-act as 
well as mouse NT-inact were detected in cell-lysate samples as a single band at around 85 kDa on top of a 
potentially unspecific double-band that was also present in control samples transfected with agrin alone. C, 
Detection of the 90-kDa agrin fragment with the anti-C-90 agrin antibody in supernatant samples. Both LN-agrin 
and SN-agrin were similarly and efficiently cleaved by neurotrypsin. The 90-kDa fragment only appeared in 
samples of cells co-transfected with agrin and NT-act. In addition, the 110-kDa agrin fragment, in cos7 
supernatants detected at around 130 kDa and representing C-terminal agrin exclusively cleaved at the α-site, 
appeared stronger in agrin and NT-act co-expression samples. D, Detection of the 22-kDa agrin fragment with 
the anti-C-22 agrin antibody in supernatant samples. Completing the results depicted in panel C, neurotrypsin 
also efficiently generated the 22-kDa fragments from both LN-agrin and SN-agrin isoforms. 
 
 The filopodia-generating activity in cultured neurons was localised to the N-terminal 
half of SN-agrin, approximately N-terminal to the neurotrypsin α-cleavage site within agrin 
(McCroskery et al., 2006). A similar functional dependency was observed in cos7 cells as 
only SN-agrin but not LN-agrin was able to generate excessive filopodia-like protrusions or 
BRF. The LN-agrin and SN-agrin variants used in this study only differed in their very N-
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terminal domain, arguing for either a direct effect of the transmembrane domain or, more 
likely, for an effect depending on SN-agrin’s targeting to the plasma membrane. However, it 
is possible that neurotrypsin-dependent cleavage of agrin and a resulting relocation of C-
terminal agrin fragments to functional interaction sites, e.g., at the cell surface, may activate 
an additional  function to generate filopodia-like protrusions. Therefore, the inactive LN-agrin 
variant represented a useful control to analyse potential effects of the C-terminal agrin 
fragments released by neurotrypsin-dependent cleavage and to determine the active region 
within agrin that causes the generation of filopodia on cos7 cells.  
Only SN-agrin was so far confirmed to be a substrate of neurotrypsin in eukaryotic 
cells and a direct interaction between LN-agrin and neurotrypsin, however expected, was not 
yet analysed. To test if LN-agrin is also a substrate of neurotrypsin, either LN-agrin or SN-
agrin variants were co-expressed with neurotrypsin in cos7 cells and potential cleavage was 
analysed by Western blotting (Fig. 34). Neurotrypsin-dependent cleavage of agrin is supposed 
to occur mainly extracellularly. However, high levels of overexpression of proteins in the 
same cell may alter their physiological properties and may therefore lead to an 
unphysiological interaction of neurotrypsin and agrin. Thus, experimental conditions were 
chosen to mainly promote detection of physiological relevant extracellular cleavage of agrin. 
This was attempted by expression of neurotrypsin and agrin from different cell pools. Cos7 
cells were single transfected with either agrin or neurotrypsin variants. These different cell 
pools were mixed 24 hour post-transfection and further co-cultured for additional 24 hours. 
However, potentially unphysiological interactions between neurotrypsin and agrin variants 
could theoretically still have occurred due to cell-lysis in culture or during the sample 
preparation procedure. In singly transfected cos7 cells, expressing either agrin variant alone, 
full-length agrin variants of both LN-agrin and SN-agrin were detected as three distinct 
groups of bands (Fig. 34A), similar to their detection in vivo (section 3.1). Yet, in LN-agrin-
expressing cell lysate samples, bottom full-length agrin was the strongest variant detected, 
whereas in lysates of SN-agrin expressing cells all three distinct groups of full-length agrin 
variants were equally as strong. This discrepancy is likely explained by the different 
characteristics of the respective agrin variants. SN-agrin is mainly expressed at the cellular 
membrane and therefore detected in cell lysates, while fully mature and heavily glycanated 
variants of LN-agrin are presumably efficiently secreted and thus only detected weakly in cell 
lysates. Anyhow, SN-agrin as well as LN-agrin were identically cleaved by neurotrypsin. 
Upon co-expression with active neurotrypsin (NT-act), the signal intensities of mainly upper 
and middle full-length agrin variants of both SN-agrin and LN-agrin decreased (Fig. 34A). In 
addition, all three C-terminal cleavage fragments were generated by neurotrypsin from both 
variants. The 130-kDa fragment, resembling C-terminal agrin solely cleaved at the α-site, 
increased only slightly when compared to samples expressing agrin alone but both the 90-kDa 
and the 22-kDa agrin were efficiently generated by the activity of ectopically expressed 
neurotrypsin. Interestingly, very low amounts of the 22-kDa fragments also appeared in cells 
expressing either LN-agrin or SN-agrin alone. This again indicated (see section 3.2.2), 
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Figure 35. Neurotrypsin inhibits the function of transmembrane agrin to generate filopodia-like structures on 
cos7 cell surfaces. Confocal microscopy analyses of transiently transfected cos7 cells. To visualise motile cell-
surface protrusions, the actin cytoskeleton was labelled with fluorescence-tagged Phalloidin (C, F, I). A-C, The 
co-transfection of neurotrypsin (A, anti-neurotrypsin antibody) and secreted agrin-x12, y4, z8 (LN-agrin, B, anti-
C-90 agrin antibody) had no effect on the generation of filopodia-like structures or branched retraction fibres 
(BRF) at the cos7 cell surface. Phalloidin signals in co-expressing cells were indistinguishable from signals 
obtained in control cells, indicating that the released C-terminal agrin fragments do not cause filopodia-like 
protrusions or BRF on cos7 cells. D-F, Co-transfection of cos7 cells with neurotrypsin (D, anti-neurotrypsin 
antibody) and transmembrane agrin-x12, y4, z8 (SN-agrin, E, anti-C-90 agrin antibody) expression constructs. 
C-terminal agrin was efficiently removed by neurotrypsin from cell-surfaces of co-expressing cells (asterisks). 
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Interestingly, co-expression of neurotrypsin and SN-agrin also resulted in the inhibition of SN-agrin’s potential 
to generate filopodia-like structures or BRF at the cos7 cell surface. Phalloidin signals in co-expressing cells 
(asterisks) were indistinguishable from signals obtained with control cells, indicating that neurotrypsin blocks 
agrin’s function to generate filopodia-like structures or BRF (F). However, filopodia-like protrusion or BRF 
were still present on some cells only singly transfected with SN-agrin (arrows).  G-K, Co-transfection of cos7 
cells with catalytically inactive neurotrypsin (NT-inact) and SN-agrin expression constructs. Permeabilised (G-I) 
as well as not permeabilised cells (J, K) co-expressing NT-inact (G, J, anti-neurotrypsin antibody) and SN-agrin 
(H, K, anti-C-90 agrin antibody) were analysed. Phalloidin signals of permeabilised, co-expressing cells were 
indistinguishable from signals obtained with control cells (I), indicating that also NT-inact blocks agrin’s 
function to generate filopodia-like structures or BRF. Therefore, the inhibition potential of neurotrypsin did not 
depend on the catalytical activity of neurotrypsin and, thus, not on agrin cleavage. Neurotrypsin is recruited to 
cell membranes when co-expressed with agrin (J, not permeabilised cells, arrowheads) and might therefore 
inhibit SN-agrin’s function by direct protein-protein interactions with agrin. L, Cos7 cells co-expressing SN-
agrin and eGFP develop an extensive amount of filopodia-like protrusions or BRF, similar to cells expressing 
SN-agrin alone. This indicates that solely co-transfection of cells does not interfere with SN-agrin’s function. 
Scale bars: 50 μm (A-C, J, K); 20 μm (D-F); 25 μm (G-I, L). 
← 
in addition to the generation of the 130-kDa fragment in cells expressing agrin alone, that 
cos7 cells either express low levels of endogenous neurotrypsin or other proteases with low 
activity on C-terminal agrin cleavage.  
To analyse if neurotrypsin-dependent cleavage alters agrin’s function to cause 
filopodia-like structures or BRF, cos7 cells were co-transfected with SN-agrin and 
neurotrypsin or with SN-agrin and a catalytically inactive variant of neurotrypsin (NT-inact). 
To determine if released C-terminal agrin fragments have a potentially positive effect on the 
generation of filopodia-like protrusions on cos7 cells (see above), LN-agrin was co-expressed 
with neurotrypsin. The transfected cells were fixed 24 hours post-transfection and stained 
with anti-neurotrypsin and anti-C-90-agrin antibodies to visualise ectopic protein expression. 
Subsequently, processed cells were stained with fluorescently labelled Phalloidin to visualise 
filopodia-like structures and were finally analysed by confocal microscopy (Fig. 35). Cos7 
cells co-expressing LN-agrin and neurotrypsin did not show any alterations in their respective 
protein expression patterns, compared to LN-agrin or neurotrypsin single transfections (Fig. 
35A-C). Furthermore, no alterations of the cell-surface morphology were observed as 
Phalloidin-signals of co-expressing cells (Fig. 35C) were indistinguishable to control cells 
(Fig. 35A, B). Thus, neurotrypsin-dependent cleavage of agrin did not cause a positive effect 
on the increase of filopodia number on cos7 cells. These results indicated that the effect of 
agrin observed in cos7 cells strictly relied on transmembrane agrin activity, presumably 
localised within the N-terminal segment prior to the α-cleavage site of agrin, similar to its 
published effects in cultured neurons (Annies et al., 2006; McCroskery et al., 2006). 
Interestingly, the co-expression of SN-agrin and neurotrypsin resulted in the inhibition of SN-
agrin’s function to generate filopodia-like structures or BRF (Fig. 35D-F). Cos7 cells co-
expressing high levels of both SN-agrin and neurotrypsin (asterisks) showed reduced cell-
surface signals of agrin due to the release of the C-terminal fragments from the 
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transmembrane-bound N-terminus of agrin (Fig. 35E). In addition, only 33.3 % of co-
expressing cells developed extensive filopodia-like or BRF structures, in strong contrast to 
86.8 % of cells expressing SN-agrin alone (Table 2; Fig. 35E, F). This inhibition of agrin’s 
function was specifically limited to co-expressing cells, as single transfected cells on the same 
coverslip, expressing agrin alone, still developed extensive filopodia-like structures (Fig. 35E, 
F, arrows). Thus, many co-expressing cells revealed a cell-surface that was almost 
indistinguishable from control cells (Fig. 35F), indicating the ability of neurotrypsin to block 
SN-agrin’s function to generate filopodia-like protrusions or BRF in cos7 cells. However, 
even catalytically inactive neurotrypsin (NT-inact) was able to block SN-agrin’s function 
(Fig. 35G-I). Again, the cell surface of cells co-expressing SN-agrin and NT-inact (asterisks) 
was rather smooth with no or only few filopodia-like protrusions (Fig. 35I), comparable to 
SN-agrin and active neurotrypsin co-expressing cells as well as to control samples. To 
exclude the possibility that the general co-transfection of cells caused alterations in cellular 
functions, possibly as a result of exceeding levels of ectopically expressed proteins, thereby 
leading to the inhibition of SN-agrin’s function, I co-transfected cos7 cells with SN-agrin and 
an unrelated eGFP expression construct. However, 70.4 % of co-transfected cells expressing 
high levels of both SN-agrin and eGFP were filopodia positive (Table 2; Fig. 35L), therefore 
confirming the specific inhibition of SN-agrin’s function by neurotrypsin in cos7 cells. 
 
Table 2: Neurotrypsin inhibits SN-agrin’s function to generate filopodia-like structures at the cos7 cell surface. 
 
 
cos7 cells  
transfected with: 
filopodia-
positive  
cells 
filopodia-
negative  
cells 
percentage  
filopodia-positive cells 
control (untransfected) 20 86 18.9 
neurotrypsin 17 90 15.9 
SN-agrin 99 15 86.8 
SN-agrin + neurotrypsin 15 45 33.3 
SN-agrin + eGFP 27 8 70.4 
 
 
 
 
Quantification of filopodia-positive cells. Transfected cos7 cells were fixed and stained with specific antibodies 
to visualise neurotrypsin and agrin expression. Additional staining with fluorescently labelled Phalloidin enabled 
the visualisation of the cell-surface morphology, including filopodia-like structures. Cells were subsequently 
analysed by confocal microscopy to roughly estimate the quantity of filopodia positive and negative cells for 
each set of transfections (Fig. 33, 35).  The appearance of an excess of filopodia-like structures at multiple sites 
of the cellular surface identified cos7 cells as filopodia-positive. In contrast, filopodia-negative cells had a 
similar appearance as the average control cell with little or no filopodia (Fig. 33A, B).  
  
Taken together, these experiments indicated that the ability of agrin to generate 
filopodia-like protrusions or BRF on cos7 cells is strictly dependent on the transmembrane 
isoform of agrin, in accordance with published effects in cultured neurons ((McCroskery et 
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al., 2006)). Furthermore, neurotrypsin inhibits SN-agrin’s function, however, independent of 
its catalytic activity. The mechanism of SN-agrin to cause filopodia in cultured neurons was 
shown to involve clustering of SN-agrin molecules (Annies et al., 2006) and the 
overexpression of this variant may have led to automatic clustering of SN-agrin proteins 
accumulating in high densities at the cellular surface. Neurotrypsin binds to extracellular 
epitopes of SN-agrin variants and is recruited to cell-membranes (Fig. 35J, arrowheads). It is 
therefore likely that the inhibiting activity of neurotrypsin was caused by its potential to form 
protein-protein interactions with agrin. Thus, binding of neurotrypsin to agrin may have 
blocked the clustering of SN-agrin variants, necessary for filopodia-generation.  
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The neuronal serine protease neurotrypsin cleaves agrin in vitro (Reif et al., 2007) and 
cleavage was also observed at the NMJ in vivo (Bolliger, M. et al., unpublished observations). 
To analyse if agrin is a substrate of neurotrypsin in the CNS, I performed a detailed 
biochemical analysis with mouse brain tissue and analysed potential functional effects of the 
neurotrypsin-agrin interaction in vitro.  
I found that neurotrypsin cleaves the extracellular proteoglycan agrin predominantly at 
or in the vicinity of synapses in the murine brain, resulting in increased concentrations of 
agrin fragments and decreased full-length agrin at synapses. To further elucidate the potential 
effects of the neurotrypsin-agrin interaction, I generated, and successfully tested, recombinant 
adenoviruses that efficiently expressed variants of transmembrane agrin in cultured neurons. 
These adenoviruses complete a series of previously produced neurotrypsin-expressing viruses 
(Frischknecht et al., 2008) and therefore enable future detailed analyses of the neurotrypsin-
agrin interaction in vitro. Adenovirus-mediated overexpression of transmembrane agrin 
resulted in the increased appearance of dendritic as well as axonal filopodia on cultured 
dissociated hippocampal neurons, thereby confirming recently published observations 
(Annies et al., 2006; McCroskery et al., 2006). Furthermore, transmembrane agrin-
overexpression also caused a similar effect in cos7 cells and here, co-expression analyses 
revealed that neurotrypsin indeed inhibits the function of agrin to induce filopodia-like 
structures, although in a catalytically independent manner. 
 
4.1 Characterisation of agrin protein expression in the murine brain. 
Agrin is a complex heparan sulphate proteoglycan and alternative splicing leads to 
tissue-dependent expression of a variety of different isoforms with distinct functional 
properties (Bezakova and Ruegg, 2003). Transcript expression analyses in the brain revealed 
that several cell types, including endothelial and glial cells, express a variety of agrin isoforms 
while neurons supposedly express these and an additional subset of alternatively spliced 
variants (Kroger and Schroder, 2002). Agrin protein is found in the CNS on neuronal cell 
surfaces at various locations, including synapses (Halfter et al., 1997; Koulen et al., 1999; 
Kroger and Schroder, 2002; Neuhuber and Daniels, 2003; Ksiazek et al., 2007; Stephan et al., 
2008), as well as in glial cells and in the basal lamina lining blood vessels (Barber and Lieth, 
1997; Halfter et al., 1997; Ksiazek et al., 2007; Stephan et al., 2008). However, due to 
limitations in the availability of isoform-specific antibodies, differentiation between 
alternative agrin variants has not been achieved.   
Using a variant of SDS-PAGE based on a Bis-Tris buffer adjusted to neutral pH, I was 
able to resolve brain-derived full-length agrin as three distinct groups of variants with 
different levels of glycanation, termed upper, middle and lower full-length agrin. The 
occurrence of differential glycanated variants may indicate differences in the molecules 
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maturation states whereby lower full-length agrin might represent the most immature agrin 
variant in an early posttranslational stage. Alternatively, agrin variants expressed by different 
cell types or with different subcellular localisations might vary in their glycanation pattern, 
thereby expressing differing functional properties (Brickman et al., 1998; Lindahl et al., 
1998).  
To investigate whether a particular isoform of agrin was predominant at CNS 
synapses, I isolated synaptosomes by subcellular fractionation and analysed them with SDS-
PAGE. I found that the upper group of agrin variants was the major form in synaptosomes, 
exceeding the lower variants five-fold, while its excess in the other cellular fractions was less 
than two-fold. This finding indeed suggests a correlation between the molecule’s glycanation 
state and its subcellular localisation. Glycanation of extracellular matrix molecules, like agrin, 
serves many diverse functions in the CNS, particularly but not exclusively at the synapse 
(Yamaguchi, 2002; Dityatev and Schachner, 2003; Kim et al., 2003; Kleene and Schachner, 
2004; Dityatev and Schachner, 2006; Van Vactor et al., 2006). Glycans have been shown to 
bind a variety of different molecules, like chemokines or cell adhesion factors (Kleene and 
Schachner, 2004; Van Vactor et al., 2006), and the heparan sulphate glycan chains of agrin in 
particular were shown to bind basic fibroblast growth factor 2 (FGF-2) and thrombospondins 
(Cotman et al., 1999). Heavy glycanation of synaptic agrin and therefore synaptic 
accumulation, e.g., of bound thrombospondins or other so far unknown factors would enable 
their spatially concentrated presentation to their respective receptors.  
 
4.2 Neurotrypsin-dependent cleavage of agrin is concentrated at synapses in vivo. 
Agrin is the only known and potentially unique substrate of neurotrypsin, considering 
neurotrypsin’s strict substrate requirements (Reif et al., 2007). In line with this argumentation, 
the temporal as well as spatial expression pattern of agrin and neurotrypsin in the CNS are 
closely related (Stephan et al., 2008; and unpublished observations).  
Neurotrypsin was shown to specifically cleave agrin in vitro, releasing two C-terminal 
fragments from the N-terminal moiety of agrin. I confirmed that agrin is also a substrate of 
neurotrypsin in the CNS and showed that the C-terminal 90-kDa and the 22-kDa agrin 
fragments were exclusively generated by neurotrypsin in the murine brain.  
Comparison of the three groups of agrin variants with regards to their in vivo cleavage 
revealed that neurotrypsin-dependent cleavage of agrin affected only the glycanated agrin, 
i.e., the upper and middle variants. Importantly, synaptic upper agrin variants were clearly the 
preferred proteolytic target of neurotrypsin when compared with agrin found in other 
subcellular fractions. Synaptosomes from neurotrypsin-overexpressing mice exhibited a 
significantly stronger reduction of full-length agrin and showed the strongest increase for both 
agrin fragments. The synaptosomal preparation protocol utilises tissue homogenisation to 
finally yield synaptosomes, biochemically enriched synaptic structures, containing mainly 
resealed presynaptic membranes associated with post- and perisynaptic structures, e.g., 
astroglial membranes enclosing the synapses in vivo.  The soluble fraction of the preparation, 
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however, contains a heterogenous pool of both soluble proteins and small membranous 
particles and fragments, including synaptic vesicles and other synaptic material. Therefore, 
contamination with targeted synaptic agrin material could explain the detection of 
neurotrypsin-dependent cleavage of agrin in the soluble fraction. Hence, neurotrypsin may 
exlusively target synaptic agrin, although extrasynaptic cleavage of agrin cannot be excluded. 
The locally concentrated increase of the 90-kDa and 22-kDa agrin fragments at the 
expense of full-length agrin that was found upon increasing neurotrypsin supports the notion 
of a precursor-product relationship between full-length agrin and its neurotrypsin-dependent 
fragments and thus characterises neurotrypsin-dependent cleavage of agrin as a locally 
concentrated event at or in the vicinity of the synapse.  
 The notion of a locally concentrated cleavage of agrin at synapses and thus a synaptic 
source of agrin fragments is corroborated by the stronger increase of the 90-kDa fragment as 
compared with the 22-kDa fragment in synaptosomes from neurotrypsin-overexpressing mice. 
Agrin binds with high affinity to α-dystroglycan through a binding site located between the 
two neurotrypsin-dependent cleavage sites (Gesemann et al., 1996; Gesemann et al., 1998). 
Therefore, the 90-kDa fragment may be efficiently retained at the site of its production. The 
22-kDa fragment, in contrast, appears to be more diffusible. Its appearance in the 
cerebrospinal fluid (CSF; unpublished observations) indicates that it is either produced in 
excess over its potential receptors or that its receptor interactions are more volatile than those 
of the 90-kDa fragment. Because at least stoichiometric amounts are expected for the 22-kDa 
fragment based on the pattern of proteolytic cleavages that are required for generating the 90-
kDa and 22-kDa fragments, its minor increase observed in synaptosomes upon increasing 
neurotrypsin indicates a synaptic source that has been cleared by a diffusional flux passing via 
the non-synaptic tissue to the CSF. In accordance with this conclusion, the increase of the 22-
kDa fragment observed under transgenic overexpression of neurotrypsin reaches considerably 
lower levels in all non-synaptosomal fractions as well as in brain homogenates, when 
compared to the synaptosomal fraction. 
 Spatially concentrated cleavage of agrin by neurotrypsin at synapses is in accordance 
with our immuno-electron microscopic localisation of neurotrypsin to presynaptic terminals 
(Molinari et al., 2002; Stephan et al., 2008) and our recent live imaging studies with cultured 
hippocampal neurons show that neurotrypsin is transported to synapses and released from 
presynaptic terminals in an activity-dependent manner (Frischknecht et al., 2008). In addition, 
neurotrypsin was found to linger at its synaptic release sites for several minutes before 
disappearing. The molecular mechanism of transient retention of neurotrypsin at the synapse 
remains to be determined. Interactions with cell surface or ECM components are possible. 
Basic segments resembling the one found at the N-terminus of neurotrypsin could exert a 
retaining function via interaction with glycosaminoglycans, possibly those of agrin, and other 
negatively charged surface components. This was already shown for other positively charged 
secreted molecules (see also section 4.2.1), including chemokines, cell adhesion molecules or 
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axon guidance factors, like netrin (Kappler et al., 2000). Restricted mobility by cell-surface 
and ECM association via its C-terminal basic segment is crucial for netrin’s role as a 
chemotropic agent in axonal guidance (Baker et al., 2006). For neurotrypsin, the transient 
local lingering at its synaptic site of externalisation may be essential for the spatially 
concentrated proteolytic action at or near the synapse. In addition, the transient nature of the 
extracellular presence of neurotrypsin after synaptic externalisation might indicate a temporal 
restriction of neurotrypsin’s synaptic actions. 
  
4.3. Neurotrypsin-dependent cleavage of agrin at the synapse: loss-of-function or gain-
of-function?  
Nerve-derived agrin plays a crucial and well characterised role at the NMJ (Ruegg and 
Bixby, 1998). However, studies about the functions of agrin in the CNS are only just 
emerging and little is known about agrin’s interplay with its potential interaction partners, 
also expressed at CNS synapses (Figure 36). A peptide containing the LG-3 domain of agrin, 
closely resembling the 22-kDa agrin fragment, was shown to bind to and signal through a 
synaptic receptor (Hoover et al., 2003) that was identified as the α3-subunit of the Na+/K+-
ATPase (Hilgenberg et al., 2006). Its inhibitory activity on the Na+/K+-ATPase was 
demonstrated to result in membrane depolarisation and increased action potential firing. A 
role of agrin in the formation or maintenance of excitatory synapses through a mechanism 
activated via the MAP kinase signalling pathway has been suggested from the observation 
that agrin-deficient mice, rescued from perinatal death by transgenic expression of agrin in 
motoneurons, exhibited a reduced number of synapses in the cerebral cortex (Ksiazek et al., 
2007). The agrin receptor in this process has not been identified. However, the authors 
demonstrated a striking coincidence of agrin-dependent synapse loss and the expression of 
MuSK in a subpopulation of excitatory synapses and suggested MuSK, which previously was 
thought not to be expressed in the CNS, as a possible agrin receptor in the CNS. As MuSK 
activation at the NMJ was unequivocally shown to depend on the C-terminal LG-3 domain of 
agrin (Gesemann et al., 1995), this domain could also play a role in the activation of MuSK in 
the CNS.  
The region covered by the 90-kDa fragment was shown to interact with heparin (i.e., 
heparan sulphate proteoglycans), α-dystroglycan and different integrins (Burgess et al., 2002). 
The diverse synaptic functions reported for these molecules (Cavaldesi et al., 1999; 
Yamaguchi, 2002; Clegg et al., 2003; Montanaro and Carbonetto, 2003; Kleene and 
Schachner, 2004; Arcangeli and Becchetti, 2006; Shi and Ethell, 2006) may be modified by 
binding of agrin or the 90-kDa fragment alone. 
Antibody-induced clustering of endogenous agrin as well as the overexpression of 
transmembrane agrin were recently reported to induce dendritic filopodia in cultured neurons 
((Annies et al., 2006; McCroskery et al., 2006); this study, section 3.2.5). Dendritic filopodia 
are discussed to represent precursors of dendritic spines (Ziv and Smith, 1996; Jontes and 
Smith, 2000; Portera-Cailliau et al., 2003; Toni et al., 2007), postsynaptic specialisations 
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mainly associated with excitatory synapses (Ethell and Pasquale, 2005; Lippman and 
Dunaevsky, 2005; Matus, 2005). Therefore, potential neurotrypsin-dependent modifications 
of agrin’s function may lead to alterations in the synaptic circuitry. Interestingly, recent 
publications have further strengthened the evidence that the dynamic plasticity of dendritic 
spines is related to learning and memory processes (Holtmaat et al., 2005; Segal, 2005; 
Holtmaat et al., 2006; Knott et al., 2006) and aberrations in dendritic structure and dendritic 
spine morphology have been correlated with MR disorders (Newey et al., 2005). Furthermore, 
newly generated spines are mainly formed in close proximity to existing synapses (Toni et al., 
2007). The addition of C-terminal agrin as well as the overexpression of transmembrane agrin 
caused the development of filopodia-like protrusions on cultured myotubes (Uhm et al., 
2001), supporting the hypothesis that neurotrypsin activity may have a direct effect on agrin’s 
function. In contrast, the N-terminal region of agrin, corresponding to the N-terminal part up 
to the first neurotrypsin cleavage site, was shown to be sufficient for filopodia induction in 
cultured neurons (McCroskery et al., 2006). For this scenario, neurotrypsin-dependent 
cleavage might destabilise agrin’s N-terminal region, leading to a rapid degradation or 
internalisation, thus negatively affecting its role in filopodia generation. 
 
Figure 36. Model of the neuro-
trypsin-dependent cleavage of 
synaptic agrin. In the CNS, 
neurotrypsin (NT) is mainly loc-
alised to intracellular vesicles in 
presynaptic terminals. In con-
trast, synaptic agrin is mainly 
localised to extracellular peri-
synaptic sites. Upon synaptic 
activity, neurotrypsin is secreted 
from presynaptic terminals and 
cleaves synaptic agrin at two 
sites, generating the 90-kDa and 
the 22-kDa fragments. Cleavage 
of agrin may either disrupt its interaction with synaptic partners or enable the released C-terminal fragments to 
bind to their respective receptors. The region of agrin corresponding to the 90-kDa fragment was shown to 
interact specifically with α-dystroglycan, integrins and heparin (i.e., heparan sulphate proteoglycans, not 
depicted, but see Fig. 19A, (Burgess et al., 2002)) that are expressed by neurons or astroglia enclosing the 
synapse (Smalheiser and Collins, 2000; Winder, 2001; Zaccaria et al., 2001; Yamaguchi, 2002; Clegg et al., 
2003). Similarly, the 22-kDa agrin fragment was shown to bind to synaptic receptors. Recent evidence suggests 
that a C-terminal agrin fragment, closely resembling the 22-kDa fragment generated by neurotrypsin, specifically 
interacts with the α3-Na+/K+-ATPase (α3) at synapses, modifying its functional properties (see Discussion). This 
isoform of Na+/K+-ATPase was shown to localise to presynaptic sites as well as to the postsynaptic plasma 
membrane (Kim et al., 2007; Taguchi et al., 2007). Another well characterised receptor for the 22-kDa agrin 
fragment is the receptor tyrosine kinase MuSK (M). MuSK was recently shown to be expressed in the CNS and 
localised to CNS synapses (Ksiazek et al., 2007), however, its specific subcellular localisation is not known. 
According to its exclusive location in the postsynaptic membrane of the NMJ, we assigned MuSK to the 
postsynaptic membrane of CNS synapses. 
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To obtain first insights into the potential effects of neurotrypsin activity on agrin’s 
function to generate filopodia-like protrusions, I studied their interaction in transiently 
transfected cos7 cells. Here, similar to published effects in cultured neurons (McCroskery et 
al., 2006), I observed that transmembrane agrin but not secreted agrin was able to generate 
filopodia-like structures on cos7 cells. This effect appeared exclusively dependent on the N-
terminal half of agrin, as an excess of C-terminal agrin fragments in the culture medium of 
cells, co- expressing neurotrypsin and secreted agrin, did not yield any impact on the cell 
morphology. Yet both catalytically active and inactive variants of neurotrypsin inhibited 
transmembrane agrin’s function on cos7 cells, arguing for an effect independent of agrin 
cleavage. The clustering of transmembrane agrin molecules was suggested to be necessary for 
the development of agrin’s function (Annies et al., 2006). Uncontrolled ectopic expression of 
agrin in cultured cells has probably triggered automatic clustering of agrin, simply by 
overloading the cell-surface with continuously delivered agrin molecules. I have shown that 
neurotrypsin binds to agrin at the cell surface and it is therefore likely that neurotrypsin acted 
as a spacer between agrin molecules, thus preventing clustering of agrin molecules and 
inhibiting its function. Observations with cos7 cells, representing a non-polarised cell-type 
employed for an initial and quick readout of the neurotrypsin-agrin interaction, may however 
not directly relate to neuronal functions. Especially the neurotrypsin-agrin interaction, 
believed to occur at or near the synapse, will eventually have to be analysed directly in 
neurons. 
The temporal as well as spatial expression pattern of agrin and neurotrypsin in the 
CNS are closely related with peak expression during early postnatal development, a period 
known for extensive synapse generation and major remodelling of synaptic circuits by 
elimination of excessive or unfavourable connections (Hua and Smith, 2004). Furthermore, 
both neurotrypsin and agrin are also, but less abundantly, expressed in the adult mouse brain 
where distinct plasticity-related changes of the synaptic circuitry continue to occur 
(Chklovskii et al., 2004; Knott et al., 2006). Their distinct developmental regulated expression 
and the reported involvement of neurotrypsin and agrin in synaptic functions suggest that they 
play potential roles in synapse generation, synapse refinement and/or synapse elimination. 
 Neurotrypsin-dependent cleavage of agrin at the synapse may alter agrin’s synaptic 
functions, either by abolishing functions of full-length agrin residing at synapses or by 
activating regions of agrin from synapse-resident agrin. Thus, the release of active fragments 
could promote interactions with their respective receptors that were inaccessible for full-
length agrin. Further work will be required to elucidate the role of neurotrypsin-dependent 
cleavage on agrin’s synaptic functions and to determine whether cleavage by neurotrypsin 
induces, modifies, or terminates the activity of agrin at the synapse. 
4.4 Virus-mediated expression of neurotrypsin and agrin variants to further analyse 
parameters of their interaction in dissociated neuronal cultures.  
Dissociated hippocampal neuron cultures have proven to be a suitable in vitro system 
to analyse neuronal properties of neurotrypsin. Studies with ectopically expressed 
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neurotrypsin variants allowed the determination of its activity-dependent synaptic capture and 
synaptic externalisation (Frischknecht et al., 2008), a finding that is in accordance with its 
presynaptic localisation in vivo (Molinari et al., 2002; Stephan et al., 2008). Efficient ectopic 
expression of neurotrypsin in cultured neurons was achieved by adenovirus-mediated 
expression and I therefore generated additional agrin-expressing adenoviruses to complete the 
tools for further analyses of the neurotrypsin-agrin interaction. Ectopically expressed 
transmembrane agrin variants were efficiently targeted to axons as well as dendrites, similar 
to endogenously expressed agrin variants in neuronal cultures ((Escher et al., 1996; Neuhuber 
and Daniels, 2003); section 3.2.1). Furthermore, the ubiquitous distribution along neuronal 
surfaces in culture is in line with agrin’s expression pattern in vivo (Halfter et al., 1997; 
Koulen et al., 1999; Ksiazek et al., 2007; Stephan et al., 2008), confirming that also the agrin 
variants are functionally ectopically expressed in cultured hippocampal neurons. It may 
therefore be concluded that this in vitro system meets the basic requirements for further 
functional studies of the neurotrypsin-agrin interaction. Preliminary experiments with cultured 
neurons co-expressing neurotrypsin and transmembrane agrin variants revealed that 
neurotrypsin cleaves agrin in cultured nerve cells. However, neurotrypsin expression led to 
the complete removal of agrin signals from cellular surfaces, contradicting the assumption of 
locally restricted synaptic cleavage which resulted from in vivo observations. This ubiquitous 
removal of agrin, however, may have been a result of the high expression levels of 
neurotrypsin detected in the analysed cells. Expression of the extracellular protease 
neurotrypsin in cos7 cells resulted in its effective secretion and deposition around cells. High 
neuronal expression of neurotrypsin may therefore have resulted in excessive extracellular 
deposition of neurotrypsin and, finally, in extrasynaptic digestion of agrin in neurons. In 
addition, intracellular interaction in early transport compartments, potentially caused by high 
expression levels and therefore overloading of the transport machinery, may also have led to 
ubiquitous agrin cleavage. Again, preliminary results obtained with cultured neurons 
expressing moderate levels of catalytically inactive neurotrypsin and transmembrane agrin 
suggested that neurotrypsin and transmembrane agrin are mainly transported in alternate 
transport compartments and argued for their mainly extracellular interaction. A precondition 
for detailed future analyses will therefore be to achieve moderate expression levels for both 
neurotrypsin and agrin proteins. Alternatively, synaptic interaction may also be studied at 
contact sites of individual neurons expressing agrin or neurotrypsin alone. In addition, 
studying the neurotrypsin-agrin system in live neurons will be an additional means to decipher 
details of their interaction. 
The co-expression of mRFP-tagged transmembrane agrin and eGFP-tagged 
neurotrypsin will allow their simultaneous detection in living neurons, thereby enabling the 
detection of dynamic parameters of their interaction. The application of either N-terminally or 
C-terminally mRFP-tagged agrin variants is believed to enable the tracking of both domains 
of agrin after neurotrypsin-dependent cleavage, potentially allowing a complete readout of 
neurotrypsin-dependent effects on agrin function or localisation. Finally, the supplementary 
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usage of uncleavable agrin variants as well as catalytically inactive variants of neurotrypsin 
will enable the verification of functional data.  
 
4.5 Conclusion:  
The severe mental retardation found in humans with a loss-of-function mutation in the 
neurotrypsin gene (Molinari et al., 2002) indicates neurotrypsin as an essential regulator of 
adaptive synaptic plasticity that is crucial for establishing and maintaining cognitive brain 
functions. I showed that neurotrypsin cleaves the proteoglycan agrin in the CNS, liberating a 
middle 90-kDa and a C-terminal 22-kDa fragment from the N-terminal moiety of agrin. 
Deciphering the regional and functional parameters of the interaction between neurotrypsin 
and agrin in the brain may thus lead us towards understanding neurotrypsin’s essential role in 
cognitive functions. In this line of thoughts, we recently demonstrated that synaptic 
neurotrypsin is contained in intracellular stores and that both recruitment of neurotrypsin to 
synapses and synaptic exocytosis of neurotrypsin are enhanced by neuronal activity 
(Frischknecht et al., 2008). In this study we also found that externalised neurotrypsin 
transiently lingers at the synapse, before it disappears by diffusion or degradation. In the 
current study I also presented evidence that neurotrypsin-dependent cleavage of agrin is 
focused at or in the vicinity of synapses, where it affects mainly the most heavily glycanated 
variants of synaptic agrin, which predominate at the synapse. Agrin is a key regulator of the 
maturation and the maintenance of the neuromuscular junction and recent evidence suggests 
that agrin may also play an important role in the formation and the maintenance of CNS 
synapses. The selective activity-dependent externalisation of neurotrypsin and its local 
cleavage of agrin at the synapse make neurotrypsin an ideal regulator of structural and 
functional reorganisations of the synaptic circuitry. However, further studies will be required 
to determine the direct functional implications of agrin’s synaptic cleavage by neurotrypsin. 
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